	Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Unnamed: 14
0	NM_007262.4(PARK7):c.[-24+75_-24+92dup;487G>A]	PARK7	E163K		Pathogenic(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000446717	1|1	8021910 - 8021911	1|1	7961850 - 7961851	446717	75266|22107	rs200968609|rs74315354	
1	NM_007375.3(TARDBP):c.-126G>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291727	1	11072687	1	11012630	291727	275977	rs886045030	
2	NM_007375.3(TARDBP):c.-117G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291729	1	11072696	1	11012639	291729	275982	rs886045031	
3	NM_007375.3(TARDBP):c.-110C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291730	1	11072703	1	11012646	291730	275839	rs577981181	
4	NM_007375.3(TARDBP):c.-77G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291731	1	11072736	1	11012679	291731	275812	rs886045032	
5	NM_007375.3(TARDBP):c.-42C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291732	1	11072771	1	11012714	291732	275983	rs886045033	
6	NM_007375.3(TARDBP):c.-12-10_-12-9del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291733	1	11073761 - 11073762	1	11013704 - 11013705	291733	275813	rs575825467	
7	NM_007375.3(TARDBP):c.111G>A (p.Gly37=)	TARDBP		TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10	Likely benign(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000537329	1	11073895	1	11013838	537329	514974	rs1553158651	
8	NM_007375.3(TARDBP):c.198T>C (p.Ala66=)	TARDBP		Amyotrophic lateral sclerosis type 10|Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign/Likely benign(Last reviewed: May 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291734	1	11073982	1	11013925	291734	275840	rs61730366	
9	NM_007375.3(TARDBP):c.238+9C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|not provided|Frontotemporal dementia	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291735	1	11074031	1	11013974	291735	275850	rs376560308	
10	NM_007375.3(TARDBP):c.239-15G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291736	1	11076886	1	11016829	291736	275814	rs200066188	
11	NM_007375.3(TARDBP):c.263C>T (p.Thr88Ile)	TARDBP	T88I	TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10	Uncertain significance(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000537328	1	11076925	1	11016868	537328	514976	rs1553159049	
12	NM_007375.3(TARDBP):c.269C>T (p.Ala90Val)	TARDBP	A90V	TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10	Uncertain significance(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000021481	1	11076931	1	11016874	21481	34333	rs80356715	
13	NM_007375.3(TARDBP):c.499A>G (p.Met167Val)	TARDBP	M167V	Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291737	1	11078886	1	11018829	291737	275988	rs886045035	
14	NM_007375.3(TARDBP):c.506A>G (p.Asp169Gly)	TARDBP	D169G	Amyotrophic lateral sclerosis type 10	Conflicting interpretations of pathogenicity(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000005233	1	11078893	1	11018836	5233	20272	rs80356717	
15	NM_007375.3(TARDBP):c.675A>G (p.Pro225=)	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|not provided|Frontotemporal dementia	Benign/Likely benign(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291738	1	11080617	1	11020560	291738	275815	rs61741294	
16	NM_007375.3(TARDBP):c.714+69dup	TARDBP		Amyotrophic lateral sclerosis type 10	Benign(Last reviewed: Jun 6, 2016)	criteria provided, single submitter	VCV000522225	1	11080723 - 11080724	1	11020666 - 11020667	522225	512791	rs143130606	
17	NM_007375.3(TARDBP):c.720G>A (p.Ala240=)	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|not provided|Frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: May 14, 2018)	criteria provided, conflicting interpretations	VCV000291739	1	11082186	1	11022129	291739	275851	rs765175133	
18	NM_007375.3(TARDBP):c.800A>G (p.Asn267Ser)	TARDBP	N267S	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000021482	1	11082266	1	11022209	21482	34334	rs80356718	
19	NM_007375.3(TARDBP):c.859G>A (p.Gly287Ser)	TARDBP	G287S	Motor neuron disease|not provided|Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2018)	criteria provided, conflicting interpretations	VCV000021483	1	11082325	1	11022268	21483	34335	rs80356719	
20	NM_007375.3(TARDBP):c.869G>C (p.Gly290Ala)	TARDBP	G290A	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: May 1, 2008)	no assertion criteria provided	VCV000005231	1	11082335	1	11022278	5231	20270	rs121908395	
21	NM_007375.3(TARDBP):c.881G>T (p.Gly294Val)	TARDBP	G294V	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 23, 2009)	no assertion criteria provided	VCV000021484	1	11082347	1	11022290	21484	34336	rs80356721	
22	NM_007375.3(TARDBP):c.881G>C (p.Gly294Ala)	TARDBP	G294A	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Oct 1, 2009)	no assertion criteria provided	VCV000005230	1	11082347	1	11022290	5230	20269	rs80356721	
23	NM_007375.3(TARDBP):c.883G>A (p.Gly295Ser)	TARDBP	G295S	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000021485	1	11082349	1	11022292	21485	34337	rs80356723	
24	NM_007375.3(TARDBP):c.892G>A (p.Gly298Ser)	TARDBP	G298S	not provided|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000005232	1	11082358	1	11022301	5232	20271	rs4884357	
25	NM_007375.3(TARDBP):c.925G>A (p.Gly309Ser)	TARDBP	G309S	Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000580997	1	11082391	1	11022334	580997	556548	rs1419402299	
26	NM_007375.3(TARDBP):c.931A>G (p.Met311Val)	TARDBP	M311V	TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000021487	1	11082397	1	11022340	21487	34339	rs80356725	
27	NM_007375.3(TARDBP):c.943G>A (p.Ala315Thr)	TARDBP	A315T	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000005236	1	11082409	1	11022352	5236	20275	rs80356726	
28	NM_007375.3(TARDBP):c.991C>A (p.Gln331Lys)	TARDBP	Q331K	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 21, 2008)	no assertion criteria provided	VCV000005229	1	11082457	1	11022400	5229	20268	rs80356727	
29	NM_007375.3(TARDBP):c.1009A>G (p.Met337Val)	TARDBP	M337V	TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 26, 2018)	criteria provided, single submitter	VCV000005228	1	11082475	1	11022418	5228	20267	rs80356730	
30	NM_007375.3(TARDBP):c.1028A>G (p.Gln343Arg)	TARDBP	Q343R	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 1, 2008)	no assertion criteria provided	VCV000005235	1	11082494	1	11022437	5235	20274	rs80356731	
31	NM_007375.3(TARDBP):c.1035C>A (p.Asn345Lys)	TARDBP	N345K	TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000021467	1	11082501	1	11022444	21467	34319	rs80356732	
32	NM_007375.3(TARDBP):c.1042G>T (p.Gly348Cys)	TARDBP	G348C	Amyotrophic lateral sclerosis type 10|not provided	Pathogenic(Last reviewed: May 19, 2016)	criteria provided, single submitter	VCV000005234	1	11082508	1	11022451	5234	20273	rs80356733	
33	NM_007375.3(TARDBP):c.1055A>G (p.Asn352Ser)	TARDBP	N352S	not provided|Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Feb 20, 2019)	criteria provided, single submitter	VCV000021468	1	11082521	1	11022464	21468	34320	rs80356734	
34	NM_007375.3(TARDBP):c.1098C>G (p.Ala366=)	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|not provided|Frontotemporal dementia|not specified	Benign/Likely benign(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000291740	1	11082564	1	11022507	291740	275852	rs148325203	
35	NM_007375.3(TARDBP):c.1108_1122dup (p.Gly370_Tyr374dup)	TARDBP		Amyotrophic lateral sclerosis type 10|TARDBP-related frontotemporal dementia	Uncertain significance(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000641575	1	11082572 - 11082573	1	11022515 - 11022516	641575	626571		
36	NM_007375.3(TARDBP):c.1121dup (p.Tyr374Ter)	TARDBP		Amyotrophic lateral sclerosis type 10	Uncertain significance(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000021471	1	11082586 - 11082587	1	11022529 - 11022530	21471	34323	rs80356737	
37	NM_007375.3(TARDBP):c.1144G>A (p.Ala382Thr)	TARDBP	A382T	not provided|Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED	Likely pathogenic(Last reviewed: Jun 22, 2016)	criteria provided, single submitter	VCV000021474	1	11082610	1	11022553	21474	34326	rs367543041	
38	NM_007375.3(TARDBP):c.1147A>G (p.Ile383Val)	TARDBP	I383V	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000021476	1	11082613	1	11022556	21476	34328	rs80356740	
39	NM_007375.3(TARDBP):c.1150G>C (p.Gly384Arg)	TARDBP	G384R	TARDBP-related frontotemporal dementia|Amyotrophic lateral sclerosis type 10|not provided|Amyotrophic lateral sclerosis type 10	Uncertain significance(Last reviewed: Jul 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000190399	1	11082616	1	11022559	190399	188225	rs797044594	
40	NM_007375.3(TARDBP):c.1153T>G (p.Trp385Gly)	TARDBP	W385G	Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Mar 12, 2015)	no assertion criteria provided	VCV000190400	1	11082619	1	11022562	190400	188226	rs797044595	
41	NM_007375.3(TARDBP):c.*83T>C	TARDBP		Amyotrophic lateral sclerosis type 10	Pathogenic(Last reviewed: Apr 23, 2009)	no assertion criteria provided	VCV000021465	1	11082794	1	11022737	21465	34317	rs80356744	
42	NM_007375.3(TARDBP):c.*129T>C	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291741	1	11082840	1	11022783	291741	276082	rs886045036	
43	NM_007375.3(TARDBP):c.*159A>C	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291742	1	11082870	1	11022813	291742	275989	rs886045037	
44	NM_007375.3(TARDBP):c.*208G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291743	1	11082919	1	11022862	291743	275853	rs148414479	
45	NM_007375.3(TARDBP):c.*214T>C	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291744	1	11082925	1	11022868	291744	275816	rs557787340	
46	NM_007375.3(TARDBP):c.*505del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291745	1	11083213	1	11023156	291745	275994	rs886045038	
47	NM_007375.3(TARDBP):c.*666G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291746	1	11083377	1	11023320	291746	275995	rs778834503	
48	NM_007375.3(TARDBP):c.*697G>A	TARDBP		Amyotrophic lateral sclerosis type 10|FRONTOTEMPORAL DEMENTIA WITH TDP43 INCLUSIONS, TARDBP-RELATED	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000005239	1	11083408	1	11023351	5239	20278	rs387906334	
49	NM_007375.3(TARDBP):c.*842G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291747	1	11083553	1	11023496	291747	275996	rs886045039	
50	NM_007375.3(TARDBP):c.*862G>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291748	1	11083573	1	11023516	291748	275855	rs886045040	
51	NM_007375.3(TARDBP):c.*963C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291749	1	11083674	1	11023617	291749	275856	rs751628760	
52	NM_007375.3(TARDBP):c.*1008T>G	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291750	1	11083719	1	11023662	291750	275998	rs141412238	
53	NM_007375.3(TARDBP):c.*1081C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291751	1	11083792	1	11023735	291751	276021	rs184303021	
54	NM_007375.3(TARDBP):c.*1084A>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291752	1	11083795	1	11023738	291752	276022	rs886045041	
55	NM_007375.3(TARDBP):c.*1597_*1600del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291753	1	11084306 - 11084309	1	11024249 - 11024252	291753	275859	rs748047297	
56	NM_007375.3(TARDBP):c.*1622A>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291754	1	11084333	1	11024276	291754	275860	rs551513393	
57	NM_007375.3(TARDBP):c.*1623T>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291756	1	11084334	1	11024277	291756	276025	rs566657331	
58	NM_007375.3(TARDBP):c.*1633del	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291755	1	11084334	1	11024277	291755	275867	rs886045043	
59	NM_007375.3(TARDBP):c.*1795A>G	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291757	1	11084506	1	11024449	291757	275817	rs886045044	
60	NM_007375.3(TARDBP):c.*2005T>C	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291758	1	11084716	1	11024659	291758	276105	rs886045045	
61	NM_007375.3(TARDBP):c.*2029C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291759	1	11084740	1	11024683	291759	275868	rs886045046	
62	NM_007375.3(TARDBP):c.*2046T>G	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291760	1	11084757	1	11024700	291760	276026	rs886045047	
63	NM_007375.3(TARDBP):c.*2154G>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291761	1	11084865	1	11024808	291761	276108	rs886045048	
64	NM_007375.3(TARDBP):c.*2252A>G	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291762	1	11084963	1	11024906	291762	275872	rs552057039	
65	NM_007375.3(TARDBP):c.*2294_*2295insGTTTT	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia|MASP2 deficiency	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291763	1	11085004 - 11085005	1	11024947 - 11024948	291763	276114	rs3059695	
66	NM_007375.3(TARDBP):c.*2331A>G	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|MASP2 deficiency|Frontotemporal dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291764	1	11085042	1	11024985	291764	275874	rs114897688	
67	NM_007375.3(TARDBP):c.*2334G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291765	1	11085045	1	11024988	291765	276127	rs182302907	
68	NM_007375.3(TARDBP):c.*2360C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291766	1	11085071	1	11025014	291766	276128	rs886045049	
69	NM_007375.3(TARDBP):c.*2538del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291767	1	11085248	1	11025191	291767	275875	rs886045050	
70	NM_007375.3(TARDBP):c.*2740G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291768	1	11085451	1	11025394	291768	276138	rs566658679	
71	NM_007375.3(TARDBP):c.*2750G>A	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291769	1	11085461	1	11025404	291769	275827	rs779882516	
72	NM_007375.3(TARDBP):c.*2773A>G	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291770	1	11085484	1	11025427	291770	276140	rs187380325	
73	NM_007375.3(TARDBP):c.*2829dup	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291771	1	11085531 - 11085532	1	11025474 - 11025475	291771	275835	rs886045051	
74	NM_006610.4(MASP2):c.*225T>C	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|MASP2 deficiency|Frontotemporal dementia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291772	1	11086717	1	11026660	291772	275885	rs1033638	
75	NM_006610.4(MASP2):c.*184C>T	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368798	1	11086758	1	11026701	368798	353027	rs115750484	
76	NM_006610.4(MASP2):c.1617T>C (p.Asn539=)	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|not provided|MASP2 deficiency|Frontotemporal dementia	Benign/Likely benign(Last reviewed: Aug 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000291779	1	11087386	1	11027329	291779	275924	rs72550845	
77	NM_006610.4(MASP2):c.1479C>T (p.Ser493=)	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|not specified|Frontotemporal dementia|MASP2 deficiency	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000291781	1	11087524	1	11027467	291781	275846	rs1782455	
78	NM_031844.3(HNRNPU):c.1259C>T (p.Ser420Leu)	HNRNPU	S420L, S401L	heterogeneous nuclear ribonucleoprotein G, human|not provided	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578810	1	245021548	1	244858246	578810	558459	rs778010676	
79	NM_022173.4(TIA1):c.1078G>A (p.Val360Met)	TIA1	V312M, V351M, V360M, V259M, V284M, V323M, V348M, V349M, V220M, V359M, V219M, V314M	Welander distal myopathy	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000651295	2	70439934	2	70212802	651295	630413		
80	NM_022173.4(TIA1):c.880G>A (p.Val294Met)	TIA1	V294M, V154M, V193M, V218M, V257M, V248M, V283M, V285M, V246M	Welander distal myopathy	Uncertain significance(Last reviewed: Apr 27, 2018)	criteria provided, single submitter	VCV000575375	2	70442511	2	70215379	575375	560898	rs144296151	
81	NM_004082.4(DCTN1):c.3824G>A (p.Arg1275His)	DCTN1	R1233H, R1275H, R1141H, R1250H, R1268H, R1136H	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000570076	2	74588639	2	74361512	570076	562030	rs560344779	
82	NM_004082.4(DCTN1):c.3803A>G (p.Gln1268Arg)	DCTN1	Q1268R, Q1134R, Q1226R, Q1261R, Q1129R, Q1243R	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Oct 2, 2017)	criteria provided, single submitter	VCV000536155	2	74588660	2	74361533	536155	518600	rs751431467	
83	NM_004082.4(DCTN1):c.3781C>T (p.Arg1261Trp)	DCTN1	R1122W, R1127W, R1236W, R1254W, R1261W, R1219W	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Aug 23, 2018)	criteria provided, single submitter	VCV000640228	2	74588682	2	74361555	640228	630524		
84	NM_004082.4(DCTN1):c.3778C>T (p.His1260Tyr)	DCTN1	H1126Y, H1260Y, H1218Y, H1253Y, H1121Y, H1235Y	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000582305	2	74588685	2	74361558	582305	560968	rs1375787578	
85	NM_004082.4(DCTN1):c.3776G>A (p.Arg1259Gln)	DCTN1	R1217Q, R1259Q, R1120Q, R1234Q, R1125Q, R1252Q	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000643909	2	74588687	2	74361560	643909	630525		
86	NM_004082.4(DCTN1):c.3760G>T (p.Ala1254Ser)	DCTN1	A1229S, A1115S, A1254S, A1120S, A1212S, A1247S	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000640080	2	74588703	2	74361576	640080	630526		
87	NM_004082.4(DCTN1):c.3759G>A (p.Ala1253=)	DCTN1		Distal hereditary motor neuronopathy|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Perry syndrome	Uncertain significance(Last reviewed: Mar 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337068	2	74588704	2	74361577	337068	290566	rs886056328	
88	NM_004082.4(DCTN1):c.3746C>T (p.Thr1249Ile)	DCTN1	T1249I, T1207I, T1115I, T1224I, T1242I, T1110I	not specified|not provided|Amyotrophic lateral sclerosis type 1|Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008402	2	74588717	2	74361590	8402	23441	rs72466496	
89	NM_004082.4(DCTN1):c.3728T>C (p.Val1243Ala)	DCTN1	V1109A, V1243A, V1201A, V1236A, V1104A, V1218A	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000665455	2	74588735	2	74361608	665455	630527		
90	NM_004082.4(DCTN1):c.3712C>G (p.Gln1238Glu)	DCTN1	Q1231E, Q1099E, Q1196E, Q1104E, Q1213E, Q1238E	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jul 31, 2018)	criteria provided, single submitter	VCV000654711	2	74588751	2	74361624	654711	630528		
91	NM_004082.4(DCTN1):c.3652A>G (p.Thr1218Ala)	DCTN1	T1176A, T1084A, T1218A, T1079A, T1211A, T1193A	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Nov 7, 2017)	criteria provided, single submitter	VCV000536146	2	74589226	2	74362099	536146	518602	rs886070472	
92	NM_004082.4(DCTN1):c.3643C>T (p.Pro1215Ser)	DCTN1	P1076S, P1173S, P1208S, P1190S, P1215S, P1081S	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000657312	2	74589235	2	74362108	657312	630529		
93	NM_004082.4(DCTN1):c.3597C>T (p.Val1199=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Jan 5, 2018)	criteria provided, single submitter	VCV000536167	2	74589789	2	74362662	536167	518669	rs767954436	
94	NM_004082.4(DCTN1):c.3557T>C (p.Met1186Thr)	DCTN1	M1052T, M1144T, M1186T, M1161T, M1047T, M1179T	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000572789	2	74589829	2	74362702	572789	558287	rs145819459	
95	NM_004082.4(DCTN1):c.3556A>G (p.Met1186Val)	DCTN1	M1052V, M1144V, M1186V, M1161V, M1047V, M1179V	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Feb 16, 2018)	criteria provided, single submitter	VCV000570153	2	74589830	2	74362703	570153	562041	rs1477782343	
96	NM_004082.4(DCTN1):c.3545C>T (p.Ser1182Leu)	DCTN1	S1157L, S1182L, S1048L, S1140L, S1175L, S1043L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000661256	2	74589841	2	74362714	661256	630530		
97	NM_004082.4(DCTN1):c.3533C>T (p.Ala1178Val)	DCTN1	A1044V, A1136V, A1178V, A1171V, A1039V, A1153V	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000468274	2	74589853	2	74362726	468274	451879	rs775442446	
98	NM_004082.4(DCTN1):c.3449G>A (p.Arg1150His)	DCTN1	R1016H, R1108H, R1150H, R1143H, R1011H, R1125H	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000536158	2	74590201	2	74363074	536158	518601	rs771822061	
99	NM_004082.4(DCTN1):c.3425A>G (p.Glu1142Gly)	DCTN1	E1100G, E1135G, E1003G, E1117G, E1142G, E1008G	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Sep 6, 2018)	criteria provided, single submitter	VCV000657154	2	74590225	2	74363098	657154	630531		
100	NM_004082.4(DCTN1):c.3382C>G (p.Pro1128Ala)	DCTN1	P1086A, P1103A, P1121A, P1128A, P989A, P994A	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000649963	2	74590268	2	74363141	649963	630532		
101	NM_004082.4(DCTN1):c.3312C>T (p.Ile1104=)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Likely benign(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000468272	2	74590454	2	74363327	468272	451884	rs777452161	
102	NM_004082.4(DCTN1):c.3302G>A (p.Arg1101Lys)	DCTN1	R1101K, R1059K, R967K, R1076K, R1094K, R962K	Amyotrophic lateral sclerosis, susceptibility to	risk factor(Last reviewed: Nov 1, 2005)	no assertion criteria provided	VCV000008405	2	74590464	2	74363337	8405	23444	rs121909345	
103	NM_004082.4(DCTN1):c.3254G>A (p.Gly1085Glu)	DCTN1	G1043E, G1085E, G951E, G946E, G1060E, G1078E	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000536151	2	74590512	2	74363385	536151	518603	rs1274754432	
104	NM_004082.4(DCTN1):c.3241G>A (p.Val1081Met)	DCTN1	V1081M, V947M, V1039M, V1074M, V1056M, V942M	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000536154	2	74590525	2	74363398	536154	518604	rs764028925	
105	NM_004082.4(DCTN1):c.3217A>G (p.Ile1073Val)	DCTN1	I1048V, I1066V, I939V, I1073V, I934V, I1031V	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000656139	2	74590549	2	74363422	656139	630533		
106	NM_004082.4(DCTN1):c.3215C>G (p.Ala1072Gly)	DCTN1	A1030G, A1072G, A938G, A1047G, A933G, A1065G	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000574007	2	74590551	2	74363424	574007	562042	rs780875333	
107	NM_004082.4(DCTN1):c.3199G>T (p.Glu1067Ter)	DCTN1	E1067*, E933*, E1060*	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000536149	2	74590753	2	74363626	536149	518609	rs376996779	
108	NM_004082.4(DCTN1):c.3172A>T (p.Thr1058Ser)	DCTN1	T924S, T1021S, T1038S, T1051S, T1058S	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000654545	2	74592226	2	74365099	654545	630534		
109	NM_004082.4(DCTN1):c.3158C>T (p.Pro1053Leu)	DCTN1	P1033L, P1046L, P1053L, P919L, P1016L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000655129	2	74592240	2	74365113	655129	630535		
110	NM_004082.4(DCTN1):c.3137A>G (p.Glu1046Gly)	DCTN1	E1046G, E912G, E1009G, E1039G, E1026G	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000468271	2	74592261	2	74365134	468271	451886	rs145857843	
111	NM_004082.4(DCTN1):c.3132G>C (p.Thr1044=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000536173	2	74592266	2	74365139	536173	518779	rs375157202	
112	NM_004082.4(DCTN1):c.3128G>A (p.Arg1043His)	DCTN1	R1006H, R1043H, R909H, R1023H, R1036H	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome|not provided	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000425206	2	74592270	2	74365143	425206	413540	rs776489779	
113	NM_004082.4(DCTN1):c.3127C>T (p.Arg1043Cys)	DCTN1	R1043C, R909C, R1006C, R1023C, R1036C	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Oct 16, 2018)	criteria provided, single submitter	VCV000536153	2	74592271	2	74365144	536153	518786	rs140066692	
114	NM_004082.4(DCTN1):c.3069C>T (p.Ile1023=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000536183	2	74592329	2	74365202	536183	518672	rs780292959	
115	NM_004082.4(DCTN1):c.3029+6G>T	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Mar 23, 2018)	criteria provided, single submitter	VCV000574930	2	74592636	2	74365509	574930	560970	rs754143116	
116	NM_004082.4(DCTN1):c.3017G>A (p.Arg1006Gln)	DCTN1	R872Q, R1006Q, R969Q, R986Q, R999Q	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Sep 22, 2017)	criteria provided, single submitter	VCV000536147	2	74592654	2	74365527	536147	518607	rs752882353	
117	NM_004082.4(DCTN1):c.2986A>G (p.Thr996Ala)	DCTN1	T862A, T996A, T959A, T976A, T989A	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000582031	2	74592685	2	74365558	582031	562043	rs1558935430	
118	NM_004082.4(DCTN1):c.2974G>A (p.Glu992Lys)	DCTN1	E955K, E992K, E858K, E972K, E985K	Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000579633	2	74592697	2	74365570	579633	558662	rs768409522	
119	NM_004082.4(DCTN1):c.2952C>G (p.Ala984=)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Likely benign(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000468269	2	74592719	2	74365592	468269	451804	rs371241720	
120	NM_004082.4(DCTN1):c.2909A>G (p.Asn970Ser)	DCTN1	N933S, N836S, N970S, N963S, N950S	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Feb 19, 2018)	criteria provided, single submitter	VCV000566389	2	74592762	2	74365635	566389	562055	rs568812456	
121	NM_004082.4(DCTN1):c.2883T>G (p.Ile961Met)	DCTN1	I961M, I941M, I954M, I827M, I924M	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000662814	2	74593023	2	74365896	662814	630536		
122	NM_004082.4(DCTN1):c.2879A>G (p.Lys960Arg)	DCTN1	K940R, K953R, K826R, K923R, K960R	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Aug 24, 2018)	criteria provided, single submitter	VCV000647047	2	74593027	2	74365900	647047	630537		
123	NM_004082.4(DCTN1):c.2872T>G (p.Ser958Ala)	DCTN1	S824A, S951A, S958A, S921A, S938A	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jul 18, 2018)	criteria provided, single submitter	VCV000655677	2	74593034	2	74365907	655677	630538		
124	NM_004082.4(DCTN1):c.2836G>A (p.Glu946Lys)	DCTN1	E939K, E946K, E812K, E909K, E926K	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000646084	2	74593070	2	74365943	646084	630539		
125	NM_004082.4(DCTN1):c.2779C>T (p.Arg927Trp)	DCTN1	R927W, R907W, R920W, R793W, R890W	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000650325	2	74593127	2	74366000	650325	630540		
126	NM_004082.4(DCTN1):c.2747G>A (p.Arg916Gln)	DCTN1	R916Q, R879Q, R782Q, R909Q, R896Q	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, single submitter	VCV000571353	2	74593384	2	74366257	571353	558664	rs375079576	
127	NM_004082.4(DCTN1):c.2731dup (p.Glu911fs)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000650790	2	74593399 - 74593400	2	74366272 - 74366273	650790	630541		
128	NM_004082.4(DCTN1):c.2647A>T (p.Ser883Cys)	DCTN1	S749C, S846C, S883C, S863C, S876C	Perry syndrome|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|not provided	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000422499	2	74593484	2	74366357	422499	406038	rs747769504	
129	NM_004082.4(DCTN1):c.2633A>G (p.Tyr878Cys)	DCTN1	Y878C, Y841C, Y744C, Y871C, Y858C	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000568956	2	74593498	2	74366371	568956	560972	rs778201974	
130	NM_004082.4(DCTN1):c.2629-7C>A	DCTN1		Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000576507	2	74593509	2	74366382	576507	558666	rs1278207608	
131	NM_004082.4(DCTN1):c.2551C>G (p.Leu851Val)	DCTN1	L814V, L831V, L717V, L844V, L851V	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000654179	2	74593663	2	74366536	654179	630542		
132	NM_004082.4(DCTN1):c.2544T>C (p.Ala848=)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Likely benign(Last reviewed: Mar 7, 2017)	criteria provided, single submitter	VCV000468266	2	74593670	2	74366543	468266	451808	rs1371265373	
133	NM_004082.4(DCTN1):c.2540C>G (p.Ala847Gly)	DCTN1	A840G, A713G, A810G, A827G, A847G	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801726	2	74593674	2	74366547	801726	790296		
134	NM_004082.4(DCTN1):c.2480T>C (p.Leu827Pro)	DCTN1	L827P, L693P, L790P, L820P, L807P	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000536145	2	74593734	2	74366607	536145	518611	rs1470946965	
135	NM_004082.4(DCTN1):c.2477C>T (p.Thr826Met)	DCTN1	T692M, T789M, T826M, T819M, T806M	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000536148	2	74593737	2	74366610	536148	518624	rs766585070	
136	NM_004082.4(DCTN1):c.2467G>A (p.Val823Ile)	DCTN1	V786I, V816I, V823I, V689I, V803I	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000652089	2	74593747	2	74366620	652089	630543		
137	NM_004082.4(DCTN1):c.2448A>G (p.Ala816=)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Distal hereditary motor neuronopathy|not specified|Perry syndrome	Benign/Likely benign(Last reviewed: Jul 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000259235	2	74593928	2	74366801	259235	250805	rs1130484	
138	NM_004082.4(DCTN1):c.2427T>G (p.Asp809Glu)	DCTN1	D802E, D675E, D772E, D789E, D809E	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000649696	2	74593949	2	74366822	649696	630544		
139	NM_004082.4(DCTN1):c.2411G>A (p.Arg804Gln)	DCTN1	R804Q, R670Q, R767Q, R784Q, R797Q	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000645944	2	74593965	2	74366838	645944	630545		
140	NM_004082.4(DCTN1):c.2384G>A (p.Arg795His)	DCTN1	R758H, R775H, R795H, R661H, R788H	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000652631	2	74593992	2	74366865	652631	630546		
141	NM_004082.4(DCTN1):c.2357A>G (p.Asp786Gly)	DCTN1	D652G, D749G, D786G, D766G, D779G	Perry syndrome|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|not provided	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000493281	2	74594019	2	74366892	493281	486244	rs752889408	
142	NM_004082.4(DCTN1):c.2353C>T (p.Arg785Trp)	DCTN1	R785W, R651W, R748W, R778W, R765W	Charcot-Marie-Tooth disease|Amyotrophic lateral sclerosis, susceptibility to|Perry syndrome|Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000008404	2	74594023	2	74366896	8404	23443	rs121909344	
143	NM_004082.4(DCTN1):c.2339T>C (p.Ile780Thr)	DCTN1	I646T, I780T, I743T, I773T, I760T	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|not provided	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468264	2	74594037	2	74366910	468264	451441	rs374163967	
144	NM_004082.4(DCTN1):c.2290G>A (p.Val764Ile)	DCTN1	V764I, V630I, V727I, V744I, V757I	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000565854	2	74594198	2	74367071	565854	558289	rs753618444	
145	NM_004082.4(DCTN1):c.2278A>G (p.Met760Val)	DCTN1	M626V, M760V, M723V, M753V, M740V	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy|not specified|not provided|Perry syndrome	Conflicting interpretations of pathogenicity(Last reviewed: Sep 4, 2018)	criteria provided, conflicting interpretations	VCV000337081	2	74594210	2	74367083	337081	290865	rs754780894	
146	NM_004082.4(DCTN1):c.2254-5C>T	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Likely benign(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000468263	2	74594239	2	74367112	468263	451810	rs746514094	
147	NM_004082.4(DCTN1):c.2254-10A>G	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000468262	2	74594244	2	74367117	468262	451443	rs954787850	
148	NM_004082.4(DCTN1):c.2238G>A (p.Leu746=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000536177	2	74594494	2	74367367	536177	518625	rs1553464441	
149	NM_004082.4(DCTN1):c.2217T>G (p.Pro739=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000536168	2	74594515	2	74367388	536168	518627	rs1553464448	
150	NM_004082.4(DCTN1):c.2209G>A (p.Glu737Lys)	DCTN1	E737K, E603K, E700K, E730K, E717K	Perry syndrome|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|not provided	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000194953	2	74594523	2	74367396	194953	192115	rs377183051	
151	NM_004082.4(DCTN1):c.2205T>G (p.Leu735=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Nov 1, 2017)	criteria provided, single submitter	VCV000536172	2	74594527	2	74367400	536172	518678	rs773099597	
152	NM_004082.4(DCTN1):c.2083C>T (p.His695Tyr)	DCTN1	H688Y, H695Y, H675Y, H561Y, H658Y	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000661544	2	74594924	2	74367797	661544	630547		
153	NM_004082.4(DCTN1):c.2016-6C>A	DCTN1		Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000656503	2	74594997	2	74367870	656503	651092		
154	NM_004082.4(DCTN1):c.2006G>A (p.Arg669His)	DCTN1	R535H, R632H, R649H, R662H, R669H	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000644992	2	74595107	2	74367980	644992	630548		
155	NM_004082.4(DCTN1):c.2005C>T (p.Arg669Cys)	DCTN1	R535C, R632C, R669C, R649C, R662C	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000536162	2	74595108	2	74367981	536162	518614	rs150746209	
156	NM_004082.4(DCTN1):c.2002C>T (p.His668Tyr)	DCTN1	H631Y, H534Y, H668Y, H661Y, H648Y	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Distal hereditary motor neuronopathy|Perry syndrome	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337085	2	74595111	2	74367984	337085	288004	rs764443534	
157	NM_004082.4(DCTN1):c.1997C>T (p.Thr666Met)	DCTN1	T666M, T532M, T629M, T646M, T659M	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000567916	2	74595116	2	74367989	567916	558668	rs143914684	
158	NM_004082.4(DCTN1):c.1936G>T (p.Ala646Ser)	DCTN1	A609S, A646S, A626S, A512S, A639S	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000653832	2	74595177	2	74368050	653832	630549		
159	NM_004082.4(DCTN1):c.1928G>A (p.Arg643Gln)	DCTN1	R509Q, R606Q, R643Q, R623Q, R636Q	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Dec 16, 2016)	criteria provided, single submitter	VCV000468260	2	74595185	2	74368058	468260	451812	rs555733849	
160	NM_004082.4(DCTN1):c.1816G>A (p.Val606Ile)	DCTN1	V569I, V472I, V606I, V586I, V599I	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000468259	2	74595893	2	74368766	468259	451449	rs375778151	
161	NM_004082.4(DCTN1):c.1807C>A (p.His603Asn)	DCTN1	H603N, H566N, H469N, H583N, H596N	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: May 4, 2018)	criteria provided, single submitter	VCV000578054	2	74595902	2	74368775	578054	558670	rs1558939544	
162	NM_004082.4(DCTN1):c.1793G>A (p.Arg598Gln)	DCTN1	R578Q, R591Q, R464Q, R598Q, R561Q	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000641474	2	74595916	2	74368789	641474	630550		
163	NM_004082.4(DCTN1):c.1784G>A (p.Ser595Asn)	DCTN1	S461N, S595N, S558N, S588N, S575N	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000536157	2	74595925	2	74368798	536157	518684	rs1243051229	
164	NM_004082.4(DCTN1):c.1780G>C (p.Asp594His)	DCTN1	D574H, D587H, D460H, D557H, D594H	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000648184	2	74595929	2	74368802	648184	630551		
165	NM_004082.4(DCTN1):c.1752C>A (p.His584Gln)	DCTN1	H450Q, H584Q, H547Q, H577Q, H564Q	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000536159	2	74595957	2	74368830	536159	518629	rs1345909454	
166	NM_004082.4(DCTN1):c.1712T>C (p.Met571Thr)	DCTN1	M571T, M437T, M534T, M564T, M551T	Amyotrophic lateral sclerosis, susceptibility to	risk factor(Last reviewed: Aug 24, 2004)	no assertion criteria provided	VCV000008403	2	74595997	2	74368870	8403	23442	rs121909343	
167	NM_004082.4(DCTN1):c.1706T>A (p.Ile569Asn)	DCTN1	I435N, I532N, I569N, I549N, I562N	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000536156	2	74596003	2	74368876	536156	518626	rs1553464828	
168	NM_004082.4(DCTN1):c.1606A>C (p.Asn536His)	DCTN1	N402H, N499H, N536H, N529H, N516H	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Mar 22, 2017)	criteria provided, single submitter	VCV000468258	2	74596320	2	74369193	468258	451452	rs1553464927	
169	NM_004082.4(DCTN1):c.1605A>G (p.Thr535=)	DCTN1		Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B|Distal hereditary motor neuronopathy|not specified|Perry syndrome	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259233	2	74596321	2	74369194	259233	250807	rs13429423	
170	NM_004082.4(DCTN1):c.1595G>A (p.Arg532Gln)	DCTN1	R398Q, R532Q, R495Q, R512Q, R525Q	Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, single submitter	VCV000579780	2	74596331	2	74369204	579780	562060	rs759306485	
171	NM_004082.4(DCTN1):c.1584+5A>G	DCTN1		Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000658060	2	74596422	2	74369295	658060	651093		
172	NM_004082.4(DCTN1):c.1526C>T (p.Thr509Met)	DCTN1	T489M, T509M, T375M, T472M, T502M	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000660668	2	74596485	2	74369358	660668	630552		
173	NM_004082.4(DCTN1):c.1486G>C (p.Val496Leu)	DCTN1	V476L, V489L, V362L, V496L, V459L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000649404	2	74596525	2	74369398	649404	630553		
174	NM_004082.4(DCTN1):c.1484G>A (p.Arg495Gln)	DCTN1	R361Q, R458Q, R495Q, R475Q, R488Q	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Perry syndrome|Distal hereditary motor neuronopathy|not specified	Benign/Likely benign(Last reviewed: Jul 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000259232	2	74596527	2	74369400	259232	250808	rs17721059	
175	NM_004082.4(DCTN1):c.1481C>T (p.Ala494Val)	DCTN1	A360V, A457V, A474V, A494V, A487V	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Aug 17, 2018)	criteria provided, single submitter	VCV000644603	2	74596530	2	74369403	644603	630554		
176	NM_004082.4(DCTN1):c.1435C>T (p.Arg479Cys)	DCTN1	R345C, R479C, R442C, R459C, R472C	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Jan 12, 2018)	criteria provided, single submitter	VCV000580500	2	74596576	2	74369449	580500	558291	rs1558940606	
177	NM_004082.4(DCTN1):c.1430A>G (p.Asn477Ser)	DCTN1	N440S, N470S, N457S, N477S, N343S	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000640876	2	74596581	2	74369454	640876	630555		
178	NM_004082.4(DCTN1):c.1393-7G>A	DCTN1		Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000653139	2	74596625	2	74369498	653139	651009		
179	NM_004082.4(DCTN1):c.1388A>G (p.Asp463Gly)	DCTN1	D329G, D426G, D463G, D456G, D443G	Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000576002	2	74597096	2	74369969	576002	562063	rs1558941192	
180	NM_004082.4(DCTN1):c.1364G>A (p.Arg455His)	DCTN1	R455H, R418H, R321H, R448H, R435H	Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Feb 17, 2018)	criteria provided, single submitter	VCV000577645	2	74597120	2	74369993	577645	560977	rs763277715	
181	NM_004082.4(DCTN1):c.1324A>G (p.Met442Val)	DCTN1	M308V, M442V, M405V, M435V, M422V	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000468257	2	74597160	2	74370033	468257	451898	rs763480310	
182	NM_004082.4(DCTN1):c.1316T>C (p.Met439Thr)	DCTN1	M419T, M305T, M402T, M432T, M439T	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000657980	2	74597168	2	74370041	657980	630556		
183	NM_004082.4(DCTN1):c.1288-6A>G	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Oct 10, 2017)	criteria provided, single submitter	VCV000536164	2	74597202	2	74370075	536164	518632	rs1236101222	
184	NM_004082.4(DCTN1):c.1288-10C>G	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000662913	2	74597206	2	74370079	662913	650953		
185	NM_004082.4(DCTN1):c.1255G>A (p.Ala419Thr)	DCTN1	A419T, A382T, A285T, A399T, A412T	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Jul 25, 2018)	criteria provided, single submitter	VCV000536150	2	74597345	2	74370218	536150	518801	rs922032527	
186	NM_004082.4(DCTN1):c.1251C>T (p.Ser417=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000536176	2	74597349	2	74370222	536176	518803	rs1553465163	
187	NM_004082.4(DCTN1):c.1225C>T (p.Arg409Trp)	DCTN1	R409W, R275W, R372W, R389W, R402W	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000648503	2	74597375	2	74370248	648503	630557		
188	NM_004082.4(DCTN1):c.1217G>A (p.Arg406Lys)	DCTN1	R272K, R369K, R406K, R399K, R386K	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000536144	2	74597383	2	74370256	536144	518639	rs1040712616	
189	NM_004082.4(DCTN1):c.1129A>C (p.Met377Leu)	DCTN1	M243L, M340L, M377L, M370L, M357L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Distal hereditary motor neuronopathy|Perry syndrome	Uncertain significance(Last reviewed: Jun 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000337090	2	74597471	2	74370344	337090	288005	rs570863800	
190	NM_004082.4(DCTN1):c.1128-3C>G	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000654124	2	74597475	2	74370348	654124	651012		
191	NM_004082.4(DCTN1):c.1127+6G>A	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, single submitter	VCV000468255	2	74597587	2	74370460	468255	451818	rs951022782	
192	NM_004082.4(DCTN1):c.1102G>A (p.Ala368Thr)	DCTN1	A368T, A234T, A331T, A348T, A361T	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000536152	2	74597618	2	74370491	536152	518691	rs1034996844	
193	NM_004082.4(DCTN1):c.859C>A (p.Leu287Met)	DCTN1	L153M, L250M, L287M, L267M, L280M	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B|Distal hereditary motor neuronopathy|not specified|Perry syndrome	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259241	2	74597937	2	74370810	259241	250810	rs13420401	
194	NM_004082.4(DCTN1):c.851A>G (p.Lys284Arg)	DCTN1	K284R, K150R, K247R, K264R, K277R	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000639176	2	74597945	2	74370818	639176	630558		
195	NM_004082.4(DCTN1):c.843+5G>T	DCTN1		Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B|not specified	Uncertain significance(Last reviewed: May 27, 2017)	criteria provided, multiple submitters, no conflicts	VCV000447240	2	74598101	2	74370974	447240	440732	rs757238618	
196	NM_004082.4(DCTN1):c.833A>T (p.Glu278Val)	DCTN1	E241V, E278V, E144V, E258V, E271V	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Apr 5, 2017)	criteria provided, single submitter	VCV000468280	2	74598116	2	74370989	468280	451820	rs1553465344	
197	NM_004082.4(DCTN1):c.824G>A (p.Arg275His)	DCTN1	R141H, R238H, R275H, R255H, R268H	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|not provided	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000393157	2	74598125	2	74370998	393157	366791	rs375266113	
198	NM_004082.4(DCTN1):c.823C>T (p.Arg275Cys)	DCTN1	R141C, R275C, R238C, R255C, R268C	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: May 14, 2018)	criteria provided, single submitter	VCV000567626	2	74598126	2	74370999	567626	558672	rs775294408	
199	NM_004082.4(DCTN1):c.821G>A (p.Arg274Gln)	DCTN1	R274Q, R267Q, R140Q, R237Q, R254Q	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000641187	2	74598128	2	74371001	641187	630559		
200	NM_004082.4(DCTN1):c.759C>T (p.Ile253=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000536180	2	74598190	2	74371063	536180	518809	rs1553465355	
201	NM_004082.4(DCTN1):c.742C>G (p.Leu248Val)	DCTN1	L211V, L228V, L241V, L248V, L114V	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000662640	2	74598207	2	74371080	662640	630560		
202	NM_004082.4(DCTN1):c.694G>C (p.Glu232Gln)	DCTN1	E232Q, E98Q, E195Q, E212Q, E225Q	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000645250	2	74598255	2	74371128	645250	630561		
203	NM_004082.4(DCTN1):c.673C>T (p.Arg225Trp)	DCTN1	R188W, R225W, R91W, R205W, R218W	not provided|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Mar 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000453052	2	74598276	2	74371149	453052	443314	rs371723224	
204	NM_004082.4(DCTN1):c.654G>A (p.Glu218=)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Likely benign(Last reviewed: Jan 13, 2017)	criteria provided, single submitter	VCV000468277	2	74598295	2	74371168	468277	451695	rs758731839	
205	NM_004082.4(DCTN1):c.638C>T (p.Pro213Leu)	DCTN1	P176L, P213L, P79L, P193L, P206L	Distal hereditary motor neuronopathy type 7B|Perry syndrome|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000577659	2	74598671	2	74371544	577659	558674	rs754827026	
206	NM_004082.4(DCTN1):c.629T>G (p.Leu210Arg)	DCTN1	L173R, L210R, L76R, L203R, L190R	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000566375	2	74598680	2	74371553	566375	558676	rs1558943273	
207	NM_004082.4(DCTN1):c.626C>T (p.Pro209Leu)	DCTN1	P172L, P209L, P75L, P189L, P202L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000580972	2	74598683	2	74371556	580972	558678	rs112725508	
208	NM_004082.4(DCTN1):c.569C>T (p.Pro190Leu)	DCTN1	P190L, P56L, P153L, P170L, P183L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000583330	2	74598740	2	74371613	583330	558293	rs765192491	
209	NM_004082.4(DCTN1):c.559G>T (p.Ala187Ser)	DCTN1	A53S, A187S, A150S, A180S, A167S	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000536161	2	74598750	2	74371623	536161	518811	rs960727301	
210	NM_004082.4(DCTN1):c.557C>T (p.Pro186Leu)	DCTN1	P149L, P186L, P52L, P166L, P179L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|not provided	Uncertain significance(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000391470	2	74598752	2	74371625	391470	367942	rs916359967	
211	NM_004082.4(DCTN1):c.460C>T (p.Arg154Cys)	DCTN1	R117C, R20C, R154C, R147C, R134C	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000574723	2	74598849	2	74371722	574723	562064	rs141670992	
212	NM_004082.4(DCTN1):c.458C>T (p.Thr153Met)	DCTN1	T133M, T146M, T116M, T153M, T19M	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, single submitter	VCV000648872	2	74598851	2	74371724	648872	630562		
213	NM_004082.4(DCTN1):c.446G>A (p.Arg149Gln)	DCTN1	R15Q, R149Q, R142Q	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000565725	2	74600062	2	74372935	565725	558295	rs149447433	
214	NM_004082.4(DCTN1):c.442C>T (p.Arg148Trp)	DCTN1	R148W, R14W, R141W	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 13, 2018)	criteria provided, conflicting interpretations	VCV000447238	2	74600066	2	74372939	447238	440734	rs148810193	
215	NM_004082.4(DCTN1):c.439A>G (p.Thr147Ala)	DCTN1	T13A, T147A, T140A	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000468276	2	74600069	2	74372942	468276	451902	rs371437767	
216	NM_004082.4(DCTN1):c.427C>T (p.Arg143Ter)	DCTN1	R9*, R143*, R136*	Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Uncertain significance(Last reviewed: Nov 22, 2017)	criteria provided, single submitter	VCV000536163	2	74601455	2	74374328	536163	518719	rs781290307	
217	NM_004082.4(DCTN1):c.424G>C (p.Ala142Pro)	DCTN1	A135P, A8P, A142P	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000641178	2	74601458	2	74374331	641178	630563		
218	NM_004082.4(DCTN1):c.419C>T (p.Pro140Leu)	DCTN1	P140L, P6L, P133L	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000576560	2	74601463	2	74374336	576560	558297	rs147939455	
219	NM_004082.4(DCTN1):c.414+1G>A	DCTN1		DCTN1-Related Disorders|Perry syndrome|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|not provided	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000282607	2	74603868	2	74376741	282607	266844	rs576198476	
220	NM_004082.4(DCTN1):c.376G>A (p.Ala126Thr)	DCTN1	A109T, A126T	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Aug 30, 2016)	criteria provided, single submitter	VCV000468275	2	74604576	2	74377449	468275	451822	rs1553466338	
221	NM_004082.4(DCTN1):c.288A>G (p.Val96=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000536174	2	74604845	2	74377718	536174	518631	rs1553466396	
222	NM_004082.4(DCTN1):c.279+1G>T	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|not provided	Uncertain significance(Last reviewed: Jan 23, 2019)	criteria provided, multiple submitters, no conflicts	VCV000565763	2	74605126	2	74377999	565763	562065	rs1393363759	
223	NM_004082.4(DCTN1):c.232T>C (p.Tyr78His)	DCTN1	Y61H, Y78H	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000582950	2	74605174	2	74378047	582950	558299	rs1558948987	
224	NM_004082.4(DCTN1):c.175G>A (p.Gly59Ser)	DCTN1	G59S, G42S	Genetic motor neuron disease|Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Pathogenic(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000008401	2	74605231	2	74378104	8401	23440	rs121909342	
225	NM_004082.4(DCTN1):c.167A>G (p.Lys56Arg)	DCTN1	K39R, K56R	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Perry syndrome	Uncertain significance(Last reviewed: Oct 28, 2017)	criteria provided, single submitter	VCV000264686	2	74605239	2	74378112	264686	259259	rs566433112	
226	NM_004082.4(DCTN1):c.142_143delinsAT (p.Gly48Ile)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000658278	2	74605263 - 74605264	2	74378136 - 74378137	658278	630564		
227	NM_004082.4(DCTN1):c.59C>T (p.Ala20Val)	DCTN1	A20V, A3V	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Distal hereditary motor neuronopathy type 7B|Perry syndrome|Distal hereditary motor neuronopathy	Uncertain significance(Last reviewed: Apr 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000337098	2	74605347	2	74378220	337098	290892	rs773420384	
228	NM_004082.4(DCTN1):c.45C>T (p.Gly15=)	DCTN1		Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000663856	2	74605361	2	74378234	663856	630565		
229	NM_004082.4(DCTN1):c.42C>T (p.Ser14=)	DCTN1		Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000536182	2	74605364	2	74378237	536182	518816	rs535554555	
230	NM_004082.4(DCTN1):c.40A>G (p.Ser14Gly)	DCTN1	S14G	not provided|Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000447237	2	74605366	2	74378239	447237	440736	rs758320436	
231	NM_020919.4(ALS2):c.*1538C>G	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333570	2	202565036	2	201700313	333570	287049	rs868173236	
232	NM_020919.4(ALS2):c.*1249G>A	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333571	2	202565325	2	201700602	333571	287060	rs886055451	
233	NM_020919.4(ALS2):c.*1202C>T	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333572	2	202565372	2	201700649	333572	284685	rs41309068	
234	NM_020919.4(ALS2):c.*1100A>G	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333573	2	202565474	2	201700751	333573	287065	rs568221522	
235	NM_020919.4(ALS2):c.*1004G>A	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333574	2	202565570	2	201700847	333574	283960	rs11300	
236	NM_020919.4(ALS2):c.*942A>G	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333575	2	202565632	2	201700909	333575	286627	rs41309066	
237	NM_020919.4(ALS2):c.*912A>G	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333576	2	202565662	2	201700939	333576	286630	rs572942753	
238	NM_020919.4(ALS2):c.*893C>T	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333577	2	202565681	2	201700958	333577	287069	rs3219174	
239	NM_020919.4(ALS2):c.*447G>A	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333578	2	202566127	2	201701404	333578	284693	rs3219173	
240	NM_020919.4(ALS2):c.*379T>A	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333579	2	202566195	2	201701472	333579	283962	rs144613080	
241	NM_020919.4(ALS2):c.*163A>G	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333580	2	202566411	2	201701688	333580	284695	rs3219172	
242	NM_020919.4(ALS2):c.*105A>C	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333581	2	202566469	2	201701746	333581	284696	rs141509107	
243	NM_020919.4(ALS2):c.*15T>G	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333582	2	202566559	2	201701836	333582	287071	rs561331219	
244	NM_020919.4(ALS2):c.4958G>A (p.Arg1653His)	ALS2	R1653H	ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333583	2	202566590	2	201701867	333583	286631	rs190606035	
245	NM_020919.4(ALS2):c.4858G>A (p.Glu1620Lys)	ALS2	E1620K	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000571279	2	202568922	2	201704199	571279	560537	rs1559027755	
246	NM_020919.4(ALS2):c.4721del (p.Val1574fs)	ALS2	V1574fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004412	2	202569294	2	201704571	4412	19451	rs386134188	
247	NM_020919.4(ALS2):c.4627G>T (p.Val1543Phe)	ALS2	V1543F	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000640352	2	202569923	2	201705200	640352	629293		
248	NM_020919.4(ALS2):c.4627-5T>C	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely benign(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000465191	2	202569928	2	201705205	465191	450491	rs764322790	
249	NM_020919.4(ALS2):c.4581-7A>G	ALS2		ALS2-Related Disorders|not provided|Amyotrophic Lateral Sclerosis, Recessive	Benign/Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000333584	2	202570191	2	201705468	333584	286635	rs114458388	
250	NM_020919.4(ALS2):c.4580+7G>A	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not specified	Benign(Last reviewed: Jul 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000261378	2	202571562	2	201706839	261378	250493	rs3219169	
251	NM_020919.4(ALS2):c.4573dup (p.Val1525fs)	ALS2		Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: Mar 25, 2014)	no assertion criteria provided	VCV000183240	2	202571575 - 202571576	2	201706852 - 201706853	183240	181373	rs730882256	
252	NM_020919.4(ALS2):c.4498G>A (p.Glu1500Lys)	ALS2	E1500K	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 19, 2015)	criteria provided, single submitter	VCV000241311	2	202571651	2	201706928	241311	238591	rs780151065	
253	NM_020919.4(ALS2):c.4495C>T (p.Arg1499Cys)	ALS2	R1499C	not specified|Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jan 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000439402	2	202571654	2	201706931	439402	433360	rs112869526	
254	NM_020919.4(ALS2):c.4435C>T (p.Pro1479Ser)	ALS2	P1479S	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Mar 20, 2018)	criteria provided, single submitter	VCV000578554	2	202571714	2	201706991	578554	559041	rs534239794	
255	NM_020919.4(ALS2):c.4416G>A (p.Thr1472=)	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2018)	criteria provided, conflicting interpretations	VCV000333585	2	202571733	2	201707010	333585	287072	rs200202953	
256	NM_020919.4(ALS2):c.4415C>T (p.Thr1472Met)	ALS2	T1472M	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000648585	2	202571734	2	201707011	648585	629294		
257	NM_020919.4(ALS2):c.4404-14C>T	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333586	2	202571759	2	201707036	333586	287073	rs375025577	
258	NM_020919.4(ALS2):c.4366G>C (p.Gly1456Arg)	ALS2	G1456R	ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333587	2	202572629	2	201707906	333587	286636	rs886055452	
259	NM_020919.4(ALS2):c.4345G>A (p.Glu1449Lys)	ALS2	E1449K	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000576790	2	202572650	2	201707927	576790	560539	rs779841299	
260	NM_020919.4(ALS2):c.4261C>T (p.Arg1421Ter)	ALS2	R1421*	Infantile-onset ascending hereditary spastic paralysis	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000242457	2	202574623	2	201709900	242457	214531	rs863225293	
261	NM_020919.4(ALS2):c.4141C>T (p.His1381Tyr)	ALS2	H1381Y	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000660166	2	202574743	2	201710020	660166	629295		
262	NM_020919.4(ALS2):c.4123-4T>C	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333588	2	202574765	2	201710042	333588	287088	rs886055453	
263	NM_020919.4(ALS2):c.4119A>G (p.Ile1373Met)	ALS2	I1373M	ALS2-Related Disorders|not specified|not provided|Amyotrophic Lateral Sclerosis, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Jun 5, 2019)	criteria provided, conflicting interpretations	VCV000282606	2	202575717	2	201710994	282606	266843	rs61757691	
264	NM_020919.4(ALS2):c.4021C>T (p.Arg1341Cys)	ALS2	R1341C	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Nov 14, 2016)	criteria provided, single submitter	VCV000412224	2	202575815	2	201711092	412224	392458	rs771371026	
265	NM_020919.4(ALS2):c.4015C>T (p.Leu1339=)	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not specified|not provided	Benign(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000261377	2	202575821	2	201711098	261377	250494	rs3219168	
266	NM_020919.4(ALS2):c.4004+6T>A	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000465190	2	202580389	2	201715666	465190	450378	rs1553502811	
267	NM_020919.4(ALS2):c.3930C>A (p.Gly1310=)	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333589	2	202580469	2	201715746	333589	287102	rs780354290	
268	NM_020919.4(ALS2):c.3885G>A (p.Ala1295=)	ALS2		not specified|Infantile-onset ascending hereditary spastic paralysis|ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Benign/Likely benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000261374	2	202580514	2	201715791	261374	250497	rs34946105	
269	NM_020919.4(ALS2):c.3876G>A (p.Lys1292=)	ALS2		ALS2-Related Disorders|not provided|Amyotrophic Lateral Sclerosis, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Aug 21, 2018)	criteria provided, conflicting interpretations	VCV000333590	2	202580523	2	201715800	333590	283963	rs200417604	
270	NM_020919.4(ALS2):c.3860_3865del (p.Val1287_Pro1288del)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000580937	2	202580534 - 202580539	2	201715811 - 201715816	580937	559043	rs759145161	
271	NM_020919.4(ALS2):c.3863C>T (p.Pro1288Leu)	ALS2	P1288L	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000533742	2	202580536	2	201715813	533742	517524	rs376835062	
272	NM_020919.4(ALS2):c.3785C>T (p.Thr1262Ile)	ALS2	T1262I	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 4, 2017)	criteria provided, single submitter	VCV000533746	2	202582851	2	201718128	533746	517526	rs1553503506	
273	NM_020919.4(ALS2):c.3746T>C (p.Phe1249Ser)	ALS2	F1249S	Hereditary spastic paraplegia|Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 18, 2018)	criteria provided, multiple submitters, no conflicts	VCV000412225	2	202582890	2	201718167	412225	392272	rs551822626	
274	NM_020919.4(ALS2):c.3625-16_3625-15del	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333591	2	202587858 - 202587859	2	201723135 - 201723136	333591	283970	rs370628135	
275	NM_020919.4(ALS2):c.3622A>T (p.Met1208Leu)	ALS2	M1208L	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000652446	2	202588055	2	201723332	652446	629296		
276	NM_020919.4(ALS2):c.3619del (p.Lys1206_Met1207insTer)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004408	2	202588058	2	201723335	4408	19447	rs386134187	
277	NM_020919.4(ALS2):c.3583G>T (p.Gly1195Ter)	ALS2	G1195*	Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 21, 2019)	criteria provided, single submitter	VCV000807368	2	202588094	2	201723371	807368	798495		
278	NM_020919.4(ALS2):c.3520A>T (p.Lys1174Ter)	ALS2	K1174*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Oct 15, 2018)	criteria provided, single submitter	VCV000645923	2	202588157	2	201723434	645923	629297		
279	NM_020919.4(ALS2):c.3486A>C (p.Gly1162=)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely benign(Last reviewed: Nov 26, 2017)	criteria provided, single submitter	VCV000533750	2	202589044	2	201724321	533750	517527	rs41309044	
280	NM_020919.4(ALS2):c.3449T>A (p.Met1150Lys)	ALS2	M1150K	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000578623	2	202589081	2	201724358	578623	557812	rs747308306	
281	NM_020919.4(ALS2):c.3415C>T (p.Arg1139Ter)	ALS2	R1139*	not provided|Amyotrophic lateral sclerosis type 2|Inborn genetic diseases	Pathogenic/Likely pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000393199	2	202589115	2	201724392	393199	366307	rs767350733	
282	NM_020919.4(ALS2):c.3319G>A (p.Gly1107Arg)	ALS2	G1107R	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000412226	2	202590107	2	201725384	412226	392520	rs757704778	
283	NM_020919.4(ALS2):c.3307C>A (p.His1103Asn)	ALS2	H1103N	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Feb 1, 2018)	criteria provided, single submitter	VCV000577205	2	202590119	2	201725396	577205	557814	rs778406073	
284	NM_020919.4(ALS2):c.3206G>A (p.Gly1069Glu)	ALS2	G1069E	ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not provided|Hereditary spastic paraplegia	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2019)	criteria provided, conflicting interpretations	VCV000333592	2	202591249	2	201726526	333592	284698	rs200706696	
285	NM_020919.4(ALS2):c.3183-3C>G	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: May 25, 2018)	criteria provided, single submitter	VCV000571278	2	202591275	2	201726552	571278	557865	rs1559049881	
286	NM_020919.4(ALS2):c.3134A>T (p.Lys1045Met)	ALS2	K1045M	Infantile-onset ascending hereditary spastic paralysis|Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000580658	2	202591435	2	201726712	580658	560541	rs781051642	
287	NM_020919.4(ALS2):c.2992C>T (p.Arg998Ter)	ALS2	R998*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004413	2	202591577	2	201726854	4413	19452	rs121908137	
288	NM_020919.4(ALS2):c.2980-2A>G	ALS2		Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004416	2	202591591	2	201726868	4416	19455	rs386134184	
289	NM_020919.4(ALS2):c.2979G>A (p.Lys993=)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000578624	2	202591935	2	201727212	578624	559045	rs1559050770	
290	NM_020919.4(ALS2):c.2909G>T (p.Gly970Val)	ALS2	G970V	ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2018)	criteria provided, conflicting interpretations	VCV000333593	2	202592431	2	201727708	333593	283971	rs375742430	
291	NM_020919.4(ALS2):c.2876T>C (p.Leu959Pro)	ALS2	L959P	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: May 11, 2018)	criteria provided, single submitter	VCV000579232	2	202592464	2	201727741	579232	559047	rs1178248335	
292	NM_020919.4(ALS2):c.2875C>A (p.Leu959Met)	ALS2	L959M	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Apr 27, 2017)	criteria provided, single submitter	VCV000465188	2	202592465	2	201727742	465188	450414	rs1553506293	
293	NM_020919.4(ALS2):c.2833C>T (p.His945Tyr)	ALS2	H945Y	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, single submitter	VCV000657160	2	202593243	2	201728520	657160	629298		
294	NM_020919.4(ALS2):c.2796C>T (p.Ser932=)	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000261369	2	202593280	2	201728557	261369	250501	rs3219161	
295	NM_020919.4(ALS2):c.2761C>T (p.Arg921Ter)	ALS2	R921*	not provided|Infantile-onset ascending hereditary spastic paralysis	Pathogenic/Likely pathogenic(Last reviewed: Feb 15, 2014)	no assertion criteria provided	VCV000100653	2	202593315	2	201728592	100653	106525	rs587777132	
296	NM_020919.4(ALS2):c.2712G>A (p.Thr904=)	ALS2		ALS2-Related Disorders|Infantile-onset ascending hereditary spastic paralysis|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000333594	2	202593775	2	201729052	333594	287103	rs201200488	
297	NM_020919.4(ALS2):c.2581-5T>A	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Mar 10, 2017)	criteria provided, single submitter	VCV000465187	2	202593911	2	201729188	465187	450496	rs1171928153	
298	NM_020919.4(ALS2):c.2566A>G (p.Thr856Ala)	ALS2	T856A	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000652809	2	202598013	2	201733290	652809	629299		
299	NM_020919.4(ALS2):c.2537_2538del (p.Asn846fs)	ALS2	N846fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004410	2	202598041 - 202598042	2	201733318 - 201733319	4410	19449	rs386134183	
300	NM_020919.4(ALS2):c.2479A>T (p.Thr827Ser)	ALS2	T827S	ALS2-Related Disorders|Infantile-onset ascending hereditary spastic paralysis|Peripheral axonal neuropathy|Amyotrophic Lateral Sclerosis, Recessive	Conflicting interpretations of pathogenicity(Last reviewed: Oct 16, 2018)	criteria provided, conflicting interpretations	VCV000333595	2	202598100	2	201733377	333595	283972	rs202219507	
301	NM_020919.4(ALS2):c.2466G>A (p.Val822=)	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not specified|not provided	Benign(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000261368	2	202598113	2	201733390	261368	250502	rs2276615	
302	NM_020919.4(ALS2):c.2241C>T (p.Tyr747=)	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 17, 2019)	criteria provided, conflicting interpretations	VCV000241310	2	202606507	2	201741784	241310	238592	rs3219160	
303	NM_020919.4(ALS2):c.2222G>A (p.Arg741Gln)	ALS2	R741Q	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000412227	2	202606526	2	201741803	412227	392522	rs753349655	
304	NM_020919.4(ALS2):c.2171-4A>G	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely benign(Last reviewed: Aug 4, 2017)	criteria provided, single submitter	VCV000465185	2	202606581	2	201741858	465185	450505	rs780648054	
305	NM_020919.4(ALS2):c.2171-7G>A	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely benign(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000465186	2	202606584	2	201741861	465186	450506	rs376270303	
306	NM_020919.4(ALS2):c.2143C>T (p.Gln715Ter)	ALS2	Q715*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004417	2	202609008	2	201744285	4417	19456	rs121908139	
307	NM_020919.4(ALS2):c.2104G>T (p.Glu702Ter)	ALS2	E702*	Infantile-onset ascending hereditary spastic paralysis|Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804391	2	202609047	2	201744324	804391	792725		
308	NM_020919.4(ALS2):c.2089G>A (p.Glu697Lys)	ALS2	E697K	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000660990	2	202609062	2	201744339	660990	629300		
309	NM_020919.4(ALS2):c.2002G>T (p.Gly668Ter)	ALS2	G668*	Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: Mar 25, 2014)	no assertion criteria provided	VCV000183239	2	202609149	2	201744426	183239	181372	rs730882255	
310	NM_020919.4(ALS2):c.1999-2A>T	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000042060	2	202609154	2	201744431	42060	51226	rs386134182	
311	NM_020919.4(ALS2):c.1998+6C>G	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000582733	2	202611283	2	201746560	582733	560543	rs1359989080	
312	NM_020919.4(ALS2):c.1998+4A>G	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000644447	2	202611285	2	201746562	644447	650938		
313	NM_020919.4(ALS2):c.1969A>G (p.Lys657Glu)	ALS2	K657E	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Feb 23, 2017)	criteria provided, single submitter	VCV000465184	2	202611318	2	201746595	465184	450512	rs753947052	
314	NM_020919.4(ALS2):c.1921C>T (p.Gln641Ter)	ALS2	Q641*	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000533744	2	202611366	2	201746643	533744	517639	rs1553511680	
315	NM_020919.4(ALS2):c.1911C>A (p.Tyr637Ter)	ALS2	Y637*	Infantile-onset ascending hereditary spastic paralysis	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000242456	2	202611376	2	201746653	242456	214532	rs863225294	
316	NM_020919.3(ALS2):c.[1911C>A;4261C>T]	ALS2	Y637*, R1421*		Pathogenic(Last reviewed: Jul 14, 2014)	no assertion criteria provided	VCV000217879	2|2	202611376	2|2	201746653	217879	214532|214531	rs863225294|rs863225293	
317	NM_020919.4(ALS2):c.1867_1868del (p.Leu623fs)	ALS2	L623fs	Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000004406	2	202611419 - 202611420	2	201746696 - 201746697	4406	19445	rs386134181	
318	NM_020919.4(ALS2):c.1816-1G>A	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely pathogenic(Last reviewed: May 27, 2016)	criteria provided, single submitter	VCV000412209	2	202611472	2	201746749	412209	392526	rs1060503672	
319	NM_020919.4(ALS2):c.1816-8C>T	ALS2		ALS2-Related Disorders|not specified|Amyotrophic Lateral Sclerosis, Recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2019)	criteria provided, conflicting interpretations	VCV000261366	2	202611479	2	201746756	261366	250503	rs185911369	
320	NM_020919.4(ALS2):c.1815+8T>G	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely benign(Last reviewed: Jun 23, 2017)	criteria provided, single submitter	VCV000465183	2	202614427	2	201749704	465183	450422	rs746020900	
321	NM_020919.4(ALS2):c.1805G>A (p.Arg602His)	ALS2	R602H	Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333596	2	202614445	2	201749722	333596	284699	rs201496655	
322	NM_020919.4(ALS2):c.1677A>G (p.Lys559=)	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2018)	criteria provided, conflicting interpretations	VCV000333597	2	202617929	2	201753206	333597	286639	rs367640165	
323	NM_020919.4(ALS2):c.1659A>G (p.Val553=)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely benign(Last reviewed: Jul 6, 2017)	criteria provided, single submitter	VCV000465182	2	202617947	2	201753224	465182	450251	rs1553513336	
324	NM_020919.4(ALS2):c.1641G>A (p.Arg547=)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000465181	2	202617965	2	201753242	465181	450392	rs34122078	
325	NM_020919.4(ALS2):c.1624G>A (p.Gly542Ser)	ALS2	G542S	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000662391	2	202619242	2	201754519	662391	629301		
326	NM_020919.4(ALS2):c.1619G>A (p.Gly540Glu)	ALS2	G540E	Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000042137	2	202619247	2	201754524	42137	51303	rs386134178	
327	NM_020919.4(ALS2):c.1600G>C (p.Gly534Arg)	ALS2	G534R	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000533748	2	202619266	2	201754543	533748	517611	rs1553513641	
328	NM_020919.4(ALS2):c.1479_1480insCGTGC (p.Leu495fs)	ALS2		ALS2-Related Disorders	Uncertain significance(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000631841	2	202619386 - 202619387	2	201754663 - 201754664	631841	620049	rs1559076828	
329	NM_020919.3(ALS2):c.1472_1481delTTTCCCCCAG	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004409	2	202619395	2	201754672	4409	19448	rs387906316	
330	NM_020919.4(ALS2):c.1439G>A (p.Arg480Gln)	ALS2	R480Q	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Aug 3, 2018)	criteria provided, single submitter	VCV000657700	2	202622157	2	201757434	657700	629302		
331	NM_020919.4(ALS2):c.1433G>C (p.Gly478Ala)	ALS2	G478A	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000465180	2	202622163	2	201757440	465180	450255	rs373603368	
332	NM_020919.4(ALS2):c.1425_1428del (p.Gly477fs)	ALS2	G477fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000241308	2	202622168 - 202622171	2	201757445 - 201757448	241308	238594	rs878855058	
333	NM_020919.4(ALS2):c.1425_1426AG[1] (p.Glu476fs)	ALS2		Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004407	2	202622168 - 202622169	2	201757445 - 201757446	4407	19446	rs386134176	
334	NM_020919.4(ALS2):c.1325G>C (p.Gly442Ala)	ALS2	G442A	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000655414	2	202622271	2	201757548	655414	629303		
335	NM_020919.4(ALS2):c.1304A>T (p.Gln435Leu)	ALS2	Q435L	Amyotrophic lateral sclerosis type 2	Uncertain significance(Last reviewed: Mar 18, 2016)	criteria provided, single submitter	VCV000225296	2	202622292	2	201757569	225296	227231	rs1085307055	
336	NM_020919.4(ALS2):c.1283C>A (p.Thr428Asn)	ALS2	T428N	Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333598	2	202622313	2	201757590	333598	284725	rs886055454	
337	NM_020919.4(ALS2):c.1251A>G (p.Ser417=)	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333599	2	202622345	2	201757622	333599	283978	rs750482532	
338	NM_020919.4(ALS2):c.1233T>G (p.Tyr411Ter)	ALS2	Y411*	Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis|Juvenile primary lateral sclerosis|Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000533743	2	202622363	2	201757640	533743	517535	rs369577952	
339	NM_020919.4(ALS2):c.1171G>A (p.Ala391Thr)	ALS2	A391T	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000465179	2	202622425	2	201757702	465179	450513	rs41308816	
340	NM_020919.4(ALS2):c.1115C>G (p.Pro372Arg)	ALS2	P372R	Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 13, 2019)	criteria provided, conflicting interpretations	VCV000241307	2	202622481	2	201757758	241307	238595	rs190369242	
341	NM_020919.4(ALS2):c.1102G>A (p.Val368Met)	ALS2	V368M	ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not specified|not provided	Benign(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000261364	2	202625615	2	201760892	261364	250505	rs3219156	
342	NM_020919.4(ALS2):c.1054_1061del (p.Leu352fs)	ALS2	L352fs	Infantile-onset ascending hereditary spastic paralysis	Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800527	2	202625656 - 202625663	2	201760933 - 201760940	800527	789113		
343	NM_020919.4(ALS2):c.1037A>G (p.Asn346Ser)	ALS2	N346S	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000533745	2	202625680	2	201760957	533745	517618	rs199757764	
344	NM_020919.4(ALS2):c.1007_1008del (p.Ile336fs)	ALS2	I336fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000004411	2	202625709 - 202625710	2	201760986 - 201760987	4411	19450	rs386134175	
345	NM_020919.4(ALS2):c.997G>T (p.Ala333Ser)	ALS2	A333S	Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333600	2	202625720	2	201760997	333600	284727	rs777806515	
346	NM_020919.4(ALS2):c.913del (p.Glu304_Leu305insTer)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000807369	2	202625804	2	201761081	807369	798496		
347	NM_020919.4(ALS2):c.601C>T (p.Arg201Ter)	ALS2	R201*	Infantile-onset ascending hereditary spastic paralysis|Juvenile primary lateral sclerosis|Amyotrophic lateral sclerosis type 2|Infantile-onset ascending hereditary spastic paralysis	Pathogenic/Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, multiple submitters, no conflicts	VCV000804392	2	202626116	2	201761393	804392	792726		
348	NM_001135745.2(ALS2):c.553del (p.Thr185fs)	ALS2	T185fs	Amyotrophic lateral sclerosis type 2|Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000004414	2	202626164	2	201761441	4414	19453	rs386134174	
349	NM_020919.4(ALS2):c.475G>A (p.Glu159Lys)	ALS2	E159K	Amyotrophic Lateral Sclerosis, Recessive|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 19, 2019)	criteria provided, multiple submitters, no conflicts	VCV000241312	2	202626242	2	201761519	241312	238596	rs3219155	
350	NM_020919.4(ALS2):c.470G>A (p.Cys157Tyr)	ALS2	C156Y, C157Y	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004415	2	202626247	2	201761524	4415	19454	rs121908138	
351	NM_020919.4(ALS2):c.358G>T (p.Ala120Ser)	ALS2	A120S	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000533747	2	202626359	2	201761636	533747	517625	rs202084736	
352	NM_020919.4(ALS2):c.329G>T (p.Gly110Val)	ALS2	G110V	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000643618	2	202626388	2	201761665	643618	629304		
353	NM_020919.4(ALS2):c.280A>G (p.Ile94Val)	ALS2	I94V	Infantile-onset ascending hereditary spastic paralysis|ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not specified	Benign/Likely benign(Last reviewed: Feb 21, 2019)	criteria provided, multiple submitters, no conflicts	VCV000261370	2	202626437	2	201761714	261370	250506	rs3219154	
354	NM_020919.4(ALS2):c.248T>G (p.Ile83Ser)	ALS2	I83S	Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333601	2	202626469	2	201761746	333601	287104	rs886055455	
355	NM_020919.4(ALS2):c.218G>A (p.Gly73Glu)	ALS2	G73E	Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000644325	2	202626499	2	201761776	644325	629305		
356	NM_020919.4(ALS2):c.138del (p.Ala47fs)	ALS2	A47fs	Amyotrophic lateral sclerosis type 2	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004405	2	202631989	2	201767266	4405	19444	rs386134173	
357	NM_020919.4(ALS2):c.20+9A>G	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333602	2	202633580	2	201768857	333602	284739	rs763370210	
358	NM_020919.4(ALS2):c.20+7T>C	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000261367	2	202633582	2	201768859	261367	250507	rs3219153	
359	NM_020919.4(ALS2):c.-31T>A	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333603	2	202633639	2	201768916	333603	286642	rs886055456	
360	NM_020919.4(ALS2):c.-93A>G	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333604	2	202645632	2	201780909	333604	284742	rs373055404	
361	NM_020919.4(ALS2):c.-95G>C	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333605	2	202645634	2	201780911	333605	286644	rs77327610	
362	NM_020919.3(ALS2):c.-128C>T	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333606	2	202645667	2	201780944	333606	283979	rs2276614	
363	NM_020919.3(ALS2):c.-328A>G	ALS2		Amyotrophic Lateral Sclerosis, Recessive|ALS2-Related Disorders	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333607	2	202645867	2	201781144	333607	283982	rs137949180	
364	NM_020919.3(ALS2):c.-329G>A	ALS2		ALS2-Related Disorders|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000333608	2	202645868	2	201781145	333608	284743	rs765669374	
365	NM_005235.3(ERBB4):c.3823C>T (p.Arg1275Trp)	ERBB4	R1275W, R1259W	Amyotrophic lateral sclerosis 19|not provided	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000064626	2	212248444	2	211383719	64626	75590	rs397514263	
366	NM_005235.3(ERBB4):c.2780G>A (p.Arg927Gln)	ERBB4	R927Q	not provided|Amyotrophic lateral sclerosis 19	Pathogenic(Last reviewed: Nov 7, 2013)	no assertion criteria provided	VCV000064625	2	212288966	2	211424241	64625	75589	rs397514262	
367	NM_005235.3(ERBB4):c.2207T>A (p.Ile736Asn)	ERBB4	I736N	Amyotrophic lateral sclerosis 19	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000801872	2	212483996	2	211619271	801872	790172		
368	NM_006000.3(TUBA4A):c.1220G>A (p.Trp407Ter)	TUBA4A	W407*, W392*	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180184	2	220115201	2	219250479	180184	178367	rs730880027	
369	NM_006000.3(TUBA4A):c.1147G>A (p.Ala383Thr)	TUBA4A	A383T, A368T	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180186	2	220115274	2	219250552	180186	178369	rs368743618	
370	NM_006000.3(TUBA4A):c.959G>A (p.Arg320His)	TUBA4A	R320H, R305H	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180183	2	220115462	2	219250740	180183	178366	rs730880026	
371	NM_006000.3(TUBA4A):c.958C>T (p.Arg320Cys)	TUBA4A	R320C, R305C	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180182	2	220115463	2	219250741	180182	178365	rs730880025	
372	NM_006000.3(TUBA4A):c.643C>T (p.Arg215Cys)	TUBA4A	R215C, R200C	Amyotrophic lateral sclerosis 22 with frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180185	2	220115778	2	219251056	180185	178368	rs730880028	
373	NM_006000.3(TUBA4A):c.433A>C (p.Thr145Pro)	TUBA4A	T145P, T130P	Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia	Pathogenic(Last reviewed: Oct 22, 2014)	no assertion criteria provided	VCV000180187	2	220115988	2	219251266	180187	178370	rs730880029	
374	NM_014043.4(CHMP2B):c.85A>G (p.Ile29Val)	CHMP2B	I29V	Amyotrophic lateral sclerosis 17|Frontotemporal Dementia, Chromosome 3-Linked|not provided|Amyotrophic lateral sclerosis 17|Frontotemporal Dementia, Chromosome 3-Linked	Uncertain significance(Last reviewed: Dec 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000021507	3	87289899	3	87240749	21507	34359	rs63750818	
375	NM_014043.4(CHMP2B):c.218C>T (p.Thr73Met)	CHMP2B	T73M, T32M	not specified|Frontotemporal Dementia, Chromosome 3-Linked|Amyotrophic lateral sclerosis 17|Frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Nov 12, 2018)	criteria provided, conflicting interpretations	VCV000346806	3	87294955	3	87245805	346806	293023	rs192188850	
376	NM_014043.4(CHMP2B):c.311C>A (p.Thr104Asn)	CHMP2B	T104N, T63N	Amyotrophic lateral sclerosis 17|Frontotemporal Dementia, Chromosome 3-Linked	Conflicting interpretations of pathogenicity(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000035472	3	87295048	3	87245898	35472	44141	rs281864934	
377	NM_014043.4(CHMP2B):c.581C>T (p.Ser194Leu)	CHMP2B	S194L, S153L	Frontotemporal Dementia, Chromosome 3-Linked|Amyotrophic lateral sclerosis 17|not provided	Uncertain significance(Last reviewed: Mar 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000581214	3	87302911	3	87253761	581214	559682	rs149380040	
378	NM_014043.4(CHMP2B):c.618A>C (p.Gln206His)	CHMP2B	Q206H, Q165H	not provided|Amyotrophic lateral sclerosis 17|Frontotemporal Dementia, Chromosome 3-Linked	Pathogenic(Last reviewed: Oct 4, 2012)	no assertion criteria provided	VCV000001654	3	87302948	3	87253798	1654	16693	rs63751126	
379	NM_006070.6(TFG):c.854C>T (p.Pro285Leu)	TFG	P285L, P281L	Spastic paraplegia 57, autosomal recessive|Neuropathy, hereditary motor and sensory, Okinawa type|not provided|Neuropathy, hereditary motor and sensory, Okinawa type	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000037089	3	100467026	3	100748182	37089	45764	rs207482230	
380	Single allele			not provided	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000559471					559471	550195		
381	NM_001199397.3(NEK1):c.3222+64T>A	NEK1		AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24	Likely benign(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000810899	4	170345640	4	169424489	810899	799347		
382	NM_012224.3(NEK1):c.3023C>G (p.Ser1008Ter)	NEK1	S1036*, S1008*, S964*, S992*, S939*	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Short rib-polydactyly syndrome, Majewski type|AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|not provided|Short rib-polydactyly syndrome, Majewski type	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000208600	4	170345819	4	169424668	208600	205144	rs199947197	
383	NM_012224.3(NEK1):c.2680+12T>A	NEK1		Short Rib Polydactyly Syndrome|not specified|AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24	Benign/Likely benign(Last reviewed: Sep 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000348101	4	170359222	4	169438071	348101	294162	rs77658514	
384	NM_012224.3(NEK1):c.2350A>T (p.Arg784Ter)	NEK1	R812*, R715*, R768*, R740*, R784*	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24	risk factor(Last reviewed: Feb 28, 2018)	no assertion criteria provided	VCV000495118	4	170398275	4	169477124	495118	486672	rs749428135	
385	NM_001199397.3(NEK1):c.2400G>C (p.Glu800Asp)	NEK1	E698D, E703D, E728D, E755D, E756D, E772D, E800D	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24	Uncertain significance(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000811174	4	170398309	4	169477158	811174	799348		
386	NM_012224.3(NEK1):c.1841C>G (p.Ala614Gly)	NEK1	A614G, A642G, A545G, A598G, A570G	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Short rib-polydactyly syndrome, Majewski type|Short rib-polydactyly syndrome, Majewski type	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000578956	4	170428270	4	169507119	578956	561972	rs529024280	
387	NM_012224.3(NEK1):c.1792G>A (p.Ala598Thr)	NEK1	A598T, A626T, A554T, A582T, A529T	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Short Rib Polydactyly Syndrome|not specified	Benign/Likely benign(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000348108	4	170428901	4	169507750	348108	297599	rs33933790	
388	NM_012224.3(NEK1):c.1746A>G (p.Glu582=)	NEK1		AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Short Rib Polydactyly Syndrome|not specified|Short rib-polydactyly syndrome, Majewski type	Benign/Likely benign(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095507	4	170429402	4	169508251	95507	101406	rs17544885	
389	NM_012224.3(NEK1):c.1648C>T (p.Arg550Ter)	NEK1	R550*, R506*, R481*	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24	risk factor(Last reviewed: Feb 28, 2018)	no assertion criteria provided	VCV000495120	4	170458977	4	169537826	495120	486674	rs371575563	
390	NM_012224.3(NEK1):c.1137T>A (p.Asp379Glu)	NEK1	D379E	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Motor neuron disease|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 15, 2018)	criteria provided, conflicting interpretations	VCV000266047	4	170482986	4	169561835	266047	260877	rs372585344	
391	NM_012224.3(NEK1):c.1081-15dup	NEK1		AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|not provided|Short rib-polydactyly syndrome, Majewski type|Short Rib Polydactyly Syndrome|not specified	Benign/Likely benign(Last reviewed: Jul 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095506	4	170483049 - 170483050	4	169561898 - 169561899	95506	101405	rs398124255	
392	NM_012224.3(NEK1):c.1068G>A (p.Arg356=)	NEK1		AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Short rib-polydactyly syndrome, Majewski type|Short Rib Polydactyly Syndrome|not specified	Benign(Last reviewed: Jul 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000348117	4	170483300	4	169562149	348117	294210	rs17055010	
393	NM_012224.3(NEK1):c.1021G>A (p.Ala341Thr)	NEK1	A341T	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Motor neuron disease|not specified|Short Rib Polydactyly Syndrome|not provided|Lymphopenia|Immunodeficiency|Cor triatriatum dexter|Cough	Conflicting interpretations of pathogenicity(Last reviewed: Feb 6, 2019)	criteria provided, conflicting interpretations	VCV000266046	4	170483347	4	169562196	266046	260878	rs189186475	
394	NM_012224.3(NEK1):c.782G>A (p.Arg261His)	NEK1	R261H	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24|Motor neuron disease|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 7, 2019)	criteria provided, conflicting interpretations	VCV000199125	4	170506525	4	169585374	199125	196284	rs200161705	
395	NM_018834.6(MATR3):c.190T>C (p.Leu64=)	MATR3		Amyotrophic lateral sclerosis 21	Likely benign(Last reviewed: Aug 28, 2017)	criteria provided, single submitter	VCV000474079	5	138643294	5	139307605	474079	454639	rs775134951	
396	NM_018834.6(MATR3):c.254C>G (p.Ser85Cys)	MATR3	S85C	not provided|Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Jun 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000014002	5	138643358	5	139307669	14002	29041	rs121434591	
397	NM_018834.6(MATR3):c.304C>T (p.Arg102Cys)	MATR3	R102C	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Nov 19, 2018)	criteria provided, single submitter	VCV000657091	5	138643408	5	139307719	657091	633476		
398	NM_018834.6(MATR3):c.322G>T (p.Ala108Ser)	MATR3	A108S	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000541136	5	138643426	5	139307737	541136	520789	rs745440760	
399	NM_018834.6(MATR3):c.344T>G (p.Phe115Cys)	MATR3	F115C	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126561	5	138643448	5	139307759	126561	132071	rs587777300	
400	NM_018834.6(MATR3):c.460C>T (p.Pro154Ser)	MATR3	P154S	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126563	5	138643564	5	139307875	126563	132073	rs587777302	
401	NM_018834.6(MATR3):c.561T>G (p.Asp187Glu)	MATR3	D187E	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000658267	5	138643665	5	139307976	658267	633477		
402	NM_018834.6(MATR3):c.793C>A (p.Leu265Ile)	MATR3	L265I	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000474084	5	138643897	5	139308208	474084	454706	rs1554146560	
403	NM_018834.6(MATR3):c.1132G>A (p.Ala378Thr)	MATR3	A90T, A378T, A40T	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000651450	5	138652744	5	139317055	651450	633478		
404	NM_018834.6(MATR3):c.1363A>G (p.Thr455Ala)	MATR3	T167A, T117A, T455A	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000663874	5	138654651	5	139318962	663874	633479		
405	NM_018834.6(MATR3):c.1435-10T>C	MATR3		Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Apr 13, 2018)	criteria provided, single submitter	VCV000566721	5	138655013	5	139319324	566721	564791	rs772340385	
406	NM_018834.6(MATR3):c.1572G>T (p.Lys524Asn)	MATR3	K236N, K186N, K524N	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000664538	5	138655160	5	139319471	664538	633480		
407	NM_018834.6(MATR3):c.1598G>A (p.Ser533Asn)	MATR3	S533N, S195N, S245N	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Jan 31, 2018)	criteria provided, single submitter	VCV000578420	5	138655186	5	139319497	578420	562858	rs1033118784	
408	NM_018834.6(MATR3):c.1602+6A>G	MATR3		Distal myopathy|not specified|Amyotrophic lateral sclerosis 21	Benign/Likely benign(Last reviewed: Aug 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000263208	5	138655196	5	139319507	263208	251792	rs80036770	
409	NM_018834.6(MATR3):c.1864A>G (p.Thr622Ala)	MATR3	T622A, T284A, T334A	Amyotrophic lateral sclerosis 21	Pathogenic(Last reviewed: Mar 30, 2014)	no assertion criteria provided	VCV000126562	5	138658372	5	139322683	126562	132072	rs587777301	
410	NM_018834.6(MATR3):c.1874A>C (p.Lys625Thr)	MATR3	K287T, K625T, K337T	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000644662	5	138658382	5	139322693	644662	633481		
411	NM_018834.6(MATR3):c.1896T>C (p.Gly632=)	MATR3		Amyotrophic lateral sclerosis 21	Likely benign(Last reviewed: Dec 28, 2017)	criteria provided, single submitter	VCV000541139	5	138658404	5	139322715	541139	521219	rs202208841	
412	NM_018834.6(MATR3):c.1912G>C (p.Asp638His)	MATR3	D638H, D300H, D350H	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Jun 5, 2017)	criteria provided, single submitter	VCV000474080	5	138658420	5	139322731	474080	454644	rs1554148872	
413	NM_018834.6(MATR3):c.1948A>C (p.Met650Leu)	MATR3	M650L, M312L, M362L	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Jul 2, 2018)	criteria provided, single submitter	VCV000578787	5	138658456	5	139322767	578787	564799	rs749026971	
414	NM_018834.6(MATR3):c.2038G>A (p.Asp680Asn)	MATR3	D680N, D392N, D342N	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Apr 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000474081	5	138658546	5	139322857	474081	455446	rs752161415	
415	NM_018834.6(MATR3):c.2161G>A (p.Glu721Lys)	MATR3	E721K, E383K, E433K	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000541137	5	138661141	5	139325452	541137	521041	rs764645698	
416	NM_018834.6(MATR3):c.2180A>G (p.Asn727Ser)	MATR3	N727S, N389S, N439S	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000571163	5	138661160	5	139325471	571163	560163	rs1468138513	
417	NM_018834.6(MATR3):c.2213A>G (p.Glu738Gly)	MATR3	E738G, E450G, E400G	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Jan 19, 2018)	criteria provided, single submitter	VCV000569504	5	138661193	5	139325504	569504	560165	rs538917496	
418	NM_018834.6(MATR3):c.2234C>T (p.Ala745Val)	MATR3	A745V, A407V, A457V	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000574594	5	138661214	5	139325525	574594	560167	rs199797401	
419	NM_018834.6(MATR3):c.2273C>A (p.Thr758Lys)	MATR3	T470K, T758K, T420K	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000640602	5	138661253	5	139325564	640602	633482		
420	NM_018834.6(MATR3):c.2282A>G (p.Asn761Ser)	MATR3	N761S, N473S, N423S	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000581337	5	138661262	5	139325573	581337	562861	rs758675030	
421	NM_018834.6(MATR3):c.2372-3dup	MATR3		Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: May 23, 2018)	criteria provided, single submitter	VCV000580361	5	138661848 - 138661849	5	139326159 - 139326160	580361	564804	rs1561945483	
422	NM_018834.6(MATR3):c.2504A>G (p.Asn835Ser)	MATR3	N835S, N497S, N547S	Distal myopathy|Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000351142	5	138665044	5	139329355	351142	295609	rs201165929	
423	NM_018834.6(MATR3):c.2521C>T (p.Arg841Cys)	MATR3	R841C, R503C, R553C	Distal myopathy|Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Oct 2, 2018)	criteria provided, multiple submitters, no conflicts	VCV000351143	5	138665061	5	139329372	351143	297398	rs781050726	
424	NM_018834.6(MATR3):c.2525G>C (p.Arg842Thr)	MATR3	R554T, R842T, R504T	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000652772	5	138665065	5	139329376	652772	633483		
425	NM_003900.5(SQSTM1):c.46G>A (p.Ala16Thr)	SQSTM1	A16T	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|not provided	Uncertain significance(Last reviewed: Nov 19, 2018)	criteria provided, multiple submitters, no conflicts	VCV000423540	5	179247982	5	179820982	423540	406734	rs773552098	
426	NM_003900.5(SQSTM1):c.86C>G (p.Pro29Arg)	SQSTM1	P29R	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Mar 23, 2017)	criteria provided, single submitter	VCV000475407	5	179248022	5	179821022	475407	455474	rs1012113887	
427	NM_003900.5(SQSTM1):c.98C>T (p.Ala33Val)	SQSTM1	A33V	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided	Likely benign(Last reviewed: Feb 7, 2019)	criteria provided, single submitter	VCV000253029	5	179248034	5	179821034	253029	247436	rs200396166	
428	NM_003900.5(SQSTM1):c.122C>T (p.Pro41Leu)	SQSTM1	P41L	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Oct 16, 2017)	criteria provided, single submitter	VCV000542157	5	179248058	5	179821058	542157	521466	rs745356508	
429	NM_003900.5(SQSTM1):c.139C>G (p.Leu47Val)	SQSTM1	L47V	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000664776	5	179248075	5	179821075	664776	633830		
430	NM_003900.5(SQSTM1):c.154G>T (p.Ala52Ser)	SQSTM1	A52S	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000646289	5	179248090	5	179821090	646289	633831		
431	NM_003900.5(SQSTM1):c.204C>G (p.Arg68=)	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|not specified	Uncertain significance(Last reviewed: May 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448530	5	179248140	5	179821140	448530	440879	rs1449269769	
432	NM_003900.5(SQSTM1):c.263C>T (p.Ser88Phe)	SQSTM1	S88F, S4F	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Aug 22, 2018)	criteria provided, single submitter	VCV000639220	5	179250015	5	179823015	639220	633832		
433	NM_003900.5(SQSTM1):c.268G>A (p.Val90Met)	SQSTM1	V90M, V6M	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000475399	5	179250020	5	179823020	475399	454867	rs181263868	
434	NM_003900.5(SQSTM1):c.317G>A (p.Arg106Gln)	SQSTM1	R22Q, R106Q	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000475400	5	179250873	5	179823873	475400	454870	rs778554903	
435	NM_003900.5(SQSTM1):c.332C>T (p.Pro111Leu)	SQSTM1	P111L, P27L	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000475401	5	179250888	5	179823888	475401	455001	rs371719657	
436	NM_003900.5(SQSTM1):c.352C>T (p.Pro118Ser)	SQSTM1	P118S, P34S	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Apr 12, 2018)	criteria provided, single submitter	VCV000567262	5	179250908	5	179823908	567262	563086	rs200152247	
437	NM_003900.5(SQSTM1):c.381C>G (p.Ile127Met)	SQSTM1	I43M, I127M	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000641109	5	179250937	5	179823937	641109	633833		
438	NM_003900.5(SQSTM1):c.401C>T (p.Pro134Leu)	SQSTM1	P50L, P134L	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000639635	5	179250957	5	179823957	639635	633834		
439	NM_003900.5(SQSTM1):c.416G>A (p.Arg139His)	SQSTM1	R139H, R55H	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000644285	5	179250972	5	179823972	644285	633835		
440	NM_003900.5(SQSTM1):c.457G>A (p.Val153Ile)	SQSTM1	V69I, V153I	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Nov 13, 2018)	criteria provided, single submitter	VCV000571746	5	179251013	5	179824013	571746	560408	rs145056421	
441	NM_003900.5(SQSTM1):c.481C>T (p.Arg161Trp)	SQSTM1	R161W, R77W	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000661331	5	179251037	5	179824037	661331	633836		
442	NM_003900.5(SQSTM1):c.530A>C (p.Glu177Ala)	SQSTM1	E177A, E93A	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Sep 15, 2017)	criteria provided, single submitter	VCV000542156	5	179251086	5	179824086	542156	521644	rs1392938040	
443	NM_003900.5(SQSTM1):c.532-7C>A	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000650579	5	179251175	5	179824175	650579	651328		
444	NM_003900.5(SQSTM1):c.571G>A (p.Gly191Arg)	SQSTM1	G191R, G107R	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Jan 2, 2019)	criteria provided, single submitter	VCV000639243	5	179251221	5	179824221	639243	633837		
445	NM_003900.5(SQSTM1):c.632C>G (p.Pro211Arg)	SQSTM1	P127R, P211R	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Oct 25, 2018)	criteria provided, single submitter	VCV000666096	5	179251282	5	179824282	666096	633838		
446	NM_003900.5(SQSTM1):c.649C>T (p.Arg217Cys)	SQSTM1	R133C, R217C	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Jul 27, 2018)	criteria provided, single submitter	VCV000644487	5	179251299	5	179824299	644487	633839		
447	NM_003900.5(SQSTM1):c.650G>A (p.Arg217His)	SQSTM1	R133H, R217H	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Sep 7, 2018)	criteria provided, single submitter	VCV000644082	5	179251300	5	179824300	644082	633840		
448	NM_003900.5(SQSTM1):c.662C>T (p.Thr221Met)	SQSTM1	T137M, T221M	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Oct 5, 2018)	criteria provided, single submitter	VCV000644501	5	179251312	5	179824312	644501	633841		
449	NM_003900.5(SQSTM1):c.683C>T (p.Pro228Leu)	SQSTM1	P144L, P228L	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Aug 1, 2018)	criteria provided, single submitter	VCV000475402	5	179252155	5	179825155	475402	455723	rs151191977	
450	NM_003900.5(SQSTM1):c.711_713GAA[1] (p.Lys238del)	SQSTM1	K154del, K238del	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	Uncertain significance(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000202213	5	179252183 - 179252185	5	179825183 - 179825185	202213	198654	rs796052214	
451	NM_003900.5(SQSTM1):c.763G>A (p.Val255Ile)	SQSTM1	V171I, V255I	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Mar 14, 2018)	criteria provided, single submitter	VCV000576548	5	179260040	5	179833040	576548	560410	rs182522590	
452	NM_003900.5(SQSTM1):c.800G>A (p.Arg267His)	SQSTM1	R183H, R267H	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Mar 19, 2018)	criteria provided, single submitter	VCV000475405	5	179260077	5	179833077	475405	455006	rs149424705	
453	NM_003900.5(SQSTM1):c.802C>G (p.Leu268Val)	SQSTM1	L184V, L268V	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Oct 6, 2017)	criteria provided, single submitter	VCV000542158	5	179260079	5	179833079	542158	521353	rs753685955	
454	NM_003900.5(SQSTM1):c.822G>C (p.Glu274Asp)	SQSTM1	E190D, E274D	Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone|Paget disease of bone 2, early-onset|not specified	Benign/Likely benign(Last reviewed: Aug 7, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259188	5	179260099	5	179833099	259188	251872	rs55793208	
455	NM_003900.5(SQSTM1):c.835_837GAG[1] (p.Glu280del)	SQSTM1	E280del, E196del	not provided|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Conflicting interpretations of pathogenicity(Last reviewed: Jan 21, 2019)	criteria provided, conflicting interpretations	VCV000475406	5	179260112 - 179260114	5	179833112 - 179833114	475406	455486	rs752009611	
456	NM_003900.5(SQSTM1):c.954C>T (p.Ser318=)	SQSTM1		Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone|not specified|Paget disease of bone 2, early-onset	Benign/Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259192	5	179260231	5	179833231	259192	251876	rs56092424	
457	NM_003900.5(SQSTM1):c.962G>A (p.Arg321His)	SQSTM1	R237H, R321H	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000660485	5	179260239	5	179833239	660485	633842		
458	NM_003900.4(SQSTM1):c.970delG (p.Glu324Asnfs)	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000542159	5	179260586	5	179833586	542159	521649	rs758377403	
459	NM_003900.5(SQSTM1):c.986A>G (p.Asp329Gly)	SQSTM1	D245G, D329G	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000650222	5	179260603	5	179833603	650222	633843		
460	NM_003900.5(SQSTM1):c.995C>T (p.Ser332Leu)	SQSTM1	S332L, S248L	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000647353	5	179260612	5	179833612	647353	633845		
461	NM_003900.5(SQSTM1):c.995C>G (p.Ser332Ter)	SQSTM1	S248*, S332*	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Oct 18, 2018)	criteria provided, single submitter	VCV000642133	5	179260612	5	179833612	642133	633844		
462	NM_003900.5(SQSTM1):c.1006G>A (p.Asp336Asn)	SQSTM1	D336N, D252N	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Jan 7, 2018)	criteria provided, single submitter	VCV000542160	5	179260623	5	179833623	542160	521476	rs1554091442	
463	NM_003900.5(SQSTM1):c.1043C>T (p.Pro348Leu)	SQSTM1	P264L, P348L	not provided	Uncertain significance(Last reviewed: Mar 17, 2017)	criteria provided, single submitter	VCV000420166	5	179260660	5	179833660	420166	406736	rs772889843	
464	NM_003900.5(SQSTM1):c.1084G>A (p.Glu362Lys)	SQSTM1	E362K, E278K	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000655119	5	179260701	5	179833701	655119	633846		
465	NM_003900.5(SQSTM1):c.1097C>G (p.Ser366Cys)	SQSTM1	S282C, S366C	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Aug 6, 2018)	criteria provided, single submitter	VCV000648242	5	179260714	5	179833714	648242	633847		
466	NM_003900.5(SQSTM1):c.1160C>T (p.Pro387Leu)	SQSTM1	P387L, P303L	Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided	Likely pathogenic(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000202211	5	179260777	5	179833777	202211	198652	rs776749939	
467	NM_003900.5(SQSTM1):c.1165+1G>A	SQSTM1		Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone, familial|GNE myopathy	Pathogenic(Last reviewed: Aug 24, 2017)	criteria provided, single submitter	VCV000008110	5	179260783	5	179833783	8110	23149	rs796051870	
468	NM_003900.5(SQSTM1):c.1166-5G>A	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000578482	5	179263431	5	179836431	578482	563088	rs765613974	
469	NM_003900.5(SQSTM1):c.1175C>T (p.Pro392Leu)	SQSTM1	P392L, P308L	Spastic paraplegia-Paget disease of bone syndrome|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|Paget disease of bone, familial|Paget disease of bone, familial|Frontotemporal dementia and/or amyotrophic lateral sclerosis 3|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2019)	criteria provided, conflicting interpretations	VCV000008108	5	179263445	5	179836445	8108	23147	rs104893941	
470	NM_003900.5(SQSTM1):c.1178G>A (p.Arg393Gln)	SQSTM1	R393Q, R309Q	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000475395	5	179263448	5	179836448	475395	454874	rs200551825	
471	NM_003900.5(SQSTM1):c.1230C>T (p.Gly410=)	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|not specified	Likely benign(Last reviewed: Jun 6, 2017)	criteria provided, multiple submitters, no conflicts	VCV000385765	5	179263500	5	179836500	385765	368616	rs766437927	
472	NM_003900.5(SQSTM1):c.1242C>A (p.Thr414=)	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Likely benign(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000475396	5	179263512	5	179836512	475396	455492	rs1554092111	
473	NM_001025366.2(VEGFA):c.-2055A>C	VEGFA		Atherosclerosis, susceptibility to	Benign(Last reviewed: Dec 1, 2009)	no assertion criteria provided	VCV000012224	6	43736389	6	43768652	12224	27263	rs699947	
474	NM_014845.5(FIG4):c.-182G>A	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided	Likely benign(Last reviewed: Jun 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000355024	6	110012457	6	109691254	355024	301199	rs55873083	
475	NM_014845.5(FIG4):c.-138T>C	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355025	6	110012501	6	109691298	355025	301202	rs550585093	
476	NM_014845.5(FIG4):c.-134C>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355026	6	110012505	6	109691302	355026	305557	rs560811735	
477	NM_014845.5(FIG4):c.-132A>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355027	6	110012507	6	109691304	355027	305565	rs548471516	
478	NM_014845.5(FIG4):c.-124A>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355028	6	110012515	6	109691312	355028	301203	rs544958043	
479	NM_014845.5(FIG4):c.-121G>A	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355029	6	110012518	6	109691315	355029	301204	rs75509752	
480	NM_014845.5(FIG4):c.-120C>T	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355030	6	110012519	6	109691316	355030	305566	rs75045314	
481	NM_014845.5(FIG4):c.-112G>A	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355031	6	110012527	6	109691324	355031	298724	rs757848529	
482	NM_014845.5(FIG4):c.-84A>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355032	6	110012555	6	109691352	355032	298725	rs764845399	
483	NM_014845.5(FIG4):c.27C>T (p.Ile9=)	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided|not specified	Benign/Likely benign(Last reviewed: May 2, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137376	6	110012665	6	109691462	137376	141079	rs141040807	
484	NM_014845.5(FIG4):c.66+10C>T	FIG4		not specified|not provided|Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Benign/Likely benign(Last reviewed: Mar 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000220332	6	110012714	6	109691511	220332	221621	rs200063827	
485	NM_014845.5(FIG4):c.67-7T>C	FIG4		not specified|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease, type 4J|Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137374	6	110036274	6	109715071	137374	141077	rs56378532	
486	NM_014845.5(FIG4):c.122T>C (p.Ile41Thr)	FIG4	I41T	Charcot-Marie-Tooth disease type 4|not specified|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Dec 14, 2018)	criteria provided, conflicting interpretations	VCV000001721	6	110036336	6	109715133	1721	16760	rs121908287	
487	NM_014845.5(FIG4):c.157G>T (p.Asp53Tyr)	FIG4	D53Y	Amyotrophic lateral sclerosis type 11	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000001728	6	110036371	6	109715168	1728	16767	rs121908290	
488	NM_014845.5(FIG4):c.173A>G (p.Tyr58Cys)	FIG4	Y58C	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000355033	6	110037655	6	109716452	355033	301206	rs145337669	
489	NM_014845.5(FIG4):c.235G>A (p.Gly79Arg)	FIG4	G79R	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355034	6	110037717	6	109716514	355034	305567	rs886060982	
490	NM_014845.5(FIG4):c.243A>G (p.Lys81=)	FIG4		Charcot-Marie-Tooth disease type 4|not provided|Amyotrophic Lateral Sclerosis, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Oct 3, 2018)	criteria provided, conflicting interpretations	VCV000355035	6	110037725	6	109716522	355035	301208	rs200257799	
491	NM_014845.5(FIG4):c.262C>T (p.Arg88Ter)	FIG4	R88*	FIG4-Related Disorders|Amyotrophic lateral sclerosis type 11	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000355036	6	110037744	6	109716541	355036	305568	rs753207473	
492	NM_014845.5(FIG4):c.350C>T (p.Ala117Val)	FIG4	A117V	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Feb 9, 2018)	criteria provided, multiple submitters, no conflicts	VCV000355037	6	110048372	6	109727169	355037	305569	rs551339249	
493	NM_014845.5(FIG4):c.547C>T (p.Arg183Ter)	FIG4	R183*	not provided|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11	Pathogenic(Last reviewed: Jun 17, 2015)	criteria provided, single submitter	VCV000001723	6	110056402	6	109735199	1723	16762	rs121908288	
494	NM_014845.5(FIG4):c.737G>A (p.Trp246Ter)	FIG4	W246*	Charcot-Marie-Tooth disease, type 4J|Polymicrogyria, bilateral temporooccipital|Amyotrophic lateral sclerosis type 11|Yunis Varon syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420149	6	110059618	6	109738415	420149	406786	rs776005417	
495	NM_014845.5(FIG4):c.759del (p.Phe254fs)	FIG4	F254fs	Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|not provided|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11	Pathogenic(Last reviewed: Jan 10, 2018)	criteria provided, multiple submitters, no conflicts	VCV000254668	6	110059638	6	109738435	254668	249211	rs764717219	
496	NM_014845.5(FIG4):c.808A>G (p.Thr270Ala)	FIG4	T270A	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not specified|not provided	Benign/Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260452	6	110062679	6	109741476	260452	252051	rs61729092	
497	NM_014845.5(FIG4):c.834A>T (p.Lys278Asn)	FIG4	K278N	Polymicrogyria, bilateral temporooccipital|not provided|Amyotrophic lateral sclerosis type 11|Yunis Varon syndrome|Charcot-Marie-Tooth disease, type 4J	Conflicting interpretations of pathogenicity(Last reviewed: Jan 4, 2019)	criteria provided, conflicting interpretations	VCV000407082	6	110062705	6	109741502	407082	395001	rs138048706	
498	NM_014845.5(FIG4):c.919G>A (p.Asp307Asn)	FIG4	D307N	Amyotrophic lateral sclerosis type 11	Uncertain significance(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000254669	6	110064355	6	109743152	254669	249212	rs573441014	
499	NM_014845.5(FIG4):c.1090A>T (p.Met364Leu)	FIG4	M364L	Charcot-Marie-Tooth disease type 4|not specified|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease, type 4J|Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137375	6	110064928	6	109743725	137375	141078	rs2295837	
500	NM_014845.6(FIG4):c.1150del (p.Arg384fs)	FIG4	R384fs	Amyotrophic lateral sclerosis type 11	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802256	6	110081462	6	109760259	802256	790574		
501	NM_014845.5(FIG4):c.1207C>T (p.Gln403Ter)	FIG4	Q403*	not provided	Pathogenic(Last reviewed: Apr 29, 2015)	criteria provided, single submitter	VCV000245747	6	110081522	6	109760319	245747	244485	rs879253926	
502	NM_014845.5(FIG4):c.1242T>C (p.Ile414=)	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided|not specified	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000355038	6	110081557	6	109760354	355038	298731	rs61729087	
503	NM_014845.5(FIG4):c.1272-10C>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 2, 2018)	criteria provided, conflicting interpretations	VCV000355039	6	110083284	6	109762081	355039	305570	rs201293291	
504	NM_014845.5(FIG4):c.1584-8T>A	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 18, 2019)	criteria provided, conflicting interpretations	VCV000260446	6	110087924	6	109766721	260446	252053	rs199522051	
505	NM_014845.5(FIG4):c.1619C>T (p.Thr540Ile)	FIG4	T540I	Amyotrophic lateral sclerosis type 11	Uncertain significance(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000254670	6	110087967	6	109766764	254670	249213	rs1057519386	
506	NM_014845.5(FIG4):c.1666dup (p.Thr556fs)	FIG4		Charcot-Marie-Tooth disease type 4|not provided|FIG4-Related Disorders	Pathogenic/Likely pathogenic(Last reviewed: Jul 16, 2019)	criteria provided, multiple submitters, no conflicts	VCV000355040	6	110088010 - 110088011	6	109766807 - 109766808	355040	298732	rs772320287	
507	NM_014845.5(FIG4):c.1793T>A (p.Phe598Tyr)	FIG4	F598Y	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355041	6	110098167	6	109776964	355041	305686	rs751399063	
508	NM_014845.5(FIG4):c.1863C>A (p.Thr621=)	FIG4		not provided|Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 15, 2018)	criteria provided, conflicting interpretations	VCV000355042	6	110098237	6	109777034	355042	305571	rs201744761	
509	NM_014845.5(FIG4):c.1940A>G (p.Tyr647Cys)	FIG4	Y647C	Charcot-Marie-Tooth disease type 4|Amyotrophic lateral sclerosis type 11	Conflicting interpretations of pathogenicity(Last reviewed: Aug 14, 2018)	criteria provided, conflicting interpretations	VCV000254671	6	110106223	6	109785020	254671	249214	rs150301327	
510	NM_014845.5(FIG4):c.1948+3A>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|not provided|Amyotrophic lateral sclerosis type 11|Charcot-Marie-Tooth disease, type 4J|Charcot-Marie-Tooth disease type 4|not specified	Benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260447	6	110106234	6	109785031	260447	252054	rs10499054	
511	NM_014845.5(FIG4):c.1961T>C (p.Val654Ala)	FIG4	V654A	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not specified|not provided|Amyotrophic lateral sclerosis type 11	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000137377	6	110107517	6	109786314	137377	141080	rs9885672	
512	NM_014845.5(FIG4):c.2035C>T (p.Arg679Trp)	FIG4	R679W	not provided	Uncertain significance(Last reviewed: Apr 25, 2016)	criteria provided, single submitter	VCV000245603	6	110107591	6	109786388	245603	244487	rs188910818	
513	NM_014845.5(FIG4):c.2080A>G (p.Met694Val)	FIG4	M694V	not provided|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000246456	6	110107636	6	109786433	246456	244488	rs143531641	
514	NM_014845.5(FIG4):c.2096G>A (p.Arg699His)	FIG4	R699H	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided	Uncertain significance(Last reviewed: Mar 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000355043	6	110107652	6	109786449	355043	301209	rs750091928	
515	NM_014845.5(FIG4):c.2200G>A (p.Glu734Lys)	FIG4	E734K	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided	Uncertain significance(Last reviewed: Aug 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000234661	6	110112598	6	109791395	234661	231652	rs372846619	
516	NM_014845.5(FIG4):c.2223G>T (p.Thr741=)	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355044	6	110112621	6	109791418	355044	305687	rs181012139	
517	NM_014845.5(FIG4):c.2377-10T>A	FIG4		Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Mar 28, 2017)	criteria provided, single submitter	VCV000476858	6	110113775	6	109792572	476858	456019	rs9481005	
518	NM_014845.5(FIG4):c.2460A>C (p.Arg820Ser)	FIG4	R820S	Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000355045	6	110117968	6	109796765	355045	301210	rs886060984	
519	NM_014845.5(FIG4):c.2547-11A>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355046	6	110146280	6	109825077	355046	301213	rs745613994	
520	NM_014845.5(FIG4):c.2547-5T>G	FIG4		Charcot-Marie-Tooth disease type 4|not provided|Amyotrophic Lateral Sclerosis, Dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2019)	criteria provided, conflicting interpretations	VCV000355047	6	110146286	6	109825083	355047	301214	rs200267243	
521	NM_014845.5(FIG4):c.2547-4A>G	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355048	6	110146287	6	109825084	355048	305691	rs886060985	
522	NM_014845.5(FIG4):c.2558C>T (p.Ser853Leu)	FIG4	S853L	Amyotrophic lateral sclerosis type 11	Uncertain significance(Last reviewed: Sep 13, 2016)	criteria provided, single submitter	VCV000254672	6	110146302	6	109825099	254672	249215	rs774805375	
523	NM_014845.5(FIG4):c.2559G>A (p.Ser853=)	FIG4		Amyotrophic Lateral Sclerosis, Dominant|not provided|Charcot-Marie-Tooth disease type 4|not specified	Benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260449	6	110146303	6	109825100	260449	252056	rs1127771	
524	NM_014845.5(FIG4):c.2568G>T (p.Ser856=)	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 13, 2018)	criteria provided, conflicting interpretations	VCV000355049	6	110146312	6	109825109	355049	305582	rs140055056	
525	NM_014845.5(FIG4):c.*7C>T	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355050	6	110146475	6	109825272	355050	305587	rs113946190	
526	NM_014845.5(FIG4):c.*14C>T	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4|not specified	Benign/Likely benign(Last reviewed: Mar 11, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260444	6	110146482	6	109825279	260444	252057	rs114136062	
527	NM_014845.5(FIG4):c.*29G>A	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355051	6	110146497	6	109825294	355051	301219	rs10659	
528	NM_014845.5(FIG4):c.*120C>T	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355052	6	110146588	6	109825385	355052	298744	rs1127775	
529	NM_014845.5(FIG4):c.*150_*151del	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355053	6	110146618 - 110146619	6	109825415 - 109825416	355053	301223	rs886060986	
530	NM_031243.3(HNRNPA2B1):c.1020_1028del (p.341_343SGG[1])	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000541427	7	26232170 - 26232178	7	26192550 - 26192558	541427	522884	rs754021381	
531	NM_031243.3(HNRNPA2B1):c.905A>T (p.Asp302Val)	HNRNPA2B1	D290V, D302V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065454	7	26232966	7	26193346	65454	76371	rs397515326	
532	NM_031243.3(HNRNPA2B1):c.833A>G (p.Asn278Ser)	HNRNPA2B1	N278S, N266S	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Jun 19, 2017)	criteria provided, single submitter	VCV000474504	7	26233239	7	26193619	474504	457114	rs1554331125	
533	NM_031243.3(HNRNPA2B1):c.705C>T (p.Gly235=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 28, 2017)	criteria provided, single submitter	VCV000541426	7	26235519	7	26195899	541426	522885	rs767263210	
534	NM_031243.3(HNRNPA2B1):c.695-4A>G	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000571200	7	26235533	7	26195913	571200	564276	rs1562711082	
535	NM_031243.3(HNRNPA2B1):c.693T>C (p.Ser231=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000662036	7	26236022	7	26196402	662036	636094		
536	NM_031243.3(HNRNPA2B1):c.669A>G (p.Pro223=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000541428	7	26236046	7	26196426	541428	523264	rs752086550	
537	NM_031243.3(HNRNPA2B1):c.614-10T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000646482	7	26236111	7	26196491	646482	651725		
538	NM_031243.3(HNRNPA2B1):c.555A>G (p.Arg185=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not specified	Benign(Last reviewed: Aug 2, 2017)	criteria provided, multiple submitters, no conflicts	VCV000261954	7	26236235	7	26196615	261954	252784	rs34317198	
539	NM_031243.3(HNRNPA2B1):c.512-3C>T	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Aug 20, 2018)	criteria provided, single submitter	VCV000659107	7	26236281	7	26196661	659107	651731		
540	NM_031243.3(HNRNPA2B1):c.153+4T>C	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2|not specified	Benign(Last reviewed: Aug 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000261953	7	26237238	7	26197618	261953	252785	rs41275982	
541	NM_031243.3(HNRNPA2B1):c.69C>G (p.Leu23=)	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000474501	7	26237326	7	26197706	474501	457125	rs774999756	
542	NM_001540.5(HSPB1):c.257C>T (p.Ser86Leu)	HSPB1	S86L	Charcot-Marie-Tooth disease type 2F	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000465269	7	75932286	7	76302969	465269	457918	rs749378020	
543	NM_001363118.2(SLC52A2):c.1289A>G (p.Tyr430Cys)	SLC52A2	Y430C, Y266C	Brown-Vialetto-Van Laere syndrome 2|Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000548482	8	145584626	8	144360966	548482	539010	rs781873022	
544	NM_001256054.2(C9orf72):c.*1469T>A	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366484	9	27546765	9	27546767	366484	318222	rs141012074	
545	NM_001256054.2(C9orf72):c.*1406T>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366485	9	27546828	9	27546830	366485	318223	rs9103	
546	NM_001256054.2(C9orf72):c.*1344C>T	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366486	9	27546890	9	27546892	366486	318747	rs13691	
547	NM_001256054.2(C9orf72):c.*1262A>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366487	9	27546972	9	27546974	366487	308072	rs886063833	
548	NM_001256054.2(C9orf72):c.*1058G>T	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366488	9	27547176	9	27547178	366488	318224	rs41272887	
549	NM_001256054.2(C9orf72):c.*1024A>G	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366489	9	27547210	9	27547212	366489	318759	rs563194682	
550	NM_001256054.2(C9orf72):c.*921C>A	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366490	9	27547313	9	27547315	366490	318227	rs3739526	
551	NM_001256054.2(C9orf72):c.*914A>G	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366491	9	27547320	9	27547322	366491	318761	rs561651779	
552	NM_001256054.2(C9orf72):c.*837G>A	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366492	9	27547397	9	27547399	366492	318229	rs80172172	
553	NM_001256054.2(C9orf72):c.*794_*797del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366493	9	27547437 - 27547440	9	27547439 - 27547442	366493	312430	rs886063834	
554	NM_001256054.2(C9orf72):c.*673T>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366494	9	27547561	9	27547563	366494	308075	rs886063835	
555	NM_001256054.2(C9orf72):c.*651G>T	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366495	9	27547583	9	27547585	366495	308076	rs548883941	
556	NM_001256054.2(C9orf72):c.*577G>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366496	9	27547657	9	27547659	366496	318239	rs886063836	
557	NM_001256054.2(C9orf72):c.*552A>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366497	9	27547682	9	27547684	366497	308078	rs886063837	
558	NM_001256054.2(C9orf72):c.*356T>G	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366498	9	27547878	9	27547880	366498	308079	rs886063838	
559	NM_001256054.2(C9orf72):c.*317A>G	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366499	9	27547917	9	27547919	366499	312434	rs886063839	
560	NM_001256054.2(C9orf72):c.*309dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366500	9	27547924 - 27547925	9	27547926 - 27547927	366500	318241	rs200583482	
561	NM_001256054.2(C9orf72):c.*250T>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366501	9	27547984	9	27547986	366501	318250	rs886063840	
562	NM_001256054.2(C9orf72):c.*248T>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366502	9	27547986	9	27547988	366502	312437	rs73440933	
563	NM_001256054.2(C9orf72):c.*174C>T	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366503	9	27548060	9	27548062	366503	312449	rs146530591	
564	NM_001256054.2(C9orf72):c.*122G>A	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366504	9	27548112	9	27548114	366504	318251	rs549202876	
565	NM_001256054.2(C9orf72):c.*73G>A	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366505	9	27548161	9	27548163	366505	318764	rs886063841	
566	NM_001256054.2(C9orf72):c.1426G>C (p.Asp476His)	C9orf72	D476H	Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366506	9	27548254	9	27548256	366506	318258	rs767272170	
567	NM_001256054.2(C9orf72):c.1424G>A (p.Arg475Gln)	C9orf72	R475Q	Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366507	9	27548256	9	27548258	366507	318767	rs750045383	
568	NM_001256054.2(C9orf72):c.1404C>T (p.Phe468=)	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia|not provided	Benign/Likely benign(Last reviewed: Sep 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000366508	9	27548276	9	27548278	366508	312464	rs141063383	
569	NM_001256054.2(C9orf72):c.1260-13dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366510	9	27548431 - 27548432	9	27548433 - 27548434	366510	308081	rs749166700	
570	NM_001256054.2(C9orf72):c.1260-12_1260-11insT	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366509	9	27548431 - 27548432	9	27548433 - 27548434	366509	318264	rs1554659312	
571	NM_001256054.2(C9orf72):c.1260-16_1260-13dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366513	9	27548432 - 27548433	9	27548434 - 27548435	366513	318288	rs1554659316	
572	NM_001256054.2(C9orf72):c.1260-13_1260-12insTT	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366512	9	27548432 - 27548433	9	27548434 - 27548435	366512	318269	rs772249544	
573	NM_001256054.2(C9orf72):c.1260-13_1260-12insT	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366511	9	27548432 - 27548433	9	27548434 - 27548435	366511	318267	rs772249544	
574	NM_001256054.2(C9orf72):c.1260-39_1260-35dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366519	9	27548433 - 27548434	9	27548435 - 27548436	366519	318304	rs11292923	
575	NM_001256054.2(C9orf72):c.1260-39_1260-36dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366518	9	27548433 - 27548434	9	27548435 - 27548436	366518	318772	rs11292923	
576	NM_001256054.2(C9orf72):c.1260-39_1260-37dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366517	9	27548433 - 27548434	9	27548435 - 27548436	366517	308089	rs11292923	
577	NM_001256054.2(C9orf72):c.1260-39dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366516	9	27548433 - 27548434	9	27548435 - 27548436	366516	318773	rs11292923	
578	NM_001256054.2(C9orf72):c.1260-15_1260-13del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366515	9	27548433 - 27548435	9	27548435 - 27548437	366515	308084	rs886063843	
579	NM_001256054.2(C9orf72):c.1260-14_1260-13del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366514	9	27548433 - 27548434	9	27548435 - 27548436	366514	308082	rs886063842	
580	NM_001256054.2(C9orf72):c.1260-16_1260-14del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366521	9	27548434 - 27548436	9	27548436 - 27548438	366521	318769	rs11292923	
581	NM_001256054.2(C9orf72):c.1260-14del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366520	9	27548434	9	27548436	366520	308091	rs11292923	
582	NM_001256054.2(C9orf72):c.1238T>C (p.Ile413Thr)	C9orf72	I413T	Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366522	9	27548576	9	27548578	366522	318312	rs760887239	
583	NM_001256054.2(C9orf72):c.1149+9T>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia|not provided	Benign/Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000366523	9	27550639	9	27550641	366523	312466	rs139352974	
584	NM_001256054.2(C9orf72):c.870C>T (p.Ser290=)	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366524	9	27556780	9	27556782	366524	318774	rs10122902	
585	NM_001256054.2(C9orf72):c.792G>T (p.Arg264Ser)	C9orf72	R264S	Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366525	9	27558552	9	27558554	366525	312468	rs886063845	
586	NM_001256054.2(C9orf72):c.620A>G (p.Asn207Ser)	C9orf72	N207S	Amyotrophic Lateral Sclerosis/Frontotemporal Dementia|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366526	9	27561628	9	27561630	366526	318781	rs17769294	
587	NM_001256054.2(C9orf72):c.462C>T (p.Val154=)	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366527	9	27565571	9	27565573	366527	308104	rs188263738	
588	NM_001256054.2(C9orf72):c.288A>G (p.Ser96=)	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366528	9	27566831	9	27566833	366528	318318	rs147752518	
589	NM_001256054.2(C9orf72):c.-27G>A	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366529	9	27567145	9	27567147	366529	312470	rs10757668	
590	Single allele	C9orf72		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Pathogenic(Last reviewed: Oct 16, 2014)	no assertion criteria provided	VCV000183034	9	27573527 - 27573532	9	27573523 - 27573524	183034	181181	rs143561967	
591	NM_001256054.2(C9orf72):c.-45+163_-45+180GGGGCC(2_25)	C9orf72		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Benign(Last reviewed: Oct 16, 2014)	no assertion criteria provided	VCV000183033	9	27573527 - 27573532	9	27573529 - 27573534	183033	181180	rs143561967	
592	NM_001256054.1(C9orf72):c.-45+163GGGGCC[>24]	C9orf72		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Pathogenic(Last reviewed: Mar 15, 2013)	no assertion criteria provided	VCV000031151	9	27573527 - 27573532	9	27573529 - 27573534	31151	40108	rs143561967	
593	NM_001256054.2(C9orf72):c.-47G>A	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366530	9	27573709	9	27573711	366530	312471	rs886063846	
594	NM_001256054.2(C9orf72):c.-113C>G	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366531	9	27573775	9	27573777	366531	318327	rs750403732	
595	NM_001256054.2(C9orf72):c.-115A>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366532	9	27573777	9	27573779	366532	318331	rs183102304	
596	NM_001256054.2(C9orf72):c.-164T>C	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366533	9	27573826	9	27573828	366533	318790	rs41272893	
597	NM_001256054.2(C9orf72):c.-169dup	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366534	9	27573830 - 27573831	9	27573832 - 27573833	366534	318333	rs886063847	
598	NM_001256054.2(C9orf72):c.-173A>G	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366535	9	27573835	9	27573837	366535	312472	rs886063848	
599	NM_005866.4(SIGMAR1):c.*51G>T	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000643550	9	34635578	9	34635581	643550	638210		
600	NM_005866.4(SIGMAR1):c.446-25_*40del	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile	Likely pathogenic	criteria provided, single submitter	VCV000431074	9	34635589 - 34635880	9	34635592 - 34635883	431074	424599	rs1554707622	
601	NM_005866.4(SIGMAR1):c.*31A>G	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: Jul 24, 2015)	no assertion criteria provided	VCV000208122	9	34635598	9	34635601	208122	204389	rs4879809	
602	NM_005866.4(SIGMAR1):c.632G>A (p.Arg211Gln)	SIGMAR1	R211Q, R180Q, R111Q, R191Q	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000573115	9	34635669	9	34635672	573115	563927	rs192644838	
603	NM_005866.4(SIGMAR1):c.623G>A (p.Arg208Gln)	SIGMAR1	R208Q, R177Q, R188Q, R108Q	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Apr 10, 2018)	criteria provided, single submitter	VCV000569077	9	34635678	9	34635681	569077	569005	rs541996857	
604	NM_005866.4(SIGMAR1):c.595C>T (p.Leu199Phe)	SIGMAR1	L99F, L168F, L179F, L199F	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000655091	9	34635706	9	34635709	655091	638211		
605	NM_005866.4(SIGMAR1):c.561_576del (p.Asp188fs)	SIGMAR1	D168fs, D157fs, D188fs, D88fs	Amyotrophic lateral sclerosis 16, juvenile	Likely pathogenic	criteria provided, single submitter	VCV000431075	9	34635725 - 34635740	9	34635728 - 34635743	431075	424598	rs1554707680	
606	NM_005866.4(SIGMAR1):c.552C>T (p.Phe184=)	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Benign(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000465870	9	34635749	9	34635752	465870	460001	rs61739588	
607	NM_005866.4(SIGMAR1):c.545T>C (p.Leu182Pro)	SIGMAR1	L182P, L151P, L82P, L162P	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile|not specified	Uncertain significance(Last reviewed: Feb 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448379	9	34635756	9	34635759	448379	441330	rs781091660	
608	NM_005866.4(SIGMAR1):c.529G>A (p.Val177Ile)	SIGMAR1	V177I, V157I, V77I, V146I	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000659848	9	34635772	9	34635775	659848	638212		
609	NM_005866.4(SIGMAR1):c.463G>A (p.Gly155Arg)	SIGMAR1	G155R, G124R, G135R, G55R, R108Q	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000465869	9	34635838	9	34635841	465869	459438	rs200076129	
610	NM_005866.4(SIGMAR1):c.453G>A (p.Thr151=)	SIGMAR1	R159Q, G105S	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Likely benign(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000534264	9	34635848	9	34635851	534264	524830	rs751571040	
611	NM_005866.4(SIGMAR1):c.446-5C>G	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000578578	9	34635860	9	34635863	578578	565878	rs1564095230	
612	NM_005866.4(SIGMAR1):c.416G>T (p.Gly139Val)	SIGMAR1	G139V, A147S, G39V, G119V	Amyotrophic lateral sclerosis 16, juvenile	Likely pathogenic(Last reviewed: Dec 3, 2017)	criteria provided, single submitter	VCV000522651	9	34637023	9	34637026	522651	513300	rs1270528470	
613	NM_005866.4(SIGMAR1):c.344G>T (p.Gly115Val)	SIGMAR1	G115V, G95V	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000534263	9	34637225	9	34637228	534263	525087	rs1241574813	
614	NM_005866.4(SIGMAR1):c.339C>T (p.Ser113=)	SIGMAR1		Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Likely benign(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000534266	9	34637230	9	34637233	534266	524937	rs754738945	
615	NM_005866.4(SIGMAR1):c.304G>C (p.Glu102Gln)	SIGMAR1	E102Q, E82Q	Amyotrophic lateral sclerosis 16, juvenile	Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000030238	9	34637265	9	34637268	30238	39194	rs387906829	
616	NM_005866.4(SIGMAR1):c.298C>G (p.Leu100Val)	SIGMAR1	L100V, L80V	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000568833	9	34637271	9	34637274	568833	569006	rs1278952640	
617	NM_005866.4(SIGMAR1):c.283dup (p.Leu95fs)	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Pathogenic(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000209190	9	34637285 - 34637286	9	34637288 - 34637289	209190	205762	rs780136067	
618	NM_005866.4(SIGMAR1):c.259G>A (p.Gly87Ser)	SIGMAR1	G87S, G67S	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Jul 9, 2018)	criteria provided, single submitter	VCV000642698	9	34637310	9	34637313	642698	638213		
619	NM_005866.4(SIGMAR1):c.247T>C (p.Phe83Leu)	SIGMAR1	F83L, F63L	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Oct 8, 2018)	criteria provided, single submitter	VCV000579502	9	34637322	9	34637325	579502	565882	rs773344340	
620	NM_005866.4(SIGMAR1):c.194T>A (p.Leu65Gln)	SIGMAR1	L65Q, L45Q	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000575556	9	34637375	9	34637378	575556	563214	rs140376902	
621	NM_005866.4(SIGMAR1):c.140G>C (p.Arg47Pro)	SIGMAR1	R47P	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000653722	9	34637555	9	34637558	653722	638214		
622	NM_005866.4(SIGMAR1):c.92G>A (p.Gly31Asp)	SIGMAR1	G31D	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000534261	9	34637603	9	34637606	534261	524939	rs532632647	
623	NM_005866.4(SIGMAR1):c.79T>A (p.Trp27Arg)	SIGMAR1	W27R	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Uncertain significance(Last reviewed: Apr 25, 2018)	criteria provided, single submitter	VCV000565401	9	34637616	9	34637619	565401	563216	rs1564096623	
624	NM_005866.4(SIGMAR1):c.61G>C (p.Val21Leu)	SIGMAR1	V21L	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: May 1, 2018)	criteria provided, single submitter	VCV000567953	9	34637634	9	34637637	567953	563941	rs1396152845	
625	NM_005866.4(SIGMAR1):c.19del (p.Arg7fs)	SIGMAR1	R7fs	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Pathogenic(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000650504	9	34637676	9	34637679	650504	638215		
626	NM_005866.4(SIGMAR1):c.13del (p.Val5fs)	SIGMAR1	V5fs	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000569448	9	34637682	9	34637685	569448	565883	rs1564096761	
627	NM_005866.4(SIGMAR1):c.11C>T (p.Ala4Val)	SIGMAR1	A4V	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2|not provided	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, multiple submitters, no conflicts	VCV000534262	9	34637684	9	34637687	534262	524527	rs367968662	
628	NM_007126.5(VCP):c.*1035dup	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366703	9	35056078 - 35056079	9	35056081 - 35056082	366703	308234	rs532528005	
629	NM_007126.5(VCP):c.*906A>G	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366704	9	35056208	9	35056211	366704	318524	rs76360394	
630	NM_007126.5(VCP):c.*788G>A	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366705	9	35056326	9	35056329	366705	312609	rs886063887	
631	NM_007126.5(VCP):c.*700C>A	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366706	9	35056414	9	35056417	366706	318528	rs537730311	
632	NM_007126.5(VCP):c.*596C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366707	9	35056518	9	35056521	366707	308235	rs55745923	
633	NM_007126.5(VCP):c.*438A>G	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366708	9	35056676	9	35056679	366708	308243	rs137953487	
634	NM_007126.5(VCP):c.*384del	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366709	9	35056730	9	35056733	366709	312615	rs532445930	
635	NM_007126.5(VCP):c.*382C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366710	9	35056732	9	35056735	366710	308244	rs749381324	
636	NM_007126.5(VCP):c.*347C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366711	9	35056767	9	35056770	366711	312619	rs886063888	
637	NM_007126.5(VCP):c.*184G>A	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366712	9	35056930	9	35056933	366712	308246	rs886063889	
638	NM_007126.5(VCP):c.*172C>G	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366713	9	35056942	9	35056945	366713	312628	rs886063890	
639	NM_007126.5(VCP):c.*153G>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366714	9	35056961	9	35056964	366714	318529	rs1053318	
640	NM_007126.5(VCP):c.*64C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366715	9	35057050	9	35057053	366715	308247	rs553370942	
641	NM_007126.5(VCP):c.*4G>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Nov 14, 2016)	criteria provided, conflicting interpretations	VCV000284304	9	35057110	9	35057113	284304	268541	rs201091341	
642	NM_007126.5(VCP):c.2397C>G (p.Asp799Glu)	VCP	D799E, D754E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000568017	9	35057138	9	35057141	568017	563943	rs1329151473	
643	NM_007126.5(VCP):c.2266G>A (p.Glu756Lys)	VCP	E711K, E756K	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000653332	9	35057422	9	35057425	653332	638217		
644	NM_007126.5(VCP):c.2214A>G (p.Glu738=)	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000194645	9	35057474	9	35057477	194645	191808	rs374391034	
645	NM_007126.5(VCP):c.2161-6C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jan 4, 2018)	criteria provided, single submitter	VCV000532766	9	35057533	9	35057536	532766	525095	rs199513619	
646	NM_007126.5(VCP):c.2014T>G (p.Leu672Val)	VCP	L627V, L672V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 9, 2018)	criteria provided, single submitter	VCV000647081	9	35059207	9	35059210	647081	638218		
647	NM_007126.5(VCP):c.1984C>T (p.Arg662Cys)	VCP	R662C, R617C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 11, 2018)	criteria provided, single submitter	VCV000572697	9	35059510	9	35059513	572697	563947	rs765795425	
648	NM_007126.5(VCP):c.1950G>A (p.Glu650=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 27, 2017)	criteria provided, single submitter	VCV000532763	9	35059544	9	35059547	532763	525101	rs752382520	
649	NM_007126.5(VCP):c.1856T>C (p.Ile619Thr)	VCP	I619T, I574T	Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366716	9	35059638	9	35059641	366716	318533	rs886063891	
650	NM_007126.5(VCP):c.1774G>A (p.Asp592Asn)	VCP	D592N, D547N	Amyotrophic lateral sclerosis 14 without frontotemporal dementia	Pathogenic(Last reviewed: Dec 9, 2010)	no assertion criteria provided	VCV000030153	9	35059720	9	35059723	30153	39109	rs387906790	
651	NM_007126.5(VCP):c.1704A>G (p.Gln568=)	VCP		Amyotrophic Lateral Sclerosis, Dominant|Inclusion Body Myopathy, Dominant|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260125	9	35059790	9	35059793	260125	253525	rs142577424	
652	NM_007126.5(VCP):c.1696-7C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Jun 12, 2017)	criteria provided, single submitter	VCV000464106	9	35059805	9	35059808	464106	459539	rs1554668202	
653	NM_007126.5(VCP):c.1695+8A>G	VCP		Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided|Inclusion Body Myopathy, Dominant	Benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000260124	9	35060302	9	35060305	260124	253526	rs684562	
654	NM_007126.5(VCP):c.1374G>C (p.Gln458His)	VCP	Q458H, Q413H	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 5, 2016)	criteria provided, single submitter	VCV000397543	9	35060906	9	35060909	397543	384436	rs1060499674	
655	NM_007126.5(VCP):c.1360-4C>G	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000532759	9	35060924	9	35060927	532759	524945	rs769279961	
656	NM_007126.5(VCP):c.1360-6T>C	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366717	9	35060926	9	35060929	366717	308255	rs370296303	
657	NM_007126.5(VCP):c.1360-14C>G	VCP		Amyotrophic Lateral Sclerosis, Dominant|not specified|Inclusion Body Myopathy, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000260122	9	35060934	9	35060937	260122	253527	rs144304208	
658	NM_007126.5(VCP):c.1329C>T (p.Asn443=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 6, 2017)	criteria provided, single submitter	VCV000532762	9	35061042	9	35061045	532762	524550	rs748816624	
659	NM_007126.5(VCP):c.1327A>C (p.Asn443His)	VCP	N443H, N398H	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000532760	9	35061044	9	35061047	532760	524552	rs770514866	
660	NM_007126.5(VCP):c.1194+3G>A	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Jul 11, 2018)	criteria provided, multiple submitters, no conflicts	VCV000565903	9	35061571	9	35061574	565903	563957	rs183223259	
661	NM_007126.5(VCP):c.1180G>A (p.Val394Met)	VCP	V394M, V349M	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000656560	9	35061588	9	35061591	656560	638219		
662	NM_007126.5(VCP):c.1092C>T (p.Asp364=)	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000366718	9	35061676	9	35061679	366718	319032	rs61752947	
663	NM_007126.5(VCP):c.1082-18_1082-8dup	VCP		not specified|not provided|Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260119	9	35061693 - 35061694	9	35061696 - 35061697	260119	253530	rs11272867	
664	NM_007126.5(VCP):c.927C>T (p.Ile309=)	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not provided|not specified	Benign/Likely benign(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000366719	9	35062232	9	35062235	366719	319044	rs34097935	
665	NM_007126.5(VCP):c.811+2_811+3inv	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000464111	9	35062972 - 35062973	9	35062975 - 35062976	464111	460015	rs1554668584	
666	NM_007126.5(VCP):c.811+3G>A	VCP		Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided|Inclusion Body Myopathy, Dominant	Benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000260128	9	35062972	9	35062975	260128	253532	rs514492	
667	NM_007126.5(VCP):c.695C>A (p.Ala232Glu)	VCP	A232E, A187E	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000008470	9	35064164	9	35064167	8470	23509	rs121909331	
668	NM_007126.5(VCP):c.572G>A (p.Arg191Gln)	VCP	R191Q, R146Q	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic/Likely pathogenic(Last reviewed: Aug 7, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008473	9	35065252	9	35065255	8473	23512	rs121909334	
669	NM_007126.5(VCP):c.553G>A (p.Glu185Lys)	VCP	E185K, E140K	Charcot-Marie-Tooth disease, axonal, type 2y|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Uncertain significance(Last reviewed: Sep 19, 2018)	criteria provided, single submitter	VCV000218305	9	35065271	9	35065274	218305	215001	rs864309501	
670	NM_007126.5(VCP):c.552C>T (p.Cys184=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Dec 11, 2017)	criteria provided, single submitter	VCV000532764	9	35065272	9	35065275	532764	524557	rs769455914	
671	NM_007126.5(VCP):c.512G>T (p.Ser171Ile)	VCP	S126I, S171I	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000640109	9	35065312	9	35065315	640109	638220		
672	NM_007126.5(VCP):c.479C>T (p.Ala160Val)	VCP	A160V, A115V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000532758	9	35065345	9	35065348	532758	525102	rs1554668804	
673	NM_007126.5(VCP):c.478G>C (p.Ala160Pro)	VCP	A160P, A115P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000532761	9	35065346	9	35065349	532761	524559	rs1554668805	
674	NM_007126.5(VCP):c.476G>A (p.Arg159His)	VCP	R159H, R114H	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008474	9	35065348	9	35065351	8474	23513	rs121909335	
675	NM_007126.5(VCP):c.475C>T (p.Arg159Cys)	VCP	R159C, R114C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Pathogenic(Last reviewed: Jul 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000280123	9	35065349	9	35065352	280123	264328	rs387906789	
676	NM_007126.5(VCP):c.475C>G (p.Arg159Gly)	VCP	R159G, R114G	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Pathogenic(Last reviewed: Dec 9, 2010)	no assertion criteria provided	VCV000030152	9	35065349	9	35065352	30152	39108	rs387906789	
677	NM_007126.5(VCP):c.464G>C (p.Arg155Pro)	VCP	R155P, R110P	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Apr 1, 2004)	no assertion criteria provided	VCV000008472	9	35065360	9	35065363	8472	23511	rs121909329	
678	NM_007126.5(VCP):c.464G>A (p.Arg155His)	VCP	R155H, R110H	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Amyotrophic lateral sclerosis 14 without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Nov 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008468	9	35065360	9	35065363	8468	23507	rs121909329	
679	NM_007126.5(VCP):c.463C>G (p.Arg155Gly)	VCP	R155G, R110G	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	VCV000217028	9	35065361	9	35065364	217028	213592	rs121909330	
680	NM_007126.5(VCP):c.463C>T (p.Arg155Cys)	VCP	R155C, R110C	Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000008469	9	35065361	9	35065364	8469	23508	rs121909330	
681	NM_007126.5(VCP):c.426G>A (p.Ala142=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 25, 2017)	criteria provided, conflicting interpretations	VCV000464109	9	35066691	9	35066694	464109	459155	rs577812326	
682	NM_007126.5(VCP):c.374G>A (p.Gly125Asp)	VCP	G125D, G80D	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jun 13, 2018)	criteria provided, single submitter	VCV000569394	9	35066743	9	35066746	569394	565887	rs1563980403	
683	NM_007126.5(VCP):c.340A>G (p.Ile114Val)	VCP	I114V, I69V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, multiple submitters, no conflicts	VCV000597496	9	35066777	9	35066780	597496	588557	rs549915384	
684	NM_007126.5(VCP):c.320A>T (p.Asp107Val)	VCP	D107V, D62V	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000575232	9	35066797	9	35066800	575232	569010	rs1563980440	
685	NM_007126.5(VCP):c.303-3C>T	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Aug 3, 2017)	criteria provided, single submitter	VCV000464108	9	35066817	9	35066820	464108	459547	rs1183711292	
686	NM_007126.5(VCP):c.283C>T (p.Arg95Cys)	VCP	R95C, R50C	not provided|Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Likely pathogenic(Last reviewed: Jun 28, 2017)	criteria provided, multiple submitters, no conflicts	VCV000280124	9	35067907	9	35067910	280124	264531	rs121909332	
687	NM_007126.5(VCP):c.283C>G (p.Arg95Gly)	VCP	R95G, R50G	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Pathogenic(Last reviewed: Jan 15, 2006)	no assertion criteria provided	VCV000008471	9	35067907	9	35067910	8471	23510	rs121909332	
688	NM_007126.5(VCP):c.278G>A (p.Arg93His)	VCP	R93H, R48H	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 17, 2017)	criteria provided, conflicting interpretations	VCV000449554	9	35067912	9	35067915	449554	444478	rs779959657	
689	NM_007126.5(VCP):c.277C>T (p.Arg93Cys)	VCP	R93C, R48C	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia|not provided	Pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000593071	9	35067913	9	35067916	593071	584135	rs1554669087	
690	NM_007126.5(VCP):c.271A>T (p.Asn91Tyr)	VCP	N91Y, N46Y	Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1	Likely pathogenic(Last reviewed: Sep 16, 2014)	no assertion criteria provided	VCV000217877	9	35067919	9	35067922	217877	214539	rs863225291	
691	NM_007126.5(VCP):c.213C>T (p.Val71=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Likely benign(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000532765	9	35067977	9	35067980	532765	525108	rs1195805928	
692	NM_007126.5(VCP):c.185A>G (p.Lys62Arg)	VCP	K62R, K17R	Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366720	9	35068005	9	35068008	366720	319050	rs886063892	
693	NM_007126.5(VCP):c.84T>A (p.Val28=)	VCP		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000638960	9	35068293	9	35068296	638960	638221		
694	NM_007126.5(VCP):c.18-5T>C	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000366721	9	35068364	9	35068367	366721	318534	rs114256093	
695	NM_007126.5(VCP):c.-53C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366722	9	35072403	9	35072406	366722	319056	rs369830702	
696	NM_007126.5(VCP):c.-233_-228GCTGCC[4]	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366724	9	35072565 - 35072566	9	35072568 - 35072569	366724	318542	rs879074973	
697	NM_007126.5(VCP):c.-215A>G	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366723	9	35072565	9	35072568	366723	312631	rs886063893	
698	NM_007126.5(VCP):c.-250C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366725	9	35072600	9	35072603	366725	312632	rs886063894	
699	NM_007126.5(VCP):c.-267C>T	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366726	9	35072617	9	35072620	366726	312633	rs184152880	
700	NM_007126.3(VCP):c.-370G>A	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366727	9	35072720	9	35072723	366727	318546	rs886063895	
701	NM_004629.1(FANCG):c.1638T>C (p.Gly546=)	VCP		Inclusion Body Myopathy, Dominant|not specified|not provided|Amyotrophic Lateral Sclerosis, Dominant|Fanconi anemia	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2019)	criteria provided, conflicting interpretations	VCV000366732	9	35074490	9	35074493	366732	319067	rs45537335	
702	NM_004629.1(FANCG):c.1636+7A>G	VCP		Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided|Inclusion Body Myopathy, Dominant|Fanconi anemia	Benign(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000259477	9	35074917	9	35074920	259477	253535	rs587118	
703	NM_004629.1(FANCG):c.1538G>A (p.Arg513Gln)	VCP	R513Q	not specified|not provided|Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000134361	9	35075022	9	35075025	134361	138100	rs17885240	
704	NM_004629.1(FANCG):c.1133C>T (p.Ser378Leu)	VCP	S378L	Amyotrophic Lateral Sclerosis, Dominant|not specified|Inclusion Body Myopathy, Dominant|not provided|Fanconi anemia	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000134370	9	35075969	9	35075972	134370	138109	rs4986939	
705	NM_004629.1(FANCG):c.890C>T (p.Thr297Ile)	VCP	T297I	Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided|Inclusion Body Myopathy, Dominant|Fanconi anemia	Benign/Likely benign(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000134367	9	35076755	9	35076758	134367	138106	rs2237857	
706	NM_004629.1(FANCG):c.640C>T (p.Arg214Cys)	VCP	R214C	not provided|Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not specified	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000134366	9	35077267	9	35077270	134366	138105	rs61757385	
707	NM_013438.5(UBQLN1):c.162G>T (p.Glu54Asp)	UBQLN1	E54D	not provided	Uncertain significance(Last reviewed: May 15, 2018)	no assertion criteria provided	VCV000523652	9	86322433	9	83707518	523652	514300	rs764735825	
708	NM_015046.7(SETX):c.*2753G>A	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365300	9	135136873	9	132261486	365300	311247	rs886063542	
709	NM_015046.7(SETX):c.*2639T>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365301	9	135136987	9	132261600	365301	316834	rs886063543	
710	NM_015046.7(SETX):c.*2610T>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365302	9	135137016	9	132261629	365302	307125	rs530469492	
711	NM_015046.7(SETX):c.*2576_*2577del	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365303	9	135137049 - 135137050	9	132261662 - 132261663	365303	317274	rs886063544	
712	NM_015046.7(SETX):c.*2506T>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365304	9	135137120	9	132261733	365304	307126	rs73545065	
713	NM_015046.7(SETX):c.*2262A>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365305	9	135137364	9	132261977	365305	307130	rs997784	
714	NM_015046.7(SETX):c.*2232T>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365306	9	135137394	9	132262007	365306	317275	rs545456048	
715	NM_015046.7(SETX):c.*2136A>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365307	9	135137490	9	132262103	365307	317281	rs886063545	
716	NM_015046.7(SETX):c.*2065dup	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365308	9	135137560 - 135137561	9	132262173 - 132262174	365308	316839	rs886063546	
717	NM_015046.7(SETX):c.*2002A>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365309	9	135137624	9	132262237	365309	316846	rs886063547	
718	NM_015046.7(SETX):c.*1713C>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365310	9	135137913	9	132262526	365310	316847	rs771853459	
719	NM_015046.7(SETX):c.*1700G>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365311	9	135137926	9	132262539	365311	316848	rs75682594	
720	NM_015046.7(SETX):c.*1534G>A	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365312	9	135138092	9	132262705	365312	311250	rs886063548	
721	NM_015046.7(SETX):c.*1523A>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365313	9	135138103	9	132262716	365313	317282	rs758582946	
722	NM_015046.7(SETX):c.*1454C>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365314	9	135138172	9	132262785	365314	317283	rs561712582	
723	NM_015046.7(SETX):c.*1442T>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365315	9	135138184	9	132262797	365315	307131	rs886063549	
724	NM_015046.7(SETX):c.*1433A>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365316	9	135138193	9	132262806	365316	317284	rs886063550	
725	NM_015046.7(SETX):c.*1368G>A	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365317	9	135138258	9	132262871	365317	316852	rs7025	
726	NM_015046.7(SETX):c.*1365G>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365318	9	135138261	9	132262874	365318	307134	rs7875801	
727	NM_015046.7(SETX):c.*1288T>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365319	9	135138338	9	132262951	365319	307135	rs72765812	
728	NM_015046.7(SETX):c.*1224G>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365320	9	135138402	9	132263015	365320	316855	rs10491906	
729	NM_015046.7(SETX):c.*1052T>A	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365321	9	135138574	9	132263187	365321	307136	rs12349210	
730	NM_015046.7(SETX):c.*988G>A	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365322	9	135138638	9	132263251	365322	307141	rs182693244	
731	NM_015046.7(SETX):c.*905A>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365323	9	135138721	9	132263334	365323	311273	rs58327306	
732	NM_015046.7(SETX):c.*891T>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365324	9	135138735	9	132263348	365324	317285	rs573743210	
733	NM_015046.7(SETX):c.*849G>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365325	9	135138777	9	132263390	365325	311308	rs74975459	
734	NM_015046.7(SETX):c.*717T>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365326	9	135138909	9	132263522	365326	317292	rs17148857	
735	NM_015046.7(SETX):c.*666C>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365327	9	135138960	9	132263573	365327	307142	rs886063551	
736	NM_015046.7(SETX):c.*626C>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365328	9	135139000	9	132263613	365328	316866	rs11795382	
737	NM_015046.7(SETX):c.*562C>A	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365329	9	135139064	9	132263677	365329	307146	rs11787894	
738	NM_015046.7(SETX):c.*561A>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365330	9	135139065	9	132263678	365330	316877	rs73661150	
739	NM_015046.7(SETX):c.*548A>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365331	9	135139078	9	132263691	365331	317295	rs139883935	
740	NM_015046.7(SETX):c.*431_*432del	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365332	9	135139194 - 135139195	9	132263807 - 132263808	365332	307148	rs112251805	
741	NM_015046.7(SETX):c.*351G>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365333	9	135139275	9	132263888	365333	317296	rs117409290	
742	NM_015046.7(SETX):c.*319C>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365334	9	135139307	9	132263920	365334	317299	rs1056912	
743	NM_015046.7(SETX):c.*266A>G	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365335	9	135139360	9	132263973	365335	307150	rs575959163	
744	NM_015046.7(SETX):c.8031A>T (p.Leu2677Phe)	SETX	L2677F, L2706F	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000642088	9	135139629	9	132264242	642088	637802		
745	NM_015046.7(SETX):c.7914C>T (p.Phe2638=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 15, 2019)	criteria provided, conflicting interpretations	VCV000365336	9	135139746	9	132264359	365336	316880	rs80296256	
746	NM_015046.7(SETX):c.7874C>T (p.Pro2625Leu)	SETX	P2625L, P2654L	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365337	9	135139786	9	132264399	365337	311314	rs553413088	
747	NM_015046.7(SETX):c.7834A>G (p.Ser2612Gly)	SETX	S2612G, S2641G	not provided|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified	Benign(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000195975	9	135139826	9	132264439	195975	193136	rs3739927	
748	NM_015046.7(SETX):c.7825C>G (p.Pro2609Ala)	SETX	P2609A, P2638A	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365338	9	135139835	9	132264448	365338	317307	rs765888424	
749	NM_015046.7(SETX):c.7814G>A (p.Arg2605Gln)	SETX	R2605Q, R2634Q	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000365339	9	135139846	9	132264459	365339	317308	rs543247171	
750	NM_015046.7(SETX):c.7787C>T (p.Ala2596Val)	SETX	A2596V, A2625V	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365340	9	135139873	9	132264486	365340	317319	rs200507089	
751	NM_015046.7(SETX):c.7759A>G (p.Ile2587Val)	SETX	I2587V, I2616V	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095669	9	135139901	9	132264514	95669	101566	rs1056899	
752	NM_015046.7(SETX):c.7735G>A (p.Val2579Ile)	SETX	V2579I, V2608I	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365341	9	135139925	9	132264538	365341	316882	rs144121978	
753	NM_015046.7(SETX):c.7724C>T (p.Pro2575Leu)	SETX	P2575L, P2604L	not provided|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Dec 26, 2018)	criteria provided, conflicting interpretations	VCV000365342	9	135139936	9	132264549	365342	311316	rs34000644	
754	NM_015046.7(SETX):c.7708_7710CCT[1] (p.Pro2571del)	SETX	P2571del	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Aug 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448348	9	135139947 - 135139949	9	132264560 - 132264562	448348	441269	rs770590408	
755	NM_015046.7(SETX):c.7708C>T (p.Pro2570Ser)	SETX	P2570S, P2599S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 9, 2017)	criteria provided, single submitter	VCV000536379	9	135139952	9	132264565	536379	524098	rs1240232139	
756	NM_015046.7(SETX):c.7660T>C (p.Phe2554Leu)	SETX	F2554L, F2583L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000568960	9	135140000	9	132264613	568960	563595	rs368269464	
757	NM_015046.7(SETX):c.7660T>A (p.Phe2554Ile)	SETX	F2554I, F2583I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 13, 2017)	criteria provided, single submitter	VCV000536388	9	135140000	9	132264613	536388	524651	rs368269464	
758	NM_015046.7(SETX):c.7640T>C (p.Ile2547Thr)	SETX	I2547T, I2576T	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2019)	criteria provided, conflicting interpretations	VCV000155748	9	135140020	9	132264633	155748	165502	rs151117904	
759	NM_015046.7(SETX):c.7590T>A (p.Pro2530=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: May 25, 2017)	criteria provided, single submitter	VCV000468525	9	135140070	9	132264683	468525	458933	rs1374204163	
760	NM_015046.7(SETX):c.7534C>T (p.Pro2512Ser)	SETX	P2512S, P2541S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000568527	9	135140126	9	132264739	568527	562850	rs557347174	
761	NM_015046.7(SETX):c.7482G>C (p.Lys2494Asn)	SETX	K2494N, K2523N	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000576128	9	135140178	9	132264791	576128	565598	rs1564464193	
762	NM_015046.7(SETX):c.7433C>G (p.Thr2478Ser)	SETX	T2478S, T2507S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000536376	9	135140227	9	132264840	536376	524653	rs771027936	
763	NM_015046.7(SETX):c.7432A>G (p.Thr2478Ala)	SETX	T2478A, T2507A	Inborn genetic diseases|Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not specified	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448346	9	135140228	9	132264841	448346	441271	rs142303658	
764	NM_015046.7(SETX):c.7413A>T (p.Arg2471Ser)	SETX	R2471S, R2500S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 5, 2017)	criteria provided, single submitter	VCV000536389	9	135140247	9	132264860	536389	524656	rs1382990384	
765	NM_015046.7(SETX):c.7406T>C (p.Leu2469Pro)	SETX	L2469P, L2498P	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365343	9	135140254	9	132264867	365343	317323	rs151304085	
766	NM_015046.7(SETX):c.7371T>C (p.His2457=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000365344	9	135140289	9	132264902	365344	317324	rs113071480	
767	NM_015046.7(SETX):c.7287+9C>A	SETX		not provided|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jan 12, 2018)	criteria provided, conflicting interpretations	VCV000365345	9	135144993	9	132269606	365345	311320	rs769170686	
768	NM_015046.7(SETX):c.7204C>G (p.Leu2402Val)	SETX	L2402V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Apr 17, 2018)	criteria provided, single submitter	VCV000569576	9	135145085	9	132269698	569576	568588	rs1402767850	
769	NM_015046.7(SETX):c.7139G>A (p.Arg2380Gln)	SETX	R2380Q	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Aug 8, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448343	9	135147157	9	132271770	448343	441274	rs145397619	
770	NM_015046.7(SETX):c.7114G>A (p.Asp2372Asn)	SETX	D2372N	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260517	9	135147182	9	132271795	260517	253350	rs150673589	
771	NM_015046.7(SETX):c.6996_7002del (p.Asp2332fs)	SETX	D2332fs	Amyotrophic lateral sclerosis type 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802521	9	135150741 - 135150747	9	132275354 - 132275360	802521	790848		
772	NM_015046.7(SETX):c.6935+8T>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000260514	9	135152439	9	132277052	260514	253353	rs17148873	
773	NM_015046.7(SETX):c.6922A>G (p.Arg2308Gly)	SETX	R2308G	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000571061	9	135152460	9	132277073	571061	562855	rs370135596	
774	NM_015046.5(SETX):c.6848_6851delCAGA (p.Thr2283Lysfs)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided|Amyotrophic lateral sclerosis type 4	Pathogenic/Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095668	9	135152531 - 135152534	9	132277144 - 132277147	95668	101565	rs398124286	
775	NM_015046.7(SETX):c.6843-16_6843-15dup	SETX		not provided|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Jun 6, 2017)	criteria provided, conflicting interpretations	VCV000365347	9	135152543 - 135152544	9	132277156 - 132277157	365347	316886	rs34769225	
776	NM_015046.7(SETX):c.6675C>T (p.Tyr2225=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365348	9	135153624	9	132278237	365348	311322	rs200382898	
777	NM_015046.7(SETX):c.6507G>A (p.Gly2169=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Benign/Likely benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000260511	9	135158690	9	132283303	260511	253356	rs34073320	
778	NM_015046.7(SETX):c.6407G>A (p.Arg2136His)	SETX	R2136H	Distal spinal muscular atrophy|Amyotrophic lateral sclerosis type 4	Conflicting interpretations of pathogenicity(Last reviewed: Jun 1, 2004)	no assertion criteria provided	VCV000002291	9	135158790	9	132283403	2291	17330	rs121434378	
779	NM_015046.7(SETX):c.6338A>T (p.Asp2113Val)	SETX	D2113V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000654239	9	135161868	9	132286481	654239	637803		
780	NM_015046.7(SETX):c.6313C>T (p.Arg2105Trp)	SETX	R2105W	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365349	9	135163634	9	132288247	365349	316887	rs142843968	
781	NM_015046.7(SETX):c.6122T>C (p.Ile2041Thr)	SETX	I2041T	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 11, 2019)	criteria provided, conflicting interpretations	VCV000639918	9	135164023	9	132288636	639918	637804		
782	NM_015046.7(SETX):c.6106+14G>A	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000260510	9	135171245	9	132295858	260510	253357	rs73661157	
783	NM_015046.7(SETX):c.6058A>G (p.Ile2020Val)	SETX	I2020V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Nov 30, 2018)	criteria provided, single submitter	VCV000640104	9	135171307	9	132295920	640104	637805		
784	NM_015046.7(SETX):c.6017G>A (p.Cys2006Tyr)	SETX	C2006Y	Amyotrophic lateral sclerosis type 4	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802522	9	135171348	9	132295961	802522	790849		
785	NM_015046.7(SETX):c.5998C>G (p.Gln2000Glu)	SETX	Q2000E	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Dec 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448339	9	135171367	9	132295980	448339	441277	rs142917412	
786	NM_015046.7(SETX):c.5949+5G>A	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jul 15, 2019)	criteria provided, conflicting interpretations	VCV000488730	9	135172269	9	132296882	488730	481843	rs374656811	
787	NM_015046.7(SETX):c.5811T>C (p.Asp1937=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095667	9	135172412	9	132297025	95667	101564	rs2296869	
788	NM_015046.7(SETX):c.5781+12dup	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified	Benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000095666	9	135173454 - 135173455	9	132298067 - 132298068	95666	101563	rs3831154	
789	NM_015046.7(SETX):c.5767A>G (p.Thr1923Ala)	SETX	T1923A	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000536390	9	135173481	9	132298094	536390	524388	rs372993859	
790	NM_015046.7(SETX):c.5563A>G (p.Thr1855Ala)	SETX	T1855A	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095665	9	135173685	9	132298298	95665	101562	rs2296871	
791	NM_015046.7(SETX):c.5473A>G (p.Thr1825Ala)	SETX	T1825A	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jun 11, 2019)	criteria provided, conflicting interpretations	VCV000663550	9	135176092	9	132300705	663550	637806		
792	NM_015046.7(SETX):c.5464A>G (p.Lys1822Glu)	SETX	K1822E	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 14, 2017)	criteria provided, single submitter	VCV000536391	9	135176101	9	132300714	536391	524109	rs1249423284	
793	NM_015046.7(SETX):c.5431G>A (p.Val1811Met)	SETX	V1811M	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 12, 2018)	criteria provided, single submitter	VCV000639608	9	135176134	9	132300747	639608	637807		
794	NM_015046.7(SETX):c.5315T>C (p.Phe1772Ser)	SETX	F1772S	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365350	9	135187203	9	132311816	365350	317333	rs886063552	
795	NM_015046.7(SETX):c.5283A>G (p.Gln1761=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 13, 2018)	criteria provided, conflicting interpretations	VCV000365351	9	135187235	9	132311848	365351	307153	rs139063885	
796	NM_015046.7(SETX):c.5264del (p.Thr1755fs)	SETX	T1755fs	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000572675	9	135201721	9	132326334	572675	568595	rs776632212	
797	NM_015046.7(SETX):c.5104G>A (p.Val1702Ile)	SETX	V1702I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 25, 2018)	criteria provided, single submitter	VCV000575379	9	135201881	9	132326494	575379	562856	rs61745659	
798	NM_015046.7(SETX):c.4982C>G (p.Pro1661Arg)	SETX	P1661R	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 31, 2019)	criteria provided, conflicting interpretations	VCV000468516	9	135202003	9	132326616	468516	458968	rs146873848	
799	NM_015046.7(SETX):c.4979A>G (p.His1660Arg)	SETX	H1660R	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000536377	9	135202006	9	132326619	536377	524390	rs371894414	
800	NM_015046.7(SETX):c.4924C>A (p.Pro1642Thr)	SETX	P1642T	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365352	9	135202061	9	132326674	365352	316896	rs375942182	
801	NM_015046.7(SETX):c.4906A>G (p.Lys1636Glu)	SETX	K1636E	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Nov 26, 2018)	criteria provided, single submitter	VCV000641834	9	135202079	9	132326692	641834	637808		
802	NM_015046.7(SETX):c.4903T>A (p.Leu1635Met)	SETX	L1635M	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 15, 2016)	criteria provided, single submitter	VCV000468515	9	135202082	9	132326695	468515	459441	rs1466879487	
803	NM_015046.7(SETX):c.4866G>A (p.Pro1622=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000468514	9	135202119	9	132326732	468514	458513	rs779472573	
804	NM_015046.7(SETX):c.4865C>T (p.Pro1622Leu)	SETX	P1622L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448330	9	135202120	9	132326733	448330	441286	rs140781535	
805	NM_015046.7(SETX):c.4828C>T (p.Leu1610Phe)	SETX	L1610F	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000574888	9	135202157	9	132326770	574888	568597	rs749891883	
806	NM_015046.7(SETX):c.4759C>T (p.Pro1587Ser)	SETX	P1587S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Apr 18, 2017)	criteria provided, single submitter	VCV000468513	9	135202226	9	132326839	468513	458973	rs916634082	
807	NM_015046.7(SETX):c.4757C>T (p.Pro1586Leu)	SETX	P1586L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 9, 2018)	criteria provided, single submitter	VCV000572586	9	135202228	9	132326841	572586	562857	rs1165229035	
808	NM_015046.7(SETX):c.4755T>G (p.Pro1585=)	SETX		Amyotrophic Lateral Sclerosis, Dominant|Ataxia with Oculomotor Apraxia|not specified|not provided	Benign/Likely benign(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260506	9	135202230	9	132326843	260506	253359	rs151237267	
809	NM_015046.7(SETX):c.4707T>C (p.Ser1569=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Apr 4, 2017)	criteria provided, single submitter	VCV000468512	9	135202278	9	132326891	468512	458524	rs769964668	
810	NM_015046.7(SETX):c.4683G>C (p.Gln1561His)	SETX	Q1561H	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000536374	9	135202302	9	132326915	536374	524661	rs772991134	
811	NM_015046.7(SETX):c.4677A>G (p.Lys1559=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Likely benign(Last reviewed: Dec 8, 2017)	criteria provided, multiple submitters, no conflicts	VCV000536405	9	135202308	9	132326921	536405	524666	rs200123129	
812	NM_015046.7(SETX):c.4670C>G (p.Thr1557Ser)	SETX	T1557S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jul 28, 2017)	criteria provided, single submitter	VCV000468511	9	135202315	9	132326928	468511	459446	rs1554820196	
813	NM_015046.7(SETX):c.4663C>G (p.Leu1555Val)	SETX	L1555V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000571954	9	135202322	9	132326935	571954	568599	rs558075773	
814	NM_015046.7(SETX):c.4660T>G (p.Cys1554Gly)	SETX	C1554G	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign/Likely benign(Last reviewed: Jul 10, 2019)	criteria provided, multiple submitters, no conflicts	VCV000260505	9	135202325	9	132326938	260505	253360	rs112089123	
815	NM_015046.7(SETX):c.4612C>T (p.Arg1538Trp)	SETX	R1538W	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Oct 25, 2018)	criteria provided, conflicting interpretations	VCV000365353	9	135202373	9	132326986	365353	317346	rs147018359	
816	NM_015046.7(SETX):c.4601A>T (p.Asp1534Val)	SETX	D1534V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000468510	9	135202384	9	132326997	468510	458974	rs1554820219	
817	NM_015046.7(SETX):c.4563A>G (p.Glu1521=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Mar 31, 2017)	criteria provided, single submitter	VCV000468509	9	135202422	9	132327035	468509	458979	rs374149839	
818	NM_015046.7(SETX):c.4459T>A (p.Ser1487Thr)	SETX	S1487T	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jul 19, 2018)	criteria provided, single submitter	VCV000664705	9	135202526	9	132327139	664705	637809		
819	NM_015046.7(SETX):c.4436C>T (p.Ala1479Val)	SETX	A1479V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: May 1, 2017)	criteria provided, single submitter	VCV000468508	9	135202549	9	132327162	468508	458525	rs761119964	
820	NM_015046.7(SETX):c.4433C>A (p.Ala1478Glu)	SETX	A1478E	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448329	9	135202552	9	132327165	448329	441287	rs143661911	
821	NM_015046.7(SETX):c.4386A>G (p.Glu1462=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Nov 27, 2017)	criteria provided, single submitter	VCV000536400	9	135202599	9	132327212	536400	524392	rs1554820336	
822	NM_015046.7(SETX):c.4369A>G (p.Ile1457Val)	SETX	I1457V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 13, 2018)	criteria provided, single submitter	VCV000579898	9	135202616	9	132327229	579898	565600	rs747804357	
823	NM_015046.7(SETX):c.4273A>G (p.Lys1425Glu)	SETX	K1425E	Charcot-Marie-Tooth disease|not provided|Amyotrophic lateral sclerosis type 4	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000155746	9	135202712	9	132327325	155746	165500	rs534886444	
824	NM_015046.7(SETX):c.4262C>G (p.Pro1421Arg)	SETX	P1421R	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000656944	9	135202723	9	132327336	656944	637810		
825	NM_015046.7(SETX):c.4225A>T (p.Asn1409Tyr)	SETX	N1409Y	Charcot-Marie-Tooth disease|Amyotrophic lateral sclerosis type 4|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000155745	9	135202760	9	132327373	155745	165499	rs373375060	
826	NM_015046.7(SETX):c.4204A>T (p.Thr1402Ser)	SETX	T1402S	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365354	9	135202781	9	132327394	365354	311323	rs150421712	
827	NM_015046.7(SETX):c.4156A>G (p.Ile1386Val)	SETX	I1386V	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign(Last reviewed: Nov 17, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095663	9	135202829	9	132327442	95663	101560	rs543573	
828	NM_015046.7(SETX):c.4114G>C (p.Asp1372His)	SETX	D1372H	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: May 16, 2018)	criteria provided, single submitter	VCV000566410	9	135202871	9	132327484	566410	563596	rs1564539457	
829	NM_015046.7(SETX):c.4113A>G (p.Thr1371=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000468506	9	135202872	9	132327485	468506	459447	rs750697305	
830	NM_015046.7(SETX):c.4103G>T (p.Cys1368Phe)	SETX	C1368F	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000568959	9	135202882	9	132327495	568959	562862	rs1445388214	
831	NM_015046.7(SETX):c.4096T>C (p.Ser1366Pro)	SETX	S1366P	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 7, 2019)	criteria provided, single submitter	VCV000468505	9	135202889	9	132327502	468505	458553	rs140147684	
832	NM_015046.7(SETX):c.4053A>G (p.Gln1351=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365355	9	135202932	9	132327545	365355	311324	rs886063553	
833	NM_015046.7(SETX):c.4051C>G (p.Gln1351Glu)	SETX	Q1351E	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Mar 13, 2017)	criteria provided, single submitter	VCV000468504	9	135202934	9	132327547	468504	458982	rs375241191	
834	NM_015046.7(SETX):c.4045C>G (p.Gln1349Glu)	SETX	Q1349E	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Dec 9, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448326	9	135202940	9	132327553	448326	441290	rs146407699	
835	NM_015046.7(SETX):c.4020G>T (p.Lys1340Asn)	SETX	K1340N	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000365356	9	135202965	9	132327578	365356	317350	rs368323660	
836	NM_015046.7(SETX):c.3992C>T (p.Pro1331Leu)	SETX	P1331L	not provided|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000365357	9	135202993	9	132327606	365357	307167	rs11243731	
837	NM_015046.7(SETX):c.3955G>A (p.Val1319Ile)	SETX	V1319I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jul 30, 2018)	criteria provided, single submitter	VCV000653482	9	135203030	9	132327643	653482	637811		
838	NM_015046.7(SETX):c.3950T>C (p.Val1317Ala)	SETX	V1317A	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Apr 19, 2018)	criteria provided, single submitter	VCV000577618	9	135203035	9	132327648	577618	565606	rs1564539968	
839	NM_015046.7(SETX):c.3900C>T (p.Ser1300=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365358	9	135203085	9	132327698	365358	311328	rs886063554	
840	NM_015046.7(SETX):c.3826C>G (p.Gln1276Glu)	SETX	Q1276E	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided|Hereditary spastic paraplegia	Conflicting interpretations of pathogenicity(Last reviewed: Jun 30, 2019)	criteria provided, conflicting interpretations	VCV000424692	9	135203159	9	132327772	424692	411570	rs148604312	
841	NM_015046.7(SETX):c.3823C>T (p.Arg1275Cys)	SETX	R1275C	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000576756	9	135203162	9	132327775	576756	565611	rs760272692	
842	NM_015046.7(SETX):c.3809C>T (p.Pro1270Leu)	SETX	P1270L	Amyotrophic Lateral Sclerosis, Dominant|Ataxia with Oculomotor Apraxia|not provided	Benign/Likely benign(Last reviewed: Jan 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242634	9	135203176	9	132327789	242634	167387	rs144334281	
843	NM_015046.5(SETX):c.[59G>A(;)3809C>T]	SETX	P1270L, R20H		Uncertain significance(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000157525	9|9	135203176	9|9	132327789	157525	167387|167386	rs144334281|rs79740039	
844	NM_015046.7(SETX):c.3802A>G (p.Ile1268Val)	SETX	I1268V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Mar 12, 2018)	criteria provided, single submitter	VCV000566196	9	135203183	9	132327796	566196	568605	rs764516725	
845	NM_015046.7(SETX):c.3754G>A (p.Gly1252Arg)	SETX	G1252R	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided|Amyotrophic lateral sclerosis type 4	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000095662	9	135203231	9	132327844	95662	101559	rs1183768	
846	NM_015046.7(SETX):c.3728A>G (p.Lys1243Arg)	SETX	K1243R	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jun 28, 2017)	criteria provided, single submitter	VCV000468502	9	135203257	9	132327870	468502	458555	rs1467137301	
847	NM_015046.7(SETX):c.3650C>T (p.Thr1217Met)	SETX	T1217M	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000641058	9	135203335	9	132327948	641058	637812		
848	NM_015046.7(SETX):c.3576T>G (p.Asp1192Glu)	SETX	D1192E	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095661	9	135203409	9	132328022	95661	101558	rs1185193	
849	NM_015046.7(SETX):c.3469G>T (p.Val1157Leu)	SETX	V1157L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000582615	9	135203516	9	132328129	582615	563600	rs748505684	
850	NM_015046.7(SETX):c.3462A>C (p.Glu1154Asp)	SETX	E1154D	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000536387	9	135203523	9	132328136	536387	524677	rs1297541939	
851	NM_015046.7(SETX):c.3455T>G (p.Phe1152Cys)	SETX	F1152C	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Benign/Likely benign(Last reviewed: Aug 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000095660	9	135203530	9	132328143	95660	101557	rs3739922	
852	NM_015046.7(SETX):c.3433C>T (p.Arg1145Trp)	SETX	R1145W	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 19, 2018)	criteria provided, single submitter	VCV000660267	9	135203552	9	132328165	660267	637813		
853	NM_015046.7(SETX):c.3422A>T (p.His1141Leu)	SETX	H1141L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Nov 21, 2017)	criteria provided, single submitter	VCV000536393	9	135203563	9	132328176	536393	524614	rs1554820904	
854	NM_015046.7(SETX):c.3341T>C (p.Ile1114Thr)	SETX	I1114T	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000568024	9	135203644	9	132328257	568024	565612	rs760535401	
855	NM_015046.7(SETX):c.3332T>G (p.Leu1111Trp)	SETX	L1111W	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000580194	9	135203653	9	132328266	580194	565615	rs1564541841	
856	NM_015046.7(SETX):c.3310C>G (p.Gln1104Glu)	SETX	Q1104E	not provided|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Nov 20, 2018)	criteria provided, conflicting interpretations	VCV000365359	9	135203675	9	132328288	365359	316914	rs113831637	
857	NM_015046.7(SETX):c.3200C>T (p.Thr1067Ile)	SETX	T1067I	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365360	9	135203785	9	132328398	365360	307168	rs374091487	
858	NM_015046.7(SETX):c.3147C>T (p.His1049=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign/Likely benign(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000193716	9	135203838	9	132328451	193716	190879	rs3739921	
859	NM_015046.7(SETX):c.3117A>G (p.Ile1039Met)	SETX	I1039M	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified	Uncertain significance(Last reviewed: Sep 8, 2016)	criteria provided, multiple submitters, no conflicts	VCV000365361	9	135203868	9	132328481	365361	311333	rs886063555	
860	NM_015046.7(SETX):c.3103A>G (p.Lys1035Glu)	SETX	K1035E	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365362	9	135203882	9	132328495	365362	316915	rs117229601	
861	NM_015046.7(SETX):c.3057_3059TGA[4] (p.Asp1023_Asp1024del)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 5, 2017)	criteria provided, single submitter	VCV000536381	9	135203911 - 135203916	9	132328524 - 132328529	536381	524114	rs572772837	
862	NM_015046.7(SETX):c.3057_3059TGA[5] (p.Asp1024del)	SETX	D1024del	not specified|not provided|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Apr 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000448320	9	135203911 - 135203913	9	132328524 - 132328526	448320	441295	rs572772837	
863	NM_015046.7(SETX):c.3053A>G (p.Asp1018Gly)	SETX	D1018G	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jul 3, 2018)	criteria provided, single submitter	VCV000576257	9	135203932	9	132328545	576257	562864	rs768510428	
864	NM_015046.7(SETX):c.3040A>G (p.Ile1014Val)	SETX	I1014V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000642321	9	135203945	9	132328558	642321	637814		
865	NM_015046.7(SETX):c.3016G>A (p.Gly1006Arg)	SETX	G1006R	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Aug 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448317	9	135203969	9	132328582	448317	441298	rs141266068	
866	NM_015046.7(SETX):c.2975A>G (p.Lys992Arg)	SETX	K992R	Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Benign/Likely benign(Last reviewed: Sep 13, 2018)	criteria provided, multiple submitters, no conflicts	VCV000260502	9	135204010	9	132328623	260502	253363	rs61742937	
867	NM_015046.7(SETX):c.2958G>A (p.Gln986=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000536401	9	135204027	9	132328640	536401	524616	rs969060686	
868	NM_015046.7(SETX):c.2854A>G (p.Thr952Ala)	SETX	T952A	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jul 10, 2017)	criteria provided, single submitter	VCV000468496	9	135204131	9	132328744	468496	458992	rs1375463032	
869	NM_015046.7(SETX):c.2779A>G (p.Met927Val)	SETX	M927V	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365363	9	135204206	9	132328819	365363	316917	rs886063556	
870	NM_015046.7(SETX):c.2755G>C (p.Val919Leu)	SETX	V919L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Jun 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000536395	9	135204230	9	132328843	536395	524399	rs561190371	
871	NM_015046.7(SETX):c.2749A>C (p.Met917Leu)	SETX	M917L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 18, 2017)	criteria provided, single submitter	VCV000536394	9	135204236	9	132328849	536394	524115	rs761943404	
872	NM_015046.7(SETX):c.2730A>C (p.Ser910=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Oct 11, 2017)	criteria provided, single submitter	VCV000536404	9	135204255	9	132328868	536404	524119	rs764898504	
873	NM_015046.7(SETX):c.2717C>T (p.Ser906Leu)	SETX	S906L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000468495	9	135204268	9	132328881	468495	458558	rs148375192	
874	NM_015046.7(SETX):c.2672T>C (p.Val891Ala)	SETX	V891A	Autosomal dominant distal hereditary motor neuropathy|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Jun 13, 2019)	criteria provided, multiple submitters, no conflicts	VCV000365364	9	135204313	9	132328926	365364	311334	rs148181729	
875	NM_015046.7(SETX):c.2479A>G (p.Lys827Glu)	SETX	K827E	not specified|not provided|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Conflicting interpretations of pathogenicity(Last reviewed: Dec 10, 2018)	criteria provided, conflicting interpretations	VCV000468494	9	135204506	9	132329119	468494	458959	rs150532677	
876	NM_015046.7(SETX):c.2469C>G (p.Phe823Leu)	SETX	F823L	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365365	9	135204516	9	132329129	365365	307171	rs141163823	
877	NM_015046.7(SETX):c.2446A>G (p.Thr816Ala)	SETX	T816A	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000468493	9	135204539	9	132329152	468493	458994	rs369470593	
878	NM_015046.7(SETX):c.2411T>C (p.Leu804Ser)	SETX	L804S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 25, 2017)	criteria provided, single submitter	VCV000536380	9	135204574	9	132329187	536380	524401	rs201096140	
879	NM_015046.7(SETX):c.2404A>G (p.Ser802Gly)	SETX	S802G	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 26, 2017)	criteria provided, single submitter	VCV000536384	9	135204581	9	132329194	536384	524681	rs1400027699	
880	NM_015046.7(SETX):c.2399G>T (p.Arg800Met)	SETX	R800M	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 10, 2018)	criteria provided, single submitter	VCV000662426	9	135204586	9	132329199	662426	637815		
881	NM_015046.7(SETX):c.2395C>T (p.His799Tyr)	SETX	H799Y	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Sep 5, 2017)	criteria provided, multiple submitters, no conflicts	VCV000448313	9	135204590	9	132329203	448313	441302	rs200459144	
882	NM_015046.7(SETX):c.2339C>T (p.Thr780Ile)	SETX	T780I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 24, 2017)	criteria provided, single submitter	VCV000536378	9	135204646	9	132329259	536378	524686	rs1554821445	
883	NM_015046.7(SETX):c.2303A>T (p.Lys768Met)	SETX	K768M	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 27, 2017)	criteria provided, single submitter	VCV000468492	9	135204682	9	132329295	468492	458964	rs1554821462	
884	NM_015046.7(SETX):c.2295C>A (p.Phe765Leu)	SETX	F765L	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365366	9	135204690	9	132329303	365366	307174	rs771954896	
885	NM_015046.7(SETX):c.2254A>G (p.Thr752Ala)	SETX	T752A	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000536375	9	135204731	9	132329344	536375	524703	rs745938575	
886	NM_015046.7(SETX):c.2216G>A (p.Gly739Glu)	SETX	G739E	not provided|Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Benign/Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000365367	9	135204769	9	132329382	365367	316918	rs36024203	
887	NM_015046.7(SETX):c.2123G>T (p.Ser708Ile)	SETX	S708I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 11, 2017)	criteria provided, single submitter	VCV000536385	9	135204862	9	132329475	536385	524706	rs1554821571	
888	NM_015046.7(SETX):c.2005A>T (p.Asn669Tyr)	SETX	N669Y	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468490	9	135204980	9	132329593	468490	458998	rs143727702	
889	NM_015046.7(SETX):c.2003A>G (p.Asn668Ser)	SETX	N668S	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000365368	9	135204982	9	132329595	365368	311335	rs780898043	
890	NM_015046.7(SETX):c.1979C>G (p.Ala660Gly)	SETX	A660G	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign(Last reviewed: Apr 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095659	9	135205006	9	132329619	95659	101556	rs882709	
891	NM_015046.7(SETX):c.1922C>G (p.Ser641Cys)	SETX	S641C	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365369	9	135205063	9	132329676	365369	307175	rs886063557	
892	NM_015046.7(SETX):c.1869A>C (p.Glu623Asp)	SETX	E623D	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Sep 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000155743	9	135205116	9	132329729	155743	165497	rs139200312	
893	NM_015046.7(SETX):c.1750C>G (p.Leu584Val)	SETX	L584V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000581423	9	135205235	9	132329848	581423	563603	rs764995848	
894	NM_015046.7(SETX):c.1714C>G (p.Leu572Val)	SETX	L572V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000663542	9	135205271	9	132329884	663542	637816		
895	NM_015046.7(SETX):c.1693T>C (p.Phe565Leu)	SETX	F565L	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000365370	9	135205292	9	132329905	365370	307176	rs143982186	
896	NM_015046.7(SETX):c.1690T>G (p.Leu564Val)	SETX	L564V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Feb 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448307	9	135205295	9	132329908	448307	441307	rs761877146	
897	NM_015046.7(SETX):c.1576A>G (p.Met526Val)	SETX	M526V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jan 25, 2018)	criteria provided, single submitter	VCV000576174	9	135205409	9	132330022	576174	568607	rs762013471	
898	NM_015046.7(SETX):c.1561C>T (p.Leu521=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Jul 29, 2017)	criteria provided, single submitter	VCV000468487	9	135205424	9	132330037	468487	458981	rs148638979	
899	NM_015046.7(SETX):c.1504C>T (p.Arg502Trp)	SETX	R502W	Charcot-Marie-Tooth disease|not provided|Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Uncertain significance(Last reviewed: Apr 27, 2019)	criteria provided, single submitter	VCV000155742	9	135205481	9	132330094	155742	165496	rs534723946	
900	NM_015046.7(SETX):c.1468G>A (p.Val490Ile)	SETX	V490I	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Feb 14, 2018)	criteria provided, multiple submitters, no conflicts	VCV000577511	9	135205517	9	132330130	577511	562866	rs763545230	
901	NM_015046.7(SETX):c.1421G>A (p.Cys474Tyr)	SETX	C474Y	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 12, 2018)	criteria provided, single submitter	VCV000656176	9	135205564	9	132330177	656176	637817		
902	NM_015046.7(SETX):c.1416A>T (p.Lys472Asn)	SETX	K472N	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365371	9	135205569	9	132330182	365371	307183	rs886063558	
903	NM_015046.7(SETX):c.1391C>T (p.Ser464Leu)	SETX	S464L	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000365372	9	135205594	9	132330207	365372	316919	rs200614765	
904	NM_015046.7(SETX):c.1374T>G (p.Phe458Leu)	SETX	F458L	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Mar 9, 2018)	criteria provided, single submitter	VCV000579304	9	135205611	9	132330224	579304	565616	rs201441886	
905	NM_015046.7(SETX):c.1358A>G (p.Lys453Arg)	SETX	K453R	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365373	9	135205627	9	132330240	365373	307184	rs886063559	
906	NM_015046.7(SETX):c.1343A>G (p.Asp448Gly)	SETX	D448G	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Apr 10, 2019)	criteria provided, conflicting interpretations	VCV000573505	9	135205642	9	132330255	573505	562868	rs370363342	
907	NM_015046.7(SETX):c.1204C>T (p.Arg402Cys)	SETX	R402C	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, single submitter	VCV000570064	9	135205781	9	132330394	570064	563604	rs772044862	
908	NM_015046.7(SETX):c.1166T>C (p.Leu389Ser)	SETX	L389S	Distal spinal muscular atrophy|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided|Amyotrophic lateral sclerosis type 4	Pathogenic(Last reviewed: Aug 16, 2017)	criteria provided, multiple submitters, no conflicts	VCV000002289	9	135205819	9	132330432	2289	17328	rs29001584	
909	NM_015046.7(SETX):c.1153G>A (p.Glu385Lys)	SETX	E385K	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 12, 2017)	criteria provided, single submitter	VCV000536386	9	135205832	9	132330445	536386	524123	rs1554821963	
910	NM_015046.7(SETX):c.1077T>C (p.Tyr359=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Benign(Last reviewed: Apr 12, 2017)	criteria provided, multiple submitters, no conflicts	VCV000095658	9	135206460	9	132331073	95658	101555	rs9411449	
911	NM_015046.7(SETX):c.968G>A (p.Ser323Asn)	SETX	S323N	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not provided	Uncertain significance(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000536383	9	135206706	9	132331319	536383	524403	rs372193033	
912	NM_015046.7(SETX):c.808A>G (p.Ile270Val)	SETX	I270V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000576744	9	135210025	9	132334638	576744	562872	rs1387745582	
913	NM_015046.7(SETX):c.768G>T (p.Leu256=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Jul 12, 2017)	criteria provided, single submitter	VCV000468526	9	135210065	9	132334678	468526	458985	rs759468738	
914	NM_015046.7(SETX):c.710A>G (p.Tyr237Cys)	SETX	Y237C	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365374	9	135211691	9	132336304	365374	317351	rs138538492	
915	NM_015046.7(SETX):c.667C>G (p.Leu223Val)	SETX	L223V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000536382	9	135211734	9	132336347	536382	524711	rs774068411	
916	NM_015046.7(SETX):c.654G>C (p.Lys218Asn)	SETX	K218N	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4|not specified	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448341	9	135211747	9	132336360	448341	441312	rs117861188	
917	NM_015046.7(SETX):c.617A>G (p.Glu206Gly)	SETX	E206G	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365375	9	135211784	9	132336397	365375	307187	rs759880306	
918	NM_015046.7(SETX):c.472T>G (p.Leu158Val)	SETX	L158V	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 22, 2019)	criteria provided, conflicting interpretations	VCV000365376	9	135218103	9	132342716	365376	316922	rs145438764	
919	NM_015046.7(SETX):c.431A>G (p.Asn144Ser)	SETX	N144S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000536403	9	135218144	9	132342757	536403	524717	rs767453182	
920	NM_015046.7(SETX):c.389-9del	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365377	9	135218195	9	132342808	365377	311342	rs534931548	
921	NM_015046.7(SETX):c.263A>G (p.Tyr88Cys)	SETX	Y88C	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000576011	9	135221773	9	132346386	576011	568612	rs149276791	
922	NM_015046.7(SETX):c.208A>G (p.Ile70Val)	SETX	I70V	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 17, 2017)	criteria provided, single submitter	VCV000536373	9	135221828	9	132346441	536373	524629	rs747469176	
923	NM_015046.7(SETX):c.93A>G (p.Gln31=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 12, 2017)	criteria provided, single submitter	VCV000468529	9	135224723	9	132349336	468529	458573	rs201795631	
924	NM_015046.7(SETX):c.77C>G (p.Pro26Arg)	SETX	P26R	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365378	9	135224739	9	132349352	365378	311351	rs377617692	
925	NM_015046.7(SETX):c.71A>G (p.Asn24Ser)	SETX	N24S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000468524	9	135224745	9	132349358	468524	459007	rs981346599	
926	NM_015046.7(SETX):c.68C>T (p.Ser23Phe)	SETX	S23F	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000468520	9	135224748	9	132349361	468520	458575	rs1323126988	
927	NM_015046.7(SETX):c.64G>T (p.Ala22Ser)	SETX	A22S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000536392	9	135224752	9	132349365	536392	524124	rs756600708	
928	NM_015046.7(SETX):c.60C>T (p.Arg20=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365379	9	135224756	9	132349369	365379	316925	rs553346505	
929	NM_015046.7(SETX):c.59G>A (p.Arg20His)	SETX	R20H	Amyotrophic Lateral Sclerosis, Dominant|not specified|Ataxia with Oculomotor Apraxia|not provided	Benign/Likely benign(Last reviewed: Apr 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000242635	9	135224757	9	132349370	242635	167386	rs79740039	
930	NM_015046.7(SETX):c.33T>C (p.Gly11=)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Mar 29, 2017)	criteria provided, single submitter	VCV000468500	9	135224783	9	132349396	468500	458576	rs1243832257	
931	NM_015046.7(SETX):c.32G>A (p.Gly11Asp)	SETX	G11D	Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365380	9	135224784	9	132349397	365380	307190	rs886063560	
932	NM_015046.7(SETX):c.14G>C (p.Cys5Ser)	SETX	C5S	Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000657071	9	135224802	9	132349415	657071	637818		
933	NM_015046.7(SETX):c.9A>G (p.Thr3=)	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365381	9	135224807	9	132349420	365381	311352	rs139681694	
934	NM_015046.7(SETX):c.8C>T (p.Thr3Ile)	SETX	T3I	Distal spinal muscular atrophy|not provided|Amyotrophic lateral sclerosis type 4	Likely pathogenic(Last reviewed: Aug 2, 2016)	criteria provided, single submitter	VCV000002290	9	135224808	9	132349421	2290	17329	rs28941475	
935	NM_015046.7(SETX):c.-107C>T	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365382	9	135229135	9	132353748	365382	307193	rs190832998	
936	NM_015046.7(SETX):c.-154G>C	SETX		Ataxia with Oculomotor Apraxia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365383	9	135230343	9	132354956	365383	316926	rs886063561	
937	NC_000009.11:g.(?_34458984)_(36277059_?)dup	SIGMAR1		Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Uncertain significance(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV000584345	9	34458984 - 36277059			584345	563212		
938	NM_001008211.1(OPTN):c.-454C>T	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368894	10	13142081	10	13100081	368894	353123	rs570587258	
939	NM_001008211.1(OPTN):c.-453G>T	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299200	10	13142082	10	13100082	299200	320644	rs886046816	
940	NM_001008211.1(OPTN):c.-448G>T	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299201	10	13142087	10	13100087	299201	314575	rs3814657	
941	NM_001008211.1(OPTN):c.-382T>C	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299202	10	13142153	10	13100153	299202	314577	rs71492279	
942	NM_001008212.2(OPTN):c.-274C>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299203	10	13142192	10	13100192	299203	314579	rs552494483	
943	NM_001008212.2(OPTN):c.-272G>T	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299204	10	13142194	10	13100194	299204	309724	rs886046817	
944	NM_001008212.2(OPTN):c.-255C>G	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299205	10	13142211	10	13100211	299205	309725	rs2580915	
945	NM_001008212.2(OPTN):c.-250C>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299206	10	13142216	10	13100216	299206	321180	rs886046818	
946	NM_001008212.2(OPTN):c.-215G>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299207	10	13142251	10	13100251	299207	314580	rs11548142	
947	NM_001008212.2(OPTN):c.-164+13A>G	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299208	10	13142315	10	13100315	299208	309726	rs556917167	
948	NC_000010.10:g.(?_13151103)_(13178886_?)del	OPTN		Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, e|Primary open angle glaucoma	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000529764	10	13151103 - 13178886	10	13109103 - 13136886	529764	525242		
949	NC_000010.10:g.(?_13151123)_(13225100_?)del	OPTN		Primary open angle glaucoma|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000583651	10	13151123 - 13225100	10	13109123 - 13183100	583651	564407		
950	NM_001008212.2(OPTN):c.14C>G (p.Pro5Arg)	OPTN	P5R	Glaucoma 1, open angle, e|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12	Uncertain significance(Last reviewed: Jan 2, 2018)	criteria provided, single submitter	VCV000565324	10	13151136	10	13109136	565324	569552	rs1564354765	
951	NM_001008212.2(OPTN):c.102G>A (p.Thr34=)	OPTN		Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive|not specified	Benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000096022	10	13151224	10	13109224	96022	101916	rs2234968	
952	NM_001008212.2(OPTN):c.123G>A (p.Leu41=)	OPTN		not specified|not provided|Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Benign/Likely benign(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000096023	10	13151245	10	13109245	96023	101917	rs11591687	
953	NM_001008212.2(OPTN):c.158_161dup (p.Lys55fs)	OPTN		Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma	Pathogenic(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000576203	10	13151279 - 13151280	10	13109279 - 13109280	576203	569554	rs1564354968	
954	NM_001008212.2(OPTN):c.247C>T (p.Arg83Cys)	OPTN	R83C	Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299209	10	13152354	10	13110354	299209	321188	rs756622651	
955	NM_001008212.2(OPTN):c.275A>T (p.Glu92Val)	OPTN	E92V	Amyotrophic lateral sclerosis	Uncertain significance(Last reviewed: Dec 18, 2017)	criteria provided, single submitter	VCV000523078	10	13152382	10	13110382	523078	513590	rs202044898	
956	NM_001008212.2(OPTN):c.293T>A (p.Met98Lys)	OPTN	M98K	Amyotrophic Lateral Sclerosis, Recessive|not specified|Primary open angle glaucoma|Glaucoma 1, open angle, e|Glaucoma, normal tension, susceptibility to	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000007099	10	13152400	10	13110400	7099	22138	rs11258194	
957	NM_001008212.2(OPTN):c.381_382insAG (p.Asp128fs)	OPTN		Primary open angle glaucoma|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: Sep 17, 2018)	criteria provided, single submitter	VCV000647662	10	13154464 - 13154465	10	13112464 - 13112465	647662	638772		
958	NM_001008212.2(OPTN):c.402C>A (p.Ala134=)	OPTN		Amyotrophic Lateral Sclerosis, Recessive|not provided|Primary open angle glaucoma	Benign/Likely benign(Last reviewed: Dec 5, 2018)	criteria provided, multiple submitters, no conflicts	VCV000299210	10	13154485	10	13112485	299210	320645	rs113955718	
959	NM_001008212.2(OPTN):c.403G>A (p.Glu135Lys)	OPTN	E135K	Primary open angle glaucoma|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12	Uncertain significance(Last reviewed: Oct 17, 2018)	criteria provided, single submitter	VCV000651429	10	13154486	10	13112486	651429	638773		
960	NM_001008212.2(OPTN):c.403G>T (p.Glu135Ter)	OPTN	E135*	not provided|Amyotrophic lateral sclerosis type 12	Conflicting interpretations of pathogenicity(Last reviewed: Dec 18, 2018)	criteria provided, conflicting interpretations	VCV000631627	10	13154486	10	13112486	631627	620347	rs140599944	
961	NM_001008212.2(OPTN):c.425A>C (p.Gln142Pro)	OPTN	Q142P	Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299211	10	13154508	10	13112508	299211	321189	rs757411888	
962	NM_001008212.2(OPTN):c.441G>A (p.Val147=)	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299212	10	13154524	10	13112524	299212	321201	rs886046819	
963	NM_001008212.2(OPTN):c.444G>A (p.Val148=)	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299213	10	13154527	10	13112527	299213	314581	rs780011442	
964	NM_001008212.2(OPTN):c.447G>A (p.Arg149=)	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299214	10	13154530	10	13112530	299214	309727	rs555741399	
965	NM_001008212.2(OPTN):c.489A>G (p.Glu163=)	OPTN		not specified|not provided|Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive	Benign/Likely benign(Last reviewed: Jul 25, 2019)	criteria provided, multiple submitters, no conflicts	VCV000256881	10	13154572	10	13112572	256881	253708	rs113811959	
966	NM_001008212.2(OPTN):c.553-5C>T	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma|not specified	Benign(Last reviewed: Jul 21, 2017)	criteria provided, multiple submitters, no conflicts	VCV000197846	10	13158262	10	13116262	197846	195007	rs2244380	
967	NM_001008212.2(OPTN):c.573A>G (p.Ser191=)	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299215	10	13158287	10	13116287	299215	320651	rs773095721	
968	NM_001008212.2(OPTN):c.626+24G>A	OPTN		Glaucoma 1, open angle, e|Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|not specified	Benign(Last reviewed: Jul 20, 2017)	criteria provided, multiple submitters, no conflicts	VCV000256883	10	13158364	10	13116364	256883	253710	rs11258211	
969	NM_001008212.2(OPTN):c.627-10T>C	OPTN		Amyotrophic Lateral Sclerosis, Recessive|not provided|Primary open angle glaucoma	Benign/Likely benign(Last reviewed: Oct 23, 2018)	criteria provided, multiple submitters, no conflicts	VCV000299216	10	13160878	10	13118878	299216	321211	rs80327830	
970	NM_001008212.2(OPTN):c.941A>T (p.Gln314Leu)	OPTN	Q314L	Primary open angle glaucoma|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12|Motor neuron disease	Conflicting interpretations of pathogenicity(Last reviewed: Sep 17, 2017)	criteria provided, conflicting interpretations	VCV000266060	10	13166053	10	13124053	266060	260885	rs142812715	
971	NM_001008212.2(OPTN):c.961A>T (p.Ser321Cys)	OPTN	S321C	Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299217	10	13166073	10	13124073	299217	314594	rs886046820	
972	NM_001008212.2(OPTN):c.963C>T (p.Ser321=)	OPTN		Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, e|Amyotrophic Lateral Sclerosis, Recessive|not provided|Primary open angle glaucoma	Conflicting interpretations of pathogenicity(Last reviewed: Nov 5, 2018)	criteria provided, conflicting interpretations	VCV000299218	10	13166075	10	13124075	299218	321213	rs150381274	
973	NM_001008212.2(OPTN):c.1192C>T (p.Gln398Ter)	OPTN	Q398*	Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: May 13, 2010)	no assertion criteria provided	VCV000007101	10	13167989	10	13125989	7101	22140	rs267606928	
974	NM_001008212.2(OPTN):c.1243-13G>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299219	10	13169732	10	13127732	299219	314616	rs374144660	
975	NM_001008212.2(OPTN):c.1401+21C>G	OPTN		Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, e	Likely benign(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000460308	10	13169924	10	13127924	460308	460629	rs553828705	
976	NM_001008212.2(OPTN):c.1402-3C>G	OPTN		Primary open angle glaucoma|Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12	Uncertain significance(Last reviewed: Nov 9, 2018)	criteria provided, single submitter	VCV000650247	10	13174064	10	13132064	650247	652314		
977	NM_001008212.2(OPTN):c.1427A>G (p.His476Arg)	OPTN	H476R	Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299220	10	13174092	10	13132092	299220	309732	rs886046821	
978	NM_001008212.2(OPTN):c.1433A>G (p.Glu478Gly)	OPTN	E478G	Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: May 13, 2010)	no assertion criteria provided	VCV000007102	10	13174098	10	13132098	7102	22141	rs267606929	
979	NM_001008212.2(OPTN):c.1532+10AG[3]	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299221	10	13174207 - 13174208	10	13132207 - 13132208	299221	314619	rs374302388	
980	NM_001008212.2(OPTN):c.1569G>A (p.Ala523=)	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299222	10	13175538	10	13133538	299222	321216	rs771316696	
981	NM_001008212.2(OPTN):c.1612+10G>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|not provided|Primary open angle glaucoma	Benign/Likely benign(Last reviewed: Feb 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000299223	10	13175591	10	13133591	299223	321224	rs191671333	
982	NM_001008212.2(OPTN):c.1634G>A (p.Arg545Gln)	OPTN	R545Q	Amyotrophic Lateral Sclerosis, Recessive|not provided|Primary open angle glaucoma|Glaucoma 1, open angle, e	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000007098	10	13178766	10	13136766	7098	22137	rs75654767	
983	NM_001008212.2(OPTN):c.*152G>T	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299224	10	13179018	10	13137018	299224	314621	rs886046823	
984	NM_001008212.2(OPTN):c.*218G>C	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299225	10	13179084	10	13137084	299225	320654	rs886046824	
985	NM_001008212.2(OPTN):c.*269C>T	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299226	10	13179135	10	13137135	299226	309734	rs111484304	
986	NM_001008212.2(OPTN):c.*306G>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299227	10	13179172	10	13137172	299227	314622	rs538280633	
987	NM_001008212.2(OPTN):c.*386C>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299228	10	13179252	10	13137252	299228	320655	rs745564491	
988	NM_001008212.2(OPTN):c.*413G>A	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299229	10	13179279	10	13137279	299229	320656	rs886046825	
989	NM_001008212.2(OPTN):c.*461G>A	OPTN		Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299230	10	13179327	10	13137327	299230	314630	rs541250740	
990	NM_001008212.2(OPTN):c.*562T>G	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299231	10	13179428	10	13137428	299231	320657	rs148646641	
991	NM_001008212.2(OPTN):c.*938C>G	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299232	10	13179804	10	13137804	299232	321225	rs886046826	
992	NM_001008212.2(OPTN):c.*1042T>G	OPTN		Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299233	10	13179908	10	13137908	299233	309739	rs886046827	
993	NM_001008212.2(OPTN):c.*1063C>A	OPTN		Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299234	10	13179929	10	13137929	299234	320658	rs530046832	
994	NM_001008212.2(OPTN):c.*1089G>A	OPTN		Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299235	10	13179955	10	13137955	299235	321235	rs758812707	
995	NM_001008212.2(OPTN):c.*1251C>G	OPTN		Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299236	10	13180117	10	13138117	299236	320662	rs542617940	
996	NM_001008212.2(OPTN):c.*1285T>C	OPTN		Primary open angle glaucoma|Amyotrophic Lateral Sclerosis, Recessive	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299237	10	13180151	10	13138151	299237	309743	rs560947786	
997	NM_001008212.2(OPTN):c.*1385T>C	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000299238	10	13180251	10	13138251	299238	321239	rs546352206	
998	NM_001008212.2(OPTN):c.*1421T>G	OPTN		Amyotrophic Lateral Sclerosis, Recessive|Primary open angle glaucoma	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368895	10	13180287	10	13138287	368895	353124	rs12415716	
999	NM_145868.2(ANXA11):c.523G>A (p.Gly175Arg)	ANXA11	G175R, G142R	AMYOTROPHIC LATERAL SCLEROSIS 23	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000488355	10	81928763	10	80169007	488355	481195	rs754594235	
1000	NM_145868.2(ANXA11):c.119A>G (p.Asp40Gly)	ANXA11	D40G, D7G	AMYOTROPHIC LATERAL SCLEROSIS 23	Pathogenic(Last reviewed: Jan 29, 2018)	no assertion criteria provided	VCV000488353	10	81930608	10	80170852	488353	481193	rs1247392012	
1001	NM_145868.2(ANXA11):c.118G>T (p.Asp40Tyr)	ANXA11	D40Y, D7Y	AMYOTROPHIC LATERAL SCLEROSIS 23	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802593	10	81930609	10	80170853	802593	790985		
1002	NM_145868.2(ANXA11):c.112G>A (p.Gly38Arg)	ANXA11	G38R, G5R	AMYOTROPHIC LATERAL SCLEROSIS 23	Pathogenic(Last reviewed: Jan 30, 2018)	no assertion criteria provided	VCV000488354	10	81930615	10	80170859	488354	481194	rs142083484	
1003	NC_000010.10:g.(?_12833157)_(13178866_?)del	OPTN		Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, e	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000584050	10	12833157 - 13178866			584050	564400		
1004	NM_000614.4(CNTF):c.115-6G>A	CNTF		CILIARY NEUROTROPHIC FACTOR POLYMORPHISM	Benign(Last reviewed: May 1, 2004)	no assertion criteria provided	VCV000017493	11	58391501	11	58624028	17493	32532	rs1800169	
1005	NM_006262.4(PRPH):c.421G>T (p.Asp141Tyr)	PRPH|LOC101927267	D141Y	not specified|not provided|Amyotrophic lateral sclerosis, susceptibility to	Conflicting interpretations of pathogenicity(Last reviewed: Feb 27, 2019)	criteria provided, conflicting interpretations	VCV000013707	12	49689404	12	49295621	13707	28746	rs58599399	
1006	NM_031157.4(HNRNPA1):c.940G>A (p.Asp314Asn)	HNRNPA1	D314N, D262N	Amyotrophic lateral sclerosis 20	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065452	12	54677628	12	54283844	65452	76369	rs397518453	
1007	NM_031157.4(HNRNPA1):c.941A>T (p.Asp314Val)	HNRNPA1	D314V, D262V	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000065451	12	54677629	12	54283845	65451	76368	rs397518452	
1008	NM_031157.4(HNRNPA1):c.956A>G (p.Asn319Ser)	HNRNPA1	N319S, N267S	Amyotrophic lateral sclerosis 20	Pathogenic(Last reviewed: Mar 28, 2013)	no assertion criteria provided	VCV000065453	12	54677644	12	54283860	65453	76370	rs397518454	
1009	NM_031157.4(HNRNPA1):c.1018C>G (p.Pro340Ala)	HNRNPA1	P288A, P340A	Inclusion body myopathy with early-onset paget disease with or without frontotemporal dementia 3	Likely pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, single submitter	VCV000637023	12	54677706	12	54283922	637023	624860		
1010	NM_004984.4(KIF5A):c.2993-3C>T	KIF5A		AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25	risk factor(Last reviewed: Mar 29, 2018)	no assertion criteria provided	VCV000504476	12	57976382	12	57582599	504476	495916	rs1402429085	
1011	NM_004984.4(KIF5A):c.3019A>G (p.Arg1007Gly)	KIF5A	R1007G, R918G	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25	risk factor(Last reviewed: Mar 29, 2018)	no assertion criteria provided	VCV000504479	12	57976411	12	57582628	504479	495919	rs1555179087	
1012	NM_004984.4(KIF5A):c.3020+1G>A	KIF5A		AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25	risk factor(Last reviewed: Mar 29, 2018)	no assertion criteria provided	VCV000504478	12	57976413	12	57582630	504478	495918	rs1555179091	
1013	NM_004984.4(KIF5A):c.3020+2T>A	KIF5A		AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 25	risk factor(Last reviewed: Mar 29, 2018)	no assertion criteria provided	VCV000504477	12	57976414	12	57582631	504477	495917	rs1218712729	
1014	NM_013254.4(TBK1):c.40A>G (p.Ile14Val)	TBK1	I14V	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000475939	12	64849690	12	64455910	475939	463294	rs781325780	
1015	NM_013254.4(TBK1):c.66T>C (p.Asn22=)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4|Glaucoma 1, open angle, p	Benign(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000475941	12	64849716	12	64455936	475941	463295	rs41292019	
1016	NM_013254.4(TBK1):c.86dup (p.Lys30fs)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807704	12	64849734 - 64849735	12	64455954 - 64455955	807704	798660		
1017	NM_013254.4(TBK1):c.87G>A (p.Lys29=)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Feb 9, 2018)	criteria provided, single submitter	VCV000807705	12	64849737	12	64455957	807705	798661		
1018	NM_013254.4(TBK1):c.230_232CAA[2] (p.Thr79del)	TBK1	T79del	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Apr 9, 2018)	criteria provided, single submitter	VCV000565435	12	64858114 - 64858116	12	64464334 - 64464336	565435	565695	rs748007618	
1019	NM_013254.4(TBK1):c.421dup (p.Ile141fs)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000580261	12	64860742 - 64860743	12	64466962 - 64466963	580261	565696	rs1565814492	
1020	NM_013254.4(TBK1):c.427C>T (p.Arg143Cys)	TBK1	R143C	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, single submitter	VCV000807706	12	64860749	12	64466969	807706	798662		
1021	NM_013254.4(TBK1):c.701+1G>A	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Likely pathogenic(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000643946	12	64868171	12	64474391	643946	652731		
1022	NM_013254.4(TBK1):c.802A>G (p.Ser268Gly)	TBK1	S268G	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000664607	12	64873892	12	64480112	664607	641361		
1023	NM_013254.4(TBK1):c.812G>A (p.Arg271Gln)	TBK1	R271Q	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Likely benign(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000542553	12	64873902	12	64480122	542553	527637	rs56196591	
1024	NM_013254.4(TBK1):c.958del (p.Thr320fs)	TBK1	T320fs	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000203438	12	64875767	12	64481987	203438	199851	rs755950225	
1025	NM_013254.4(TBK1):c.992C>T (p.Thr331Ile)	TBK1	T331I	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000475942	12	64875801	12	64482021	475942	463299	rs200758840	
1026	NM_013254.4(TBK1):c.992+1G>A	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jan 8, 2018)	criteria provided, single submitter	VCV000807707	12	64875802	12	64482022	807707	798663		
1027	NM_013254.4(TBK1):c.1069C>T (p.Arg357Ter)	TBK1	R357*	not provided	Pathogenic(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000620149	12	64878159	12	64484379	620149	611774	rs1328949478	
1028	NM_013254.4(TBK1):c.1072C>T (p.Arg358Cys)	TBK1	R358C	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Nov 28, 2018)	criteria provided, single submitter	VCV000654729	12	64878162	12	64484382	654729	641362		
1029	NM_013254.4(TBK1):c.1116A>G (p.Lys372=)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000571522	12	64878206	12	64484426	571522	565701	rs775134475	
1030	NM_013254.4(TBK1):c.1148G>T (p.Ser383Ile)	TBK1	S383I	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Oct 11, 2018)	criteria provided, single submitter	VCV000645888	12	64878238	12	64484458	645888	641363		
1031	NM_013254.4(TBK1):c.1190-9A>G	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Likely benign(Last reviewed: Sep 27, 2017)	criteria provided, single submitter	VCV000542555	12	64879226	12	64485446	542555	527335	rs375547018	
1032	NM_013254.4(TBK1):c.1201A>G (p.Lys401Glu)	TBK1	K401E	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000203441	12	64879246	12	64485466	203441	199854	rs756751089	
1033	NM_013254.4(TBK1):c.1340+1G>A	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000203439	12	64879798	12	64486018	203439	199852	rs767898276	
1034	NM_013254.4(TBK1):c.1341-3del	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Benign(Last reviewed: Jul 31, 2017)	criteria provided, single submitter	VCV000475934	12	64882258	12	64488478	475934	463300	rs201728462	
1035	NM_013254.4(TBK1):c.1345_1348TTAA[1] (p.Ile450fs)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000203435	12	64882269 - 64882272	12	64488489 - 64488492	203435	199848	rs876657404	
1036	NM_013254.4(TBK1):c.1359T>G (p.Asp453Glu)	TBK1	D453E	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: May 8, 2018)	criteria provided, single submitter	VCV000568127	12	64882285	12	64488505	568127	571988	rs1565821771	
1037	NM_013254.4(TBK1):c.1387_1388del (p.Glu463fs)	TBK1	E463fs	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000542552	12	64882312 - 64882313	12	64488532 - 64488533	542552	527327	rs1555204731	
1038	NM_013254.4(TBK1):c.1391T>C (p.Val464Ala)	TBK1	V464A	Glaucoma 1, open angle, p|Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Benign(Last reviewed: Aug 11, 2017)	criteria provided, multiple submitters, no conflicts	VCV000475935	12	64882317	12	64488537	475935	462450	rs35635889	
1039	NM_013254.4(TBK1):c.1412G>C (p.Cys471Ser)	TBK1	C471S	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000542551	12	64882338	12	64488558	542551	527640	rs369875862	
1040	NM_013254.4(TBK1):c.1434_1435TG[1] (p.Val479fs)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000203436	12	64882360 - 64882361	12	64488580 - 64488581	203436	199849	rs876657405	
1041	NM_013254.4(TBK1):c.1505A>G (p.His502Arg)	TBK1	H502R	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000655436	12	64883883	12	64490103	655436	641364		
1042	NM_013254.4(TBK1):c.1603G>A (p.Ala535Thr)	TBK1	A535T	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Jul 5, 2018)	criteria provided, single submitter	VCV000575829	12	64889344	12	64495564	575829	571995	rs199905735	
1043	NM_013254.3(TBK1):c.1644-5_1644-2del	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4|not provided	Uncertain significance(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000444300	12	64889472 - 64889475	12	64495692 - 64495695	444300	437940	rs755646937	
1044	NM_013254.4(TBK1):c.1718G>A (p.Arg573His)	TBK1	R573H	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Aug 7, 2017)	criteria provided, single submitter	VCV000475936	12	64889553	12	64495773	475936	463303	rs186475789	
1045	NM_013254.4(TBK1):c.1792A>G (p.Met598Val)	TBK1	M598V	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Apr 23, 2018)	criteria provided, conflicting interpretations	VCV000516884	12	64890760	12	64496980	516884	505020	rs899858451	
1046	NM_013254.4(TBK1):c.1922_1924AAG[2] (p.Glu643del)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jan 22, 2018)	criteria provided, single submitter	VCV000807508	12	64891001 - 64891003	12	64497221 - 64497223	807508	798664		
1047	NM_013254.4(TBK1):c.1952C>A (p.Thr651Asn)	TBK1	T651N	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000647255	12	64891032	12	64497252	647255	641365		
1048	NM_013254.4(TBK1):c.1957G>C (p.Glu653Gln)	TBK1	E653Q	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, single submitter	VCV000580527	12	64891037	12	64497257	580527	567036	rs144370662	
1049	NM_013254.4(TBK1):c.1960-7G>T	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4|not provided	Likely benign(Last reviewed: May 1, 2018)	criteria provided, multiple submitters, no conflicts	VCV000542556	12	64891421	12	64497641	542556	527646	rs768189768	
1050	NM_013254.4(TBK1):c.2086G>A (p.Glu696Lys)	TBK1	E696K	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jul 1, 2015)	no assertion criteria provided	VCV000203440	12	64891767	12	64497987	203440	199853	rs748112833	
1051	NM_013254.4(TBK1):c.2138+2T>C	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000203437	12	64891821	12	64498041	203437	199850	rs876657406	
1052	NM_013254.4(TBK1):c.2177T>C (p.Val726Ala)	TBK1	V726A	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000573808	12	64895148	12	64501368	573808	567047	rs765585935	
1053	GRCh37/hg19 12q14.2(chr12:64868010-64895161)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000813327	12	64868010 - 64895161			813327	801575		
1054	NM_001145.4(ANG):c.-594C>A	ANG		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312759	14	21152342	14	20684183	312759	335460	rs886050394	
1055	NM_001145.4(ANG):c.-579G>C	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312760	14	21152357	14	20684198	312760	335468	rs117466368	
1056	NM_001145.4(ANG):c.-534C>T	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312761	14	21152402	14	20684243	312761	320276	rs117787610	
1057	NM_001145.4(ANG):c.-530T>C	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312762	14	21152406	14	20684247	312762	328854	rs117053048	
1058	NM_001145.4(ANG):c.-524G>A	ANG		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312763	14	21152412	14	20684253	312763	328855	rs886050395	
1059	NM_001145.4(ANG):c.-423C>T	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312764	14	21152513	14	20684354	312764	328869	rs149147430	
1060	NM_001145.4(ANG):c.-401G>T	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312765	14	21152535	14	20684376	312765	337328	rs45591635	
1061	NM_001145.4(ANG):c.-383C>G	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312766	14	21152553	14	20684394	312766	335469	rs113950902	
1062	NM_001145.4(ANG):c.-381C>T	ANG		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312767	14	21152555	14	20684396	312767	328872	rs886050396	
1063	NM_001145.4(ANG):c.-332C>A	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312768	14	21152604	14	20684445	312768	320277	rs28589501	
1064	NM_001145.4(ANG):c.-237A>C	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312769	14	21152699	14	20684540	312769	335472	rs45525731	
1065	NM_002937.5(RNASE4):c.-114G>C	ANG		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312770	14	21152821	14	20684662	312770	337329	rs886050397	
1066	NM_002937.5(RNASE4):c.-40T>C	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312771	14	21152895	14	20684736	312771	320278	rs117978329	
1067	NM_002937.5(RNASE4):c.-18+11A>C	ANG		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312772	14	21152928	14	20684769	312772	328873	rs184963428	
1068	NM_002937.5(RNASE4):c.-17-5692C>T	ANG		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312773	14	21161822	14	20693663	312773	328874	rs563139057	
1069	NM_002937.5(RNASE4):c.-17-5684A>T	ANG	Q12L, Q36L	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018073	14	21161830	14	20693671	18073	33112	rs121909535	
1070	NM_002937.5(RNASE4):c.-17-5670A>G	ANG	K17E, K41E	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018075	14	21161844	14	20693685	18075	33114	rs121909537	
1071	NM_002937.5(RNASE4):c.-17-5669A>T	ANG	K17I, K41I	Amyotrophic Lateral Sclerosis, Dominant|not provided|Amyotrophic lateral sclerosis type 9	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000018074	14	21161845	14	20693686	18074	33113	rs121909536	
1072	NM_002937.5(RNASE4):c.-17-5636G>A	ANG	S28N, S52N	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000018080	14	21161878	14	20693719	18080	33119	rs121909542	
1073	NM_002937.5(RNASE4):c.-17-5627G>A	ANG	R31K, R55K	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018076	14	21161887	14	20693728	18076	33115	rs121909538	
1074	NM_002937.5(RNASE4):c.-17-5602C>G	ANG	C39W, C63W	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018077	14	21161912	14	20693753	18077	33116	rs121909539	
1075	NM_002937.5(RNASE4):c.-17-5600A>T	ANG	K40I, K64I	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Apr 1, 2006)	no assertion criteria provided	VCV000018078	14	21161914	14	20693755	18078	33117	rs121909540	
1076	NM_002937.5(RNASE4):c.-17-5583A>G	ANG	I46V, I70V	not provided|Amyotrophic lateral sclerosis type 9	Uncertain significance(Last reviewed: Nov 12, 2015)	criteria provided, single submitter	VCV000018079	14	21161931	14	20693772	18079	33118	rs121909541	
1077	NM_002937.5(RNASE4):c.-17-5541A>G	ANG	K84E	Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided|Amyotrophic lateral sclerosis type 9	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000312774	14	21161973	14	20693814	312774	335474	rs17560	
1078	NM_002937.5(RNASE4):c.-17-5461T>G	ANG		not specified|Amyotrophic Lateral Sclerosis, Dominant	Benign/Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, multiple submitters, no conflicts	VCV000257559	14	21162053	14	20693894	257559	254908	rs11701	
1079	NM_002937.5(RNASE4):c.-17-5428A>T	ANG		Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000312775	14	21162086	14	20693927	312775	320290	rs2228653	
1080	NM_002937.5(RNASE4):c.-17-5426C>T	ANG	A122V	Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312776	14	21162088	14	20693929	312776	335476	rs374766597	
1081	NM_002937.5(RNASE4):c.-17-5384C>T	ANG	P112L, P136L	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Dec 1, 2007)	no assertion criteria provided	VCV000018081	14	21162130	14	20693971	18081	33120	rs121909543	
1082	NM_002937.5(RNASE4):c.-17-5382G>A	ANG	V113I, V137I	Amyotrophic lateral sclerosis type 9	Pathogenic(Last reviewed: Feb 1, 2008)	no assertion criteria provided	VCV000018082	14	21162132	14	20693973	18082	33121	rs121909544	
1083	NM_002937.5(RNASE4):c.-17-5350G>A	ANG		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312777	14	21162164	14	20694005	312777	337360	rs759928848	
1084	NM_002937.5(RNASE4):c.-17-5337C>T	ANG		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000312778	14	21162177	14	20694018	312778	328877	rs778543068	
1085	NM_003384.3(VRK1):c.362A>G (p.Lys121Arg)	VRK1	K121R	not provided|Pontocerebellar hypoplasia type 1	Uncertain significance(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000424454	14	97313669	14	96847332	424454	409180	rs1064796973	
1086	NM_003384.3(VRK1):c.961C>T (p.Arg321Cys)	VRK1	R321C	Pontocerebellar hypoplasia type 1|not specified|Pontocerebellar hypoplasia type 1A	Conflicting interpretations of pathogenicity(Last reviewed: Jun 21, 2018)	criteria provided, conflicting interpretations	VCV000209205	14	97326965	14	96860628	209205	205777	rs772731615	
1087	NM_025137.4(SPG11):c.7155T>G (p.Tyr2385Ter)	SPG11	Y2385*, Y2272*	Spastic paraplegia 11, autosomal recessive|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Mar 5, 2018)	criteria provided, conflicting interpretations	VCV000378638	15	44855496	15	44563298	378638	374516	rs778305085	
1088	NM_025137.4(SPG11):c.7029dup (p.Val2344fs)	SPG11		Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041358	15	44856866 - 44856867	15	44564668 - 44564669	41358	49782	rs312262788	
1089	NM_025137.4(SPG11):c.6950G>A (p.Gly2317Asp)	SPG11	G2317D, G2204D	Spastic Paraplegia, Recessive|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Nov 22, 2017)	criteria provided, multiple submitters, no conflicts	VCV000316077	15	44858101	15	44565903	316077	338993	rs79186522	
1090	NM_025137.4(SPG11):c.6899T>G (p.Leu2300Arg)	SPG11	L2300R, L2187R	Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Dec 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000560924	15	44858152	15	44565954	560924	552181	rs371334506	
1091	NM_025137.4(SPG11):c.6625C>T (p.Arg2209Cys)	SPG11	R2209C, R2096C	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5|not provided|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Feb 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000466559	15	44859751	15	44567553	466559	465035	rs374057859	
1092	NM_025137.4(SPG11):c.6157G>A (p.Val2053Met)	SPG11	V2053M	not provided|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000041341	15	44865793	15	44573595	41341	49765	rs149003934	
1093	NM_025137.4(SPG11):c.6043G>A (p.Asp2015Asn)	SPG11	D2015N	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000466550	15	44865907	15	44573709	466550	465061	rs771242219	
1094	NM_025137.4(SPG11):c.5974C>T (p.Arg1992Ter)	SPG11	R1992*	not provided|Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 9, 2016)	criteria provided, single submitter	VCV000041333	15	44867132	15	44574934	41333	49757	rs200793464	
1095	NM_025137.4(SPG11):c.5471G>A (p.Arg1824Gln)	SPG11	R1824Q	Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000571323	15	44876407	15	44584209	571323	569374	rs752401008	
1096	NM_025137.4(SPG11):c.5392G>A (p.Glu1798Lys)	SPG11	E1798K	Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Oct 27, 2017)	criteria provided, single submitter	VCV000534882	15	44876486	15	44584288	534882	529202	rs201254271	
1097	NM_025137.4(SPG11):c.5199del (p.Lys1733fs)	SPG11	K1733fs	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804472	15	44876679	15	44584481	804472	792796		
1098	NM_025137.4(SPG11):c.4888G>T (p.Glu1630Ter)	SPG11	E1630*	Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000561117	15	44881468	15	44589270	561117	552182	rs368276916	
1099	NM_025137.4(SPG11):c.3425C>G (p.Ser1142Cys)	SPG11	S1142C	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000406532	15	44900670	15	44608472	406532	400608	rs201082396	
1100	NM_025137.4(SPG11):c.3075dup (p.Glu1026fs)	SPG11		Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001117	15	44905697 - 44905698	15	44613499 - 44613500	1117	16156	rs312262752	
1101	NM_025137.4(SPG11):c.2198T>G (p.Leu733Ter)	SPG11	L733*	Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jan 31, 2013)	no assertion criteria provided	VCV000041287	15	44918575	15	44626377	41287	49711	rs312262739	
1102	NM_025137.4(SPG11):c.1085G>A (p.Trp362Ter)	SPG11	W362*	Spastic paraplegia 11, autosomal recessive|Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5|not provided	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000488833	15	44944060	15	44651862	488833	482070	rs140385286	
1103	NM_025137.4(SPG11):c.733_734del (p.Met245fs)	SPG11	M245fs	Amyotrophic lateral sclerosis type 5|not provided|Hereditary spastic paraplegia|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Dec 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000001112	15	44949428 - 44949429	15	44657230 - 44657231	1112	16151	rs312262720	
1104	NM_025137.4(SPG11):c.604A>G (p.Met202Val)	SPG11	M202V	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5|Spastic Paraplegia, Recessive|Spastic paraplegia 11, autosomal recessive	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000316113	15	44951340	15	44659142	316113	339019	rs201875705	
1105	NM_025137.4(SPG11):c.267G>A (p.Trp89Ter)	SPG11	W89*	Amyotrophic lateral sclerosis type 5|Spastic paraplegia 11, autosomal recessive	Pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, single submitter	VCV000041294	15	44952805	15	44660607	41294	49718	rs312262709	
1106	NM_025137.4(SPG11):c.118C>T (p.Gln40Ter)	SPG11	Q40*	Spastic paraplegia 11, autosomal recessive|Charcot-Marie-Tooth disease, axonal type 2X|Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Nov 10, 2015)	no assertion criteria provided	VCV000001111	15	44955728	15	44663530	1111	16150	rs267607084	
1107	NM_017672.6(TRPM7):c.4445C>T (p.Thr1482Ile)	TRPM7	T1482I	Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1, susceptibility to	risk factor(Last reviewed: Jan 5, 2010)	no assertion criteria provided	VCV000004807	15	50878630	15	50586433	4807	19846	rs8042919	
1108	NM_004960.3(FUS):c.-54A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318979	16	31191482	16	31180161	318979	334778	rs929867	
1109	NM_004960.3(FUS):c.-53C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318980	16	31191483	16	31180162	318980	334784	rs759668256	
1110	NM_004960.3(FUS):c.-49G>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318981	16	31191487	16	31180166	318981	342763	rs200997075	
1111	NM_004960.3(FUS):c.-39A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318982	16	31191497	16	31180176	318982	342765	rs67676356	
1112	NM_004960.3(FUS):c.147C>A (p.Gly49=)	FUS		Amyotrophic Lateral Sclerosis, Dominant|not specified|Amyotrophic lateral sclerosis type 6	Benign(Last reviewed: Apr 14, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259594	16	31193942	16	31182621	259594	255698	rs741810	
1113	NM_004960.3(FUS):c.153C>T (p.Gly51=)	FUS		Amyotrophic Lateral Sclerosis, Dominant|Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4|not specified	Benign/Likely benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259595	16	31193948	16	31182627	259595	255699	rs61733962	
1114	NM_004960.3(FUS):c.190+9T>C	FUS		Amyotrophic Lateral Sclerosis, Dominant|Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4|not specified	Benign/Likely benign(Last reviewed: Aug 3, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259596	16	31193994	16	31182673	259596	255700	rs73530283	
1115	NM_004960.3(FUS):c.192A>G (p.Thr64=)	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318983	16	31195180	16	31183859	318983	325119	rs776333956	
1116	NM_004960.3(FUS):c.291C>T (p.Tyr97=)	FUS		Amyotrophic Lateral Sclerosis, Dominant|not specified|Amyotrophic lateral sclerosis type 6	Benign(Last reviewed: May 31, 2017)	criteria provided, multiple submitters, no conflicts	VCV000259598	16	31195279	16	31183958	259598	255702	rs1052352	
1117	NM_004960.3(FUS):c.403A>G (p.Ser135Gly)	FUS	S135G, S134G	Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318984	16	31195597	16	31184276	318984	334786	rs886051934	
1118	NM_004960.3(FUS):c.521_523+3delGAGGTG	FUS		not provided|Amyotrophic lateral sclerosis type 6	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000540281	16	31195715 - 31195720	16	31184372 - 31184377	540281	530443	rs537605135	
1119	NM_004960.3(FUS):c.524-5C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Feb 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000318985	16	31196255	16	31184934	318985	325121	rs73530287	
1120	NM_004960.3(FUS):c.616G>A (p.Gly206Ser)	FUS	G206S, G205S, G202S	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000029708	16	31196352	16	31185031	29708	38663	rs387906628	
1121	NM_004960.3(FUS):c.646C>T (p.Arg216Cys)	FUS	R216C, R212C, R215C	Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000016227	16	31196382	16	31185061	16227	31266	rs267606832	
1122	NM_004960.3(FUS):c.661_663del (p.Ser221del)	FUS	S221del, S217del, S220del	Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6|not provided	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503718	16	31196397 - 31196399	16	31185076 - 31185078	503718	495622	rs746633090	
1123	NM_001170634.1(FUS):c.666_668CGG[8] (p.Gly229_Gly230dup)	FUS		Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000649131	16	31196402 - 31196403	16	31185081 - 31185082	649131	644615		
1124	NM_001170634.1(FUS):c.666_668CGG[7] (p.Gly230dup)	FUS		not provided|Amyotrophic Lateral Sclerosis, Dominant|not specified	Benign/Likely benign(Last reviewed: Dec 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000318986	16	31196402 - 31196403	16	31185081 - 31185082	318986	325125	rs72550890	
1125	NM_004960.3(FUS):c.673G>A (p.Gly225Ser)	FUS	G225S, G221S, G224S	Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Oct 23, 2018)	criteria provided, single submitter	VCV000666021	16	31196409	16	31185088	666021	644616		
1126	NM_001170634.1(FUS):c.682_684GGT[6] (p.Gly228_Gly230dup)	FUS		Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Aug 7, 2018)	criteria provided, single submitter	VCV000654997	16	31196420 - 31196421	16	31185099 - 31185100	654997	644617		
1127	NM_004960.3(FUS):c.685_687GGT[5] (p.Gly230_Gly231dup)	FUS		Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000582491	16	31196420 - 31196421	16	31185099 - 31185100	582491	570256	rs757651881	
1128	NM_004960.3(FUS):c.688G>T (p.Gly230Cys)	FUS	G226C, G229C, G230C	Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Dec 7, 2018)	criteria provided, single submitter	VCV000647759	16	31196424	16	31185103	647759	644618		
1129	NM_004960.3(FUS):c.743G>A (p.Arg248His)	FUS	R248H, R247H, R244H	Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000581527	16	31196479	16	31185158	581527	570258	rs760351730	
1130	NM_004960.3(FUS):c.760A>G (p.Met254Val)	FUS	M254V, M250V, M253V	not provided	Likely pathogenic(Last reviewed: May 21, 2015)	criteria provided, single submitter	VCV000427141	16	31196496	16	31185175	427141	415490	rs752076094	
1131	NM_004960.3(FUS):c.764+12A>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318987	16	31196512	16	31185191	318987	325126	rs143916861	
1132	NM_004960.3(FUS):c.868C>T (p.Gln290Ter)	FUS	Q290*, Q286*, Q289*	Tremor, hereditary essential, 4	Pathogenic(Last reviewed: Aug 10, 2012)	no assertion criteria provided	VCV000037070	16	31200479	16	31189158	37070	45746	rs387907274	
1133	NM_004960.3(FUS):c.937-10C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318988	16	31200976	16	31189655	318988	334787	rs199705472	
1134	NM_004960.3(FUS):c.951G>A (p.Thr317=)	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318989	16	31201000	16	31189679	318989	342767	rs771216742	
1135	NM_004960.3(FUS):c.1111C>T (p.Arg371Cys)	FUS	R371C, R370C, R367C	Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Jun 11, 2018)	criteria provided, single submitter	VCV000566220	16	31201405	16	31190084	566220	568102	rs773141319	
1136	NM_004960.3(FUS):c.1156C>A (p.Arg386=)	FUS		Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Feb 3, 2019)	criteria provided, multiple submitters, no conflicts	VCV000318990	16	31201450	16	31190129	318990	341258	rs61733965	
1137	NM_004960.3(FUS):c.1171C>G (p.Pro391Ala)	FUS	P391A, P390A, P387A	Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6	Uncertain significance(Last reviewed: Oct 26, 2017)	criteria provided, single submitter	VCV000540278	16	31201598	16	31190277	540278	530449	rs560450437	
1138	NM_004960.3(FUS):c.1181G>T (p.Arg394Leu)	FUS	R394L, R390L, R393L	Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318991	16	31201608	16	31190287	318991	341259	rs886051936	
1139	NM_004960.3(FUS):c.1204_1206del (p.Ser402del)	FUS	S402del, S401del, S398del	Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000653781	16	31201631 - 31201633	16	31190310 - 31190312	653781	644619		
1140	NM_004960.3(FUS):c.1292C>T (p.Pro431Leu)	FUS	P431L, P430L, P427L	Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4|not provided|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000037069	16	31201719	16	31190398	37069	45745	rs186547381	
1141	NM_004960.3(FUS):c.1292+22dup	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318992	16	31201734 - 31201735	16	31190413 - 31190414	318992	342768	rs572228309	
1142	NM_004960.3(FUS):c.1394-2del	FUS		not provided|Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Jun 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000447355	16	31202282	16	31190961	447355	441905	rs1555509569	
1143	NM_004960.3(FUS):c.1394G>A (p.Gly465Glu)	FUS	G464E, G465E, G461E	Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Jul 13, 2018)	criteria provided, single submitter	VCV000659572	16	31202284	16	31190963	659572	644620		
1144	NM_004960.3(FUS):c.1446C>T (p.Gly482=)	FUS		Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Sep 21, 2018)	criteria provided, single submitter	VCV000665814	16	31202336	16	31191015	665814	644621		
1145	NM_004960.3(FUS):c.1483C>T (p.Arg495Ter)	FUS	R495*, R494*, R491*	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000029707	16	31202373	16	31191052	29707	38662	rs387906627	
1146	NM_001170634.1(FUS):c.1504_1505AG[3] (p.Gly503fs)	FUS		Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000665141	16	31202396 - 31202397	16	31191075 - 31191076	665141	644622		
1147	NM_004960.3(FUS):c.1520G>A (p.Gly507Asp)	FUS	G507D, G506D, G503D	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000016226	16	31202410	16	31191089	16226	31265	rs267606831	
1148	NM_004960.4(FUS):c.1540A>T (p.Arg514Trp)	FUS	R514W, R510W, R513W	Amyotrophic lateral sclerosis type 6	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803253	16	31202430	16	31191109	803253	791586		
1149	NM_004960.4(FUS):c.1542-1G>T	FUS		Amyotrophic lateral sclerosis type 6	Uncertain significance(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803254	16	31202719	16	31191398	803254	791587		
1150	NM_004960.3(FUS):c.1550A>G (p.His517Arg)	FUS	H517R, H513R, H516R	not provided	Likely pathogenic(Last reviewed: Dec 29, 2017)	criteria provided, single submitter	VCV000427191	16	31202728	16	31191407	427191	415491	rs1085308015	
1151	NM_004960.3(FUS):c.1551C>G (p.His517Gln)	FUS	H517Q, H513Q, H516Q	Amyotrophic lateral sclerosis 6, autosomal recessive	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016221	16	31202729	16	31191408	16221	31260	rs121909667	
1152	NM_004960.3(FUS):c.1553G>A (p.Arg518Lys)	FUS	R518K, R514K, R517K	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016223	16	31202731	16	31191410	16223	31262	rs121909669	
1153	NM_004960.3(FUS):c.1555C>G (p.Gln519Glu)	FUS	Q518E, Q515E, Q519E	Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000650787	16	31202733	16	31191412	650787	644623		
1154	NM_004960.3(FUS):c.1561C>T (p.Arg521Cys)	FUS	R521C, R517C, R520C	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Aug 31, 2010)	no assertion criteria provided	VCV000016224	16	31202739	16	31191418	16224	31263	rs121909668	
1155	NM_004960.3(FUS):c.1561C>G (p.Arg521Gly)	FUS	R521G, R520G, R517G	Amyotrophic lateral sclerosis type 6|Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Pathogenic(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000016222	16	31202739	16	31191418	16222	31261	rs121909668	
1156	NM_004960.3(FUS):c.1562G>A (p.Arg521His)	FUS	R521H, R517H, R520H	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Feb 27, 2009)	no assertion criteria provided	VCV000016225	16	31202740	16	31191419	16225	31264	rs121909671	
1157	NM_004960.3(FUS):c.1564A>G (p.Arg522Gly)	FUS	R522G, R518G, R521G	Tremor, hereditary essential, 4|Amyotrophic lateral sclerosis type 6|Amyotrophic lateral sclerosis type 6	Uncertain significance(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000540279	16	31202742	16	31191421	540279	530252	rs1555509693	
1158	NM_004960.3(FUS):c.1570A>T (p.Arg524Trp)	FUS	R524W, R520W, R523W	Amyotrophic lateral sclerosis type 6	Pathogenic(Last reviewed: Apr 1, 2010)	no assertion criteria provided	VCV000016228	16	31202748	16	31191427	16228	31267	rs267606833	
1159	NM_004960.3(FUS):c.1572G>C (p.Arg524Ser)	FUS	R524S, R520S, R523S	not provided	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000280109	16	31202750	16	31191429	280109	264704	rs886041389	
1160	NM_004960.3(FUS):c.1574C>T (p.Pro525Leu)	FUS	P525L, P521L, P524L	not provided	Pathogenic(Last reviewed: Mar 12, 2016)	criteria provided, multiple submitters, no conflicts	VCV000280110	16	31202752	16	31191431	280110	264787	rs886041390	
1161	NM_004960.3(FUS):c.*41G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided|Amyotrophic lateral sclerosis type 6	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000318993	16	31202800	16	31191479	318993	325127	rs80301724	
1162	NM_004960.3(FUS):c.*108C>T	FUS		Amyotrophic lateral sclerosis type 6|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000567482	16	31202867	16	31191546	567482	574045	rs780606789	
1163	NM_004960.3(FUS):c.*196C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318994	16	31202955	16	31191634	318994	341263	rs886051938	
1164	NM_004960.3(FUS):c.*214C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318995	16	31202973	16	31191652	318995	334788	rs140875749	
1165	NM_004960.3(FUS):c.*270A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318996	16	31203029	16	31191708	318996	334816	rs886051939	
1166	NM_004960.3(FUS):c.*356G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318997	16	31203115	16	31191794	318997	325133	rs886051940	
1167	NM_004960.3(FUS):c.*408A>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318998	16	31203167	16	31191846	318998	341264	rs553760130	
1168	NM_004960.3(FUS):c.*415A>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000318999	16	31203174	16	31191853	318999	341268	rs771689682	
1169	NM_004960.3(FUS):c.*491T>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319000	16	31203250	16	31191929	319000	341269	rs73530293	
1170	NM_004960.3(FUS):c.*614dup	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319001	16	31203372 - 31203373	16	31192051 - 31192052	319001	334817	rs1216489571	
1171	NM_004960.3(FUS):c.*626G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319002	16	31203385	16	31192064	319002	342769	rs115626460	
1172	NM_004960.3(FUS):c.*687G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319003	16	31203446	16	31192125	319003	334820	rs549602004	
1173	NM_004960.3(FUS):c.*770G>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319004	16	31203529	16	31192208	319004	325136	rs4889537	
1174	NM_004960.3(FUS):c.*805C>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319005	16	31203564	16	31192243	319005	341272	rs886051942	
1175	NM_004960.3(FUS):c.*910C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319006	16	31203669	16	31192348	319006	342775	rs118018900	
1176	NM_004960.3(FUS):c.*926T>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319007	16	31203685	16	31192364	319007	341273	rs886051943	
1177	NM_004960.3(FUS):c.*989C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319008	16	31203748	16	31192427	319008	342778	rs114772555	
1178	NM_004960.3(FUS):c.*1004dup	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319009	16	31203761 - 31203762	16	31192440 - 31192441	319009	325141	rs886051944	
1179	NM_004960.3(FUS):c.*1145_*1146del	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319010	16	31203903 - 31203904	16	31192582 - 31192583	319010	342779	rs1211904015	
1180	NM_004960.3(FUS):c.*1148A>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319011	16	31203907	16	31192586	319011	342789	rs140326191	
1181	NM_004960.3(FUS):c.*1230C>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319012	16	31203989	16	31192668	319012	334827	rs886051945	
1182	NM_004960.3(FUS):c.*1273C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319013	16	31204032	16	31192711	319013	341274	rs371771617	
1183	NM_004960.3(FUS):c.*1286C>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319014	16	31204045	16	31192724	319014	341284	rs547623704	
1184	NM_004960.3(FUS):c.*1375C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319015	16	31204134	16	31192813	319015	341286	rs542241137	
1185	NM_004960.3(FUS):c.*1420C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319016	16	31204179	16	31192858	319016	341289	rs73530295	
1186	NM_004960.3(FUS):c.*1476T>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319017	16	31204235	16	31192914	319017	334828	rs11860134	
1187	NM_004960.3(FUS):c.*1580A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319018	16	31204339	16	31193018	319018	325144	rs886051946	
1188	NM_004960.3(FUS):c.*1581T>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319019	16	31204340	16	31193019	319019	325145	rs751331525	
1189	NM_004960.3(FUS):c.*1593C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319020	16	31204352	16	31193031	319020	325147	rs577955571	
1190	NM_004960.3(FUS):c.*1601C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319021	16	31204360	16	31193039	319021	325148	rs886051947	
1191	NM_004960.3(FUS):c.*1610C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319022	16	31204369	16	31193048	319022	341292	rs538629605	
1192	NM_004960.3(FUS):c.*1650C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319023	16	31204409	16	31193088	319023	342790	rs886051948	
1193	NM_004960.3(FUS):c.*1734C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319024	16	31204493	16	31193172	319024	341293	rs886051949	
1194	NM_004960.3(FUS):c.*1803C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319025	16	31204562	16	31193241	319025	341301	rs16956408	
1195	NM_004960.3(FUS):c.*1810C>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319026	16	31204569	16	31193248	319026	325149	rs886051950	
1196	NM_004960.3(FUS):c.*1843G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319027	16	31204602	16	31193281	319027	342791	rs886051951	
1197	NM_004960.3(FUS):c.*1883T>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319028	16	31204642	16	31193321	319028	342793	rs549012470	
1198	NM_004960.3(FUS):c.*1908C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319029	16	31204667	16	31193346	319029	334834	rs886051952	
1199	NM_004960.3(FUS):c.*1916A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319030	16	31204675	16	31193354	319030	341306	rs759332004	
1200	NM_004960.3(FUS):c.*1942G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319031	16	31204701	16	31193380	319031	341311	rs886051953	
1201	NM_004960.3(FUS):c.*1992A>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319032	16	31204751	16	31193430	319032	342794	rs146490489	
1202	NM_004960.3(FUS):c.*1998T>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319033	16	31204757	16	31193436	319033	342799	rs182437252	
1203	NM_004960.3(FUS):c.*2005G>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319034	16	31204764	16	31193443	319034	342804	rs140979886	
1204	NM_004960.3(FUS):c.*2259G>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319035	16	31205018	16	31193697	319035	342805	rs886051954	
1205	NM_004960.3(FUS):c.*2299A>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319036	16	31205058	16	31193737	319036	342809	rs774311328	
1206	NM_004960.3(FUS):c.*2348G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319037	16	31205107	16	31193786	319037	342810	rs775218493	
1207	NM_004960.3(FUS):c.*2393dup	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319038	16	31205140 - 31205141	16	31193819 - 31193820	319038	342814	rs753379140	
1208	NM_004960.3(FUS):c.*2393del	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319039	16	31205141	16	31193820	319039	341312	rs753379140	
1209	NM_004960.3(FUS):c.*2393T>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319040	16	31205152	16	31193831	319040	342813	rs541197027	
1210	NM_004960.3(FUS):c.*2443A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319041	16	31205202	16	31193881	319041	334836	rs189787862	
1211	NM_004960.3(FUS):c.*2459_*2461dup	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319042	16	31205217 - 31205218	16	31193896 - 31193897	319042	342820	rs886051957	
1212	NM_004960.3(FUS):c.*2486G>A	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319043	16	31205245	16	31193924	319043	341316	rs73530298	
1213	NM_004960.3(FUS):c.*2794G>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319044	16	31205553	16	31194232	319044	341318	rs17839571	
1214	NM_004960.3(FUS):c.*2884A>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319045	16	31205643	16	31194322	319045	334839	rs554281103	
1215	NM_004960.3(FUS):c.*2955A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319046	16	31205714	16	31194393	319046	341320	rs149361851	
1216	NM_004960.3(FUS):c.*2988C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319047	16	31205747	16	31194426	319047	334841	rs73530301	
1217	NM_004960.3(FUS):c.*3092C>T	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319048	16	31205851	16	31194530	319048	341321	rs886051958	
1218	NM_004960.3(FUS):c.*3174T>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319049	16	31205933	16	31194612	319049	325153	rs3764324	
1219	NM_004960.3(FUS):c.*3230A>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319050	16	31205989	16	31194668	319050	325154	rs550798081	
1220	NM_004960.3(FUS):c.*3231T>C	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319051	16	31205990	16	31194669	319051	325158	rs193018950	
1221	NM_004960.3(FUS):c.*3263T>G	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319052	16	31206022	16	31194701	319052	341324	rs886051959	
1222	NM_003119.4(SPG7):c.637C>T (p.Arg213Ter)	SPG7	R213*	Spastic paraplegia 7|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Jan 22, 2019)	criteria provided, conflicting interpretations	VCV000285368	16	89592755	16	89526347	285368	269605	rs774774648	
1223	NM_003119.4(SPG7):c.1045G>A (p.Gly349Ser)	SPG7	G349S	not provided|Spastic paraplegia 7	Pathogenic/Likely pathogenic(Last reviewed: Dec 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000006819	16	89598369	16	89531961	6819	21858	rs141659620	
1224	NM_005022.3(PFN1):c.353G>T (p.Gly118Val)	PFN1	G118V	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037036	17	4849265	17	4945970	37036	45722	rs387907266	
1225	NM_005022.3:c.350_351delinsGT	PFN1		not provided	Uncertain significance(Last reviewed: Jul 30, 2019)	criteria provided, multiple submitters, no conflicts	VCV000646360	17	4849267 - 4849268	17	4945972 - 4945973	646360	646165		
1226	NM_005022.3(PFN1):c.350A>G (p.Glu117Gly)	PFN1	E117G	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037037	17	4849268	17	4945973	37037	45723	rs140547520	
1227	NM_005022.3(PFN1):c.341T>C (p.Met114Thr)	PFN1	M114T	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037035	17	4849277	17	4945982	37035	45721	rs387907265	
1228	NM_005022.3(PFN1):c.211T>G (p.Cys71Gly)	PFN1	C71G	Amyotrophic lateral sclerosis 18	Pathogenic(Last reviewed: Aug 23, 2012)	no assertion criteria provided	VCV000037034	17	4850037	17	4946742	37034	45720	rs387907264	
1229	NM_002087.3(GRN):c.229G>A (p.Val77Ile)	GRN	V77I	Frontotemporal dementia, ubiquitin-positive|Ceroid lipofuscinosis, neuronal, 11	Uncertain significance(Last reviewed: Dec 28, 2018)	criteria provided, single submitter	VCV000651116	17	42426884	17	44349516	651116	646082		
1230	NM_016835.4(MAPT):c.1901A>T (p.Lys634Met)	MAPT	K317M, K634M, K259M, K288M, K228M, K257M, K652M, K286M	not provided|Frontotemporal dementia	Pathogenic(Last reviewed: May 10, 2005)	no assertion criteria provided	VCV000014268	17	44091643	17	46014277	14268	29307	rs63750092	
1231	NM_001127221.1(CACNA1A):c.2396A>T (p.Asp799Val)	CACNA1A	D799V, D802V, D798V	Cerebellar ataxia|Amyotrophic lateral sclerosis|Chorea	Uncertain significance(Last reviewed: May 3, 2016)	criteria provided, single submitter	VCV000397544	19	13410054	19	13299240	397544	384443	rs1060499675	
1232	NM_001031726.3(C19orf12):c.197_199del	C19orf12	G55del, G66del	Neurodegeneration with brain iron accumulation 4	Pathogenic(Last reviewed: Oct 1, 2013)	no assertion criteria provided	VCV000088866	19	30193879 - 30193881	19	29702972 - 29702974	88866	94435	rs398122409	
1233	Single allele	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000453292	20	739832	20	759188	453292	446899	rs544939272	
1234	NC_000020.10:g.(?_741650)_(746438_?)dup	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Aug 21, 2018)	criteria provided, single submitter	VCV000652376	20	741650 - 746438	20	761006 - 765794	652376	653643		
1235	NC_000020.10:g.(?_741650)_(746438_?)del	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000640455	20	741650 - 746438	20	761006 - 765794	640455	653115		
1236	NM_033409.4(SLC52A3):c.1403_1404insTGCCTTCTGCAATCTGCACTGTCC (p.Phe462_Ala469dup)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Aug 8, 2018)	criteria provided, single submitter	VCV000651312	20	741676 - 741677	20	761032 - 761033	651312	648849		
1237	NM_033409.4(SLC52A3):c.1381G>T (p.Asp461Tyr)	SLC52A3	D461Y	not provided|Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000476604	20	741699	20	761055	476604	469481	rs140360713	
1238	NM_033409.4(SLC52A3):c.1374G>T (p.Ser458=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Likely benign(Last reviewed: Mar 2, 2017)	criteria provided, single submitter	VCV000476603	20	741706	20	761062	476603	469482	rs758484328	
1239	NM_033409.4(SLC52A3):c.1373C>A (p.Ser458Ter)	SLC52A3	S458*	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000655082	20	741707	20	761063	655082	648850		
1240	NM_033409.4(SLC52A3):c.1371C>G (p.Phe457Leu)	SLC52A3	F457L	not provided|Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210029	20	741709	20	761065	210029	206610	rs145431028	
1241	NM_033409.4(SLC52A3):c.1363C>T (p.Arg455Trp)	SLC52A3	R455W	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jun 13, 2017)	criteria provided, single submitter	VCV000476602	20	741717	20	761073	476602	471502	rs939576852	
1242	NM_033409.4(SLC52A3):c.1327_1338del (p.Gly443_Leu446del)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000645920	20	741742 - 741753	20	761098 - 761109	645920	648851		
1243	NM_033409.4(SLC52A3):c.1334T>C (p.Leu445Pro)	SLC52A3	L445P	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000663677	20	741746	20	761102	663677	648852		
1244	NM_033409.4(SLC52A3):c.1326C>A (p.Leu442=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 27, 2018)	criteria provided, single submitter	VCV000657282	20	741754	20	761110	657282	648853		
1245	NM_033409.4(SLC52A3):c.1325_1326del (p.Leu442fs)	SLC52A3	L442fs	not provided|Brown-Vialetto-Van Laere syndrome 1	Likely pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000000139	20	741754 - 741755	20	761110 - 761111	139	15178	rs794728004	
1246	NM_033409.4(SLC52A3):c.1316G>A (p.Gly439Asp)	SLC52A3	G439D	Brown-Vialetto-Van Laere syndrome 1	Likely pathogenic(Last reviewed: Aug 15, 2016)	criteria provided, single submitter	VCV000488380	20	741764	20	761120	488380	481243	rs1555783467	
1247	NM_033409.4(SLC52A3):c.1311G>C (p.Gln437His)	SLC52A3	Q437H	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000476601	20	741769	20	761125	476601	471504	rs1555783468	
1248	NM_033409.4(SLC52A3):c.1296C>A (p.Cys432Ter)	SLC52A3	C432*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210027	20	741784	20	761140	210027	206611	rs758570021	
1249	NM_033409.4(SLC52A3):c.1293G>A (p.Trp431Ter)	SLC52A3	W431*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210036	20	741787	20	761143	210036	206635	rs1060499531	
1250	NM_033409.4(SLC52A3):c.1270C>T (p.Leu424Phe)	SLC52A3	L424F	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jul 17, 2017)	criteria provided, single submitter	VCV000476599	20	741810	20	761166	476599	469486	rs369230517	
1251	NM_033409.4(SLC52A3):c.1255G>A (p.Val419Met)	SLC52A3	V419M	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210035	20	741825	20	761181	210035	206612	rs797045198	
1252	NM_033409.4(SLC52A3):c.1238T>C (p.Val413Ala)	SLC52A3	V413A	not specified|Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000000144	20	741842	20	761198	144	15183	rs267606687	
1253	NM_033409.4(SLC52A3):c.1201G>A (p.Ala401Thr)	SLC52A3	A401T	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Mar 5, 2018)	criteria provided, single submitter	VCV000581822	20	741879	20	761235	581822	571412	rs544612142	
1254	NM_033409.4(SLC52A3):c.1198-2A>C	SLC52A3		Brown-Vialetto-Van Laere syndrome 1|Progressive bulbar palsy of childhood	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210025	20	741884	20	761240	210025	206613	rs754753126	
1255	NM_033409.4(SLC52A3):c.1160C>T (p.Pro387Leu)	SLC52A3	P387L	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Sep 27, 2018)	criteria provided, single submitter	VCV000642968	20	742382	20	761738	642968	648854		
1256	NM_033409.4(SLC52A3):c.1154C>T (p.Pro385Leu)	SLC52A3	P385L	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000623321	20	742388	20	761744	623321	612335	rs1568717900	
1257	NM_033409.4(SLC52A3):c.1149G>A (p.Met383Ile)	SLC52A3	M383I	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000543056	20	742393	20	761749	543056	534297	rs763995965	
1258	NM_033409.4(SLC52A3):c.1102G>A (p.Val368Met)	SLC52A3	V368M	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: May 29, 2018)	criteria provided, single submitter	VCV000571043	20	742440	20	761796	571043	572987	rs148181353	
1259	NM_033409.4(SLC52A3):c.1095C>T (p.Val365=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Likely benign(Last reviewed: Nov 2, 2017)	criteria provided, single submitter	VCV000543065	20	742447	20	761803	543065	533736	rs776667122	
1260	NM_033409.4(SLC52A3):c.1048T>A (p.Leu350Met)	SLC52A3	L350M	not provided|Brown-Vialetto-Van Laere syndrome 1|not specified	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210024	20	744167	20	763523	210024	206614	rs76947760	
1261	NM_033409.4(SLC52A3):c.994G>A (p.Val332Ile)	SLC52A3	V332I	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 8, 2017)	criteria provided, single submitter	VCV000476621	20	744221	20	763577	476621	470544	rs890765839	
1262	NM_033409.4(SLC52A3):c.989G>T (p.Gly330Val)	SLC52A3	G330V	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210023	20	744226	20	763582	210023	206615	rs797045196	
1263	NM_033409.4(SLC52A3):c.987T>C (p.Tyr329=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Likely benign(Last reviewed: Aug 9, 2017)	criteria provided, single submitter	VCV000543060	20	744228	20	763584	543060	533720	rs376546378	
1264	NM_033409.4(SLC52A3):c.955C>T (p.Pro319Ser)	SLC52A3	P319S	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210022	20	744260	20	763616	210022	206616	rs797045195	
1265	NM_033409.4(SLC52A3):c.950T>C (p.Met317Thr)	SLC52A3	M317T	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jun 20, 2018)	criteria provided, single submitter	VCV000581134	20	744265	20	763621	581134	571416	rs1251411780	
1266	NM_033409.4(SLC52A3):c.935C>T (p.Ala312Val)	SLC52A3	A312V	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jul 25, 2017)	criteria provided, single submitter	VCV000210021	20	744280	20	763636	210021	206617	rs752218005	
1267	NM_033409.4(SLC52A3):c.914C>A (p.Thr305Asn)	SLC52A3	T305N	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: May 9, 2018)	criteria provided, single submitter	VCV000574157	20	744301	20	763657	574157	575139	rs201254395	
1268	NM_033409.4(SLC52A3):c.894G>A (p.Ala298=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Likely benign(Last reviewed: May 24, 2017)	criteria provided, single submitter	VCV000476616	20	744321	20	763677	476616	471051	rs532778217	
1269	NM_033409.4(SLC52A3):c.893C>T (p.Ala298Val)	SLC52A3	A298V	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Aug 8, 2017)	criteria provided, single submitter	VCV000543057	20	744322	20	763678	543057	533738	rs543436922	
1270	NM_033409.4(SLC52A3):c.890C>T (p.Pro297Leu)	SLC52A3	P297L	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000570161	20	744325	20	763681	570161	575140	rs201990981	
1271	NM_033409.4(SLC52A3):c.803G>A (p.Arg268Gln)	SLC52A3	R268Q	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Oct 29, 2018)	criteria provided, single submitter	VCV000648925	20	744412	20	763768	648925	648855		
1272	NM_033409.4(SLC52A3):c.796C>T (p.Arg266Trp)	SLC52A3	R266W	Brown-Vialetto-Van Laere syndrome 1|not provided	Uncertain significance(Last reviewed: Jul 17, 2018)	criteria provided, multiple submitters, no conflicts	VCV000210020	20	744419	20	763775	210020	206618	rs370499474	
1273	NM_033409.4(SLC52A3):c.787C>T (p.His263Tyr)	SLC52A3	H263Y	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 20, 2018)	criteria provided, single submitter	VCV000579662	20	744428	20	763784	579662	573683	rs150159842	
1274	NM_033409.4(SLC52A3):c.754G>A (p.Val252Met)	SLC52A3	V252M	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Sep 13, 2018)	criteria provided, single submitter	VCV000659119	20	744461	20	763817	659119	648856		
1275	NM_033409.4(SLC52A3):c.753del (p.Val252fs)	SLC52A3	V252fs	Brown-Vialetto-Van Laere syndrome 1	Likely pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000623230	20	744462	20	763818	623230	612166	rs1568721373	
1276	NM_033409.4(SLC52A3):c.728G>A (p.Arg243His)	SLC52A3	R243H	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 29, 2018)	criteria provided, single submitter	VCV000651280	20	744487	20	763843	651280	648857		
1277	NM_033409.4(SLC52A3):c.706G>A (p.Val236Met)	SLC52A3	V236M	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000654493	20	744509	20	763865	654493	648858		
1278	NM_033409.4(SLC52A3):c.671T>G (p.Phe224Cys)	SLC52A3	F224C	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210033	20	744544	20	763900	210033	206619	rs797045197	
1279	NM_033409.4(SLC52A3):c.670T>C (p.Phe224Leu)	SLC52A3	F224L	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000142	20	744545	20	763901	142	15181	rs267606685	
1280	NM_033409.4(SLC52A3):c.659C>A (p.Pro220His)	SLC52A3	P220H	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210019	20	744556	20	763912	210019	206620	rs797045194	
1281	NM_033409.4(SLC52A3):c.646G>A (p.Ala216Thr)	SLC52A3	A216T	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jun 6, 2018)	criteria provided, single submitter	VCV000573783	20	744569	20	763925	573783	573685	rs202130911	
1282	NM_033409.4(SLC52A3):c.639C>G (p.Tyr213Ter)	SLC52A3	Y213*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210018	20	744576	20	763932	210018	206621	rs778363575	
1283	NM_033409.4(SLC52A3):c.634C>T (p.Arg212Cys)	SLC52A3	R212C	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Dec 30, 2017)	criteria provided, single submitter	VCV000210032	20	744581	20	763937	210032	206622	rs778479139	
1284	NM_033409.4(SLC52A3):c.628G>A (p.Glu210Lys)	SLC52A3	E210K	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 21, 2017)	criteria provided, single submitter	VCV000543058	20	744587	20	763943	543058	533724	rs747663714	
1285	NM_033409.4(SLC52A3):c.618G>A (p.Leu206=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Likely benign(Last reviewed: Oct 23, 2017)	criteria provided, single submitter	VCV000543064	20	744597	20	763953	543064	533730	rs1418663109	
1286	NM_033409.4(SLC52A3):c.601G>A (p.Gly201Arg)	SLC52A3	G201R	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000664046	20	744614	20	763970	664046	648859		
1287	NM_033409.4(SLC52A3):c.600C>T (p.Pro200=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1|not specified	Benign(Last reviewed: Aug 23, 2017)	criteria provided, multiple submitters, no conflicts	VCV000262236	20	744615	20	763971	262236	257436	rs16992990	
1288	NM_033409.3(SLC52A3):c.568-16_568-15insATTGACCTG	SLC52A3		not specified|Brown-Vialetto-Van Laere syndrome 1	Benign	criteria provided, single submitter	VCV000262235	20	744662 - 744663	20	764018 - 764019	262235	257437	rs3833341	
1289	NM_033409.4(SLC52A3):c.525C>G (p.Ser175Arg)	SLC52A3	S175R	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jun 6, 2017)	criteria provided, single submitter	VCV000476612	20	745894	20	765250	476612	470546	rs143641819	
1290	NM_033409.4(SLC52A3):c.517T>C (p.Ser173Pro)	SLC52A3	S173P	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Aug 2, 2018)	criteria provided, single submitter	VCV000569208	20	745902	20	765258	569208	573695	rs749602815	
1291	NM_033409.4(SLC52A3):c.515T>C (p.Ile172Thr)	SLC52A3	I172T	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 3, 2018)	criteria provided, single submitter	VCV000662152	20	745904	20	765260	662152	648860		
1292	NM_033409.4(SLC52A3):c.499G>A (p.Val167Ile)	SLC52A3	V167I	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 24, 2018)	criteria provided, single submitter	VCV000642283	20	745920	20	765276	642283	648861		
1293	NM_033409.4(SLC52A3):c.403A>G (p.Thr135Ala)	SLC52A3	T135A	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000210031	20	746016	20	765372	210031	206623	rs527853872	
1294	NM_033409.4(SLC52A3):c.395G>A (p.Arg132Gln)	SLC52A3	R132Q	not specified|Brown-Vialetto-Van Laere syndrome 1	Conflicting interpretations of pathogenicity(Last reviewed: May 10, 2018)	criteria provided, conflicting interpretations	VCV000476610	20	746024	20	765380	476610	470549	rs142157418	
1295	NM_033409.4(SLC52A3):c.394C>T (p.Arg132Trp)	SLC52A3	R132W	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000000141	20	746025	20	765381	141	15180	rs267606684	
1296	NM_033409.4(SLC52A3):c.374C>A (p.Thr125Asn)	SLC52A3	T125N	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210030	20	746045	20	765401	210030	206624	rs767263985	
1297	NM_033409.4(SLC52A3):c.327G>T (p.Leu109Phe)	SLC52A3	L109F	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Oct 31, 2018)	criteria provided, single submitter	VCV000639327	20	746092	20	765448	639327	648862		
1298	NM_033409.4(SLC52A3):c.319G>A (p.Ala107Thr)	SLC52A3	A107T	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jul 19, 2017)	criteria provided, single submitter	VCV000476608	20	746100	20	765456	476608	469501	rs370718326	
1299	NM_033409.4(SLC52A3):c.272T>G (p.Phe91Cys)	SLC52A3	F91C	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Apr 5, 2018)	criteria provided, single submitter	VCV000569011	20	746147	20	765503	569011	571418	rs1481097414	
1300	NM_033409.4(SLC52A3):c.250G>A (p.Val84Ile)	SLC52A3	V84I	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 21, 2018)	criteria provided, single submitter	VCV000663811	20	746169	20	765525	663811	648863		
1301	NM_033409.4(SLC52A3):c.250G>C (p.Val84Leu)	SLC52A3	V84L	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jul 14, 2017)	criteria provided, single submitter	VCV000476607	20	746169	20	765525	476607	471067	rs142064992	
1302	NM_033409.4(SLC52A3):c.224T>C (p.Ile75Thr)	SLC52A3	I75T	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210016	20	746195	20	765551	210016	206625	rs797045193	
1303	NM_033409.4(SLC52A3):c.211G>A (p.Glu71Lys)	SLC52A3	E71K	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210015	20	746208	20	765564	210015	206626	rs267606683	
1304	NM_033409.4(SLC52A3):c.211G>T (p.Glu71Ter)	SLC52A3	E71*	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000140	20	746208	20	765564	140	15179	rs267606683	
1305	NM_033409.4(SLC52A3):c.203G>C (p.Cys68Ser)	SLC52A3	C68S	Brown-Vialetto-Van Laere syndrome 1|not provided	Uncertain significance(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000452583	20	746216	20	765572	452583	446305	rs149622425	
1306	NM_033409.4(SLC52A3):c.194G>A (p.Arg65Gln)	SLC52A3	R65Q	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000476605	20	746225	20	765581	476605	471530	rs144337813	
1307	NM_033409.4(SLC52A3):c.173T>A (p.Val58Asp)	SLC52A3	V58D	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210014	20	746246	20	765602	210014	206627	rs797045192	
1308	NM_033409.4(SLC52A3):c.160G>A (p.Gly54Arg)	SLC52A3	G54R	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210013	20	746259	20	765615	210013	206628	rs797045191	
1309	NM_033409.4(SLC52A3):c.140T>C (p.Val47Ala)	SLC52A3	V47A	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: May 18, 2018)	criteria provided, single submitter	VCV000543055	20	746279	20	765635	543055	533742	rs1555784013	
1310	NM_033409.4(SLC52A3):c.135G>A (p.Thr45=)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Feb 28, 2018)	criteria provided, single submitter	VCV000573718	20	746284	20	765640	573718	571420	rs373887707	
1311	NM_033409.4(SLC52A3):c.134C>T (p.Thr45Met)	SLC52A3	T45M	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000543054	20	746285	20	765641	543054	534307	rs776065357	
1312	NM_033409.4(SLC52A3):c.106G>A (p.Glu36Lys)	SLC52A3	E36K	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000000143	20	746313	20	765669	143	15182	rs267606686	
1313	NM_033409.4(SLC52A3):c.82C>A (p.Pro28Thr)	SLC52A3	P28T	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000000145	20	746337	20	765693	145	15184	rs267606688	
1314	NM_033409.4(SLC52A3):c.62A>G (p.Asn21Ser)	SLC52A3	N21S	not specified|Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Apr 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000210012	20	746357	20	765713	210012	206629	rs199588390	
1315	NM_033409.4(SLC52A3):c.49T>C (p.Trp17Arg)	SLC52A3	W17R	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210011	20	746370	20	765726	210011	206630	rs797045190	
1316	NM_033409.4(SLC52A3):c.31G>A (p.Val11Ile)	SLC52A3	V11I	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: May 12, 2017)	criteria provided, single submitter	VCV000476609	20	746388	20	765744	476609	469502	rs746808726	
1317	NM_033409.4(SLC52A3):c.5C>T (p.Ala2Val)	SLC52A3	A2V	Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Apr 18, 2018)	criteria provided, single submitter	VCV000578853	20	746414	20	765770	578853	572991	rs1472734097	
1318	NM_033409.4(SLC52A3):c.-52+394T>C	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Mar 2, 2016)	criteria provided, single submitter	VCV000453291	20	748547	20	767903	453291	446898	rs750886042	
1319	NM_000311.5(PRNP):c.385A>G (p.Met129Val)	PRNP	M129V	not specified|Genetic prion diseases|Prion disease, susceptibility to|Alzheimer disease, early-onset, susceptibility to|Aphasia, primary progressive, susceptibility to|Huntington disease-like 1	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000013397	20	4680251	20	4699605	13397	28436	rs1799990	
1320	NM_004738.4(VAPB):c.-292G>C	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338918	20	56964224	20	58389168	338918	345625	rs2234484	
1321	NM_004738.4(VAPB):c.-283A>C	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338919	20	56964233	20	58389177	338919	345637	rs886056804	
1322	NM_004738.4(VAPB):c.-229_-226dupGTGC	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338920	20	56964263 - 56964264	20	58389207 - 58389208	338920	351241	rs750324709	
1323	NM_001195677.2(VAPB):c.-198_-193GCCCTC[3]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338921	20	56964313 - 56964314	20	58389257 - 58389258	338921	345642	rs765965868	
1324	NM_004738.4(VAPB):c.-189C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338922	20	56964327	20	58389271	338922	350177	rs886056807	
1325	NM_004738.4(VAPB):c.-159_-158insCC	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338924	20	56964357 - 56964358	20	58389301 - 58389302	338924	350179	rs886056808	
1326	NM_004738.4(VAPB):c.-159_-158insC	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338923	20	56964357 - 56964358	20	58389301 - 58389302	338923	345650	rs886056808	
1327	NM_004738.4(VAPB):c.-149dup	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338925	20	56964358 - 56964359	20	58389302 - 58389303	338925	345651	rs546898989	
1328	NM_004738.4(VAPB):c.-152C>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338926	20	56964364	20	58389308	338926	350180	rs753958893	
1329	NM_004738.4(VAPB):c.-33C>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338927	20	56964483	20	58389427	338927	350182	rs201547974	
1330	NM_004738.4(VAPB):c.-12C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338928	20	56964504	20	58389448	338928	350184	rs886056810	
1331	NM_004738.4(VAPB):c.30C>T (p.Leu10=)	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338929	20	56964545	20	58389489	338929	350186	rs886056811	
1332	NM_004738.4(VAPB):c.58+5G>A	VAPB		Amyotrophic lateral sclerosis type 8|Spinal muscular atrophy, late-onset, finkel type	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000574276	20	56964578	20	58389522	574276	572940	rs753611165	
1333	NM_004738.4(VAPB):c.104C>T (p.Pro35Leu)	VAPB	P35L	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Nov 9, 2017)	criteria provided, single submitter	VCV000534272	20	56993312	20	58418256	534272	533631	rs1456089445	
1334	NM_004738.4(VAPB):c.111C>A (p.Asp37Glu)	VAPB	D37E	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000579701	20	56993319	20	58418263	579701	572941	rs781691837	
1335	NM_004738.4(VAPB):c.137C>T (p.Thr46Ile)	VAPB	T46I	not provided|Amyotrophic lateral sclerosis type 8	Pathogenic(Last reviewed: Dec 17, 2010)	no assertion criteria provided	VCV000030510	20	56993345	20	58418289	30510	39467	rs281875284	
1336	NM_004738.4(VAPB):c.166C>T (p.Pro56Ser)	VAPB	P56S	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8|not provided|Amyotrophic lateral sclerosis type 8|Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis, typical	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000004806	20	56993374	20	58418318	4806	19845	rs74315431	
1337	NM_004738.4(VAPB):c.194C>T (p.Ala65Val)	VAPB	A65V	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000534269	20	56993402	20	58418346	534269	533650	rs1555813002	
1338	NM_004738.4(VAPB):c.195C>A (p.Ala65=)	VAPB		Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Likely benign(Last reviewed: Oct 8, 2017)	criteria provided, single submitter	VCV000534273	20	56993403	20	58418347	534273	533583	rs1555813003	
1339	NM_004738.4(VAPB):c.199A>G (p.Ile67Val)	VAPB	I67V	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Sep 11, 2018)	criteria provided, single submitter	VCV000656346	20	56993407	20	58418351	656346	648778		
1340	NM_004738.4(VAPB):c.289A>G (p.Thr97Ala)	VAPB	T97A	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Oct 10, 2018)	criteria provided, single submitter	VCV000534270	20	57009735	20	58434679	534270	533643	rs752091117	
1341	NM_004738.4(VAPB):c.332C>T (p.Pro111Leu)	VAPB	P111L	Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338930	20	57014017	20	58438961	338930	350187	rs777316448	
1342	NM_004738.4(VAPB):c.348T>C (p.Asp116=)	VAPB		Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Likely benign(Last reviewed: Jun 27, 2017)	criteria provided, single submitter	VCV000465873	20	57014033	20	58438977	465873	470961	rs751762415	
1343	NM_004738.4(VAPB):c.390T>G (p.Asp130Glu)	VAPB	D130E	Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not specified|not provided	Likely benign(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000259538	20	57014075	20	58439019	259538	257379	rs146459055	
1344	NM_001195677.2(VAPB):c.212-3088_212-3086del	VAPB	S160del	Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not provided	Likely benign(Last reviewed: Mar 5, 2019)	criteria provided, multiple submitters, no conflicts	VCV000338931	20	57016040 - 57016042	20	58440984 - 58440986	338931	345654	rs566283411	
1345	NM_004738.4(VAPB):c.482T>C (p.Leu161Ser)	VAPB	L161S	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000534271	20	57016048	20	58440992	534271	534171	rs1555815825	
1346	NM_004738.4(VAPB):c.493G>A (p.Glu165Lys)	VAPB	E165K	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Jun 15, 2018)	criteria provided, single submitter	VCV000570108	20	57016059	20	58441003	570108	575121	rs772254840	
1347	NM_004738.4(VAPB):c.510G>A (p.Met170Ile)	VAPB	M170I	not specified|not provided|Amyotrophic lateral sclerosis type 8	Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000465875	20	57016076	20	58441020	465875	471456	rs143144050	
1348	NM_004738.4(VAPB):c.545G>A (p.Arg182Lys)	VAPB	R182K	Amyotrophic lateral sclerosis type 8|Spinal muscular atrophy, late-onset, finkel type	Uncertain significance(Last reviewed: Apr 4, 2018)	criteria provided, single submitter	VCV000574815	20	57016111	20	58441055	574815	571320	rs1568720020	
1349	NM_004738.4(VAPB):c.574-4G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Feb 12, 2019)	criteria provided, conflicting interpretations	VCV000338932	20	57019129	20	58444073	338932	350190	rs201798741	
1350	NM_004738.4(VAPB):c.618C>T (p.Ser206=)	VAPB	P86S	Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338933	20	57019177	20	58444121	338933	345656	rs747208140	
1351	NM_004738.4(VAPB):c.656G>T (p.Gly219Val)	VAPB	G219V, R98S	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8|not provided|not specified	Uncertain significance(Last reviewed: Jun 26, 2017)	criteria provided, multiple submitters, no conflicts	VCV000191163	20	57019215	20	58444159	191163	188966	rs786205553	
1352	NM_004738.4(VAPB):c.667C>T (p.Arg223Trp)	VAPB	R223W	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8|not specified	Uncertain significance(Last reviewed: Oct 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000448853	20	57019226	20	58444170	448853	442305	rs144718603	
1353	NM_004738.4(VAPB):c.668G>C (p.Arg223Pro)	VAPB	R223P	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Sep 26, 2018)	criteria provided, single submitter	VCV000639834	20	57019227	20	58444171	639834	648779		
1354	NM_004738.4(VAPB):c.674T>C (p.Leu225Ser)	VAPB	L225S	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Nov 16, 2018)	criteria provided, single submitter	VCV000647542	20	57019233	20	58444177	647542	648780		
1355	NM_004738.4(VAPB):c.688T>G (p.Leu230Val)	VAPB	L230V	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000650970	20	57019247	20	58444191	650970	648781		
1356	NM_004738.4(VAPB):c.709A>G (p.Ile237Val)	VAPB	I237V	Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Oct 24, 2017)	criteria provided, single submitter	VCV000534267	20	57019268	20	58444212	534267	533585	rs1555816248	
1357	NM_004738.4(VAPB):c.*75G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338934	20	57019366	20	58444310	338934	345658	rs138521885	
1358	NM_004738.4(VAPB):c.*200_*214delinsGTTGAGGGGGAAACATTAAAAG	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338935	20	57019491 - 57019505	20	58444435 - 58444449	338935	350191	rs386815633	
1359	NM_004738.4(VAPB):c.*348C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338936	20	57019639	20	58444583	338936	335926	rs182950622	
1360	NM_004738.4(VAPB):c.*375C>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338937	20	57019666	20	58444610	338937	351244	rs540854828	
1361	NM_004738.4(VAPB):c.*596C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338938	20	57019887	20	58444831	338938	345660	rs118055109	
1362	NM_004738.4(VAPB):c.*602G>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338939	20	57019893	20	58444837	338939	351246	rs536862661	
1363	NM_004738.4(VAPB):c.*726A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338940	20	57020017	20	58444961	338940	345665	rs560832981	
1364	NM_004738.4(VAPB):c.*753C>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338941	20	57020044	20	58444988	338941	345671	rs6070466	
1365	NM_004738.4(VAPB):c.*884A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338942	20	57020175	20	58445119	338942	345673	rs3746398	
1366	NM_004738.4(VAPB):c.*937G>C	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338943	20	57020228	20	58445172	338943	345678	rs1059794	
1367	NM_004738.4(VAPB):c.*1050G>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338944	20	57020341	20	58445285	338944	351249	rs551974797	
1368	NM_004738.4(VAPB):c.*1168G>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338945	20	57020459	20	58445403	338945	350193	rs570596321	
1369	NM_004738.4(VAPB):c.*1265G>C	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338946	20	57020556	20	58445500	338946	350194	rs7400	
1370	NM_004738.4(VAPB):c.*1282A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338947	20	57020573	20	58445517	338947	335929	rs1802459	
1371	NM_004738.4(VAPB):c.*1335C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338948	20	57020626	20	58445570	338948	345680	rs187441988	
1372	NM_004738.4(VAPB):c.*1413C>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338949	20	57020704	20	58445648	338949	335932	rs190582293	
1373	NM_004738.4(VAPB):c.*1431G>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338950	20	57020722	20	58445666	338950	351250	rs886056813	
1374	NM_001195677.2(VAPB):c.*1521_*1522GT[20]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338952	20	57020740 - 57020741	20	58445684 - 58445685	338952	335933	rs138225455	
1375	NM_001195677.2(VAPB):c.*1521_*1522GT[19]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338951	20	57020740 - 57020741	20	58445684 - 58445685	338951	351255	rs138225455	
1376	NM_001195677.2(VAPB):c.*1521_*1522GT[16]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338954	20	57020741 - 57020744	20	58445685 - 58445688	338954	350195	rs138225455	
1377	NM_001195677.2(VAPB):c.*1521_*1522GT[17]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338953	20	57020741 - 57020742	20	58445685 - 58445686	338953	351252	rs138225455	
1378	NM_004738.4(VAPB):c.*1773G>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338955	20	57021064	20	58446008	338955	335935	rs75999456	
1379	NM_004738.4(VAPB):c.*1800A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338956	20	57021091	20	58446035	338956	350197	rs564187580	
1380	NM_004738.4(VAPB):c.*1919A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338957	20	57021210	20	58446154	338957	345692	rs886056816	
1381	NM_004738.4(VAPB):c.*2224C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338958	20	57021515	20	58446459	338958	351256	rs189009703	
1382	NM_004738.4(VAPB):c.*2320T>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338959	20	57021611	20	58446555	338959	345693	rs181028077	
1383	NM_004738.4(VAPB):c.*2671A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338960	20	57021962	20	58446906	338960	351259	rs115191022	
1384	NM_004738.4(VAPB):c.*2676A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338961	20	57021967	20	58446911	338961	351262	rs886056817	
1385	NM_004738.4(VAPB):c.*2748A>C	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338962	20	57022039	20	58446983	338962	345695	rs368079533	
1386	NM_004738.4(VAPB):c.*2766C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338963	20	57022057	20	58447001	338963	335939	rs6128346	
1387	NM_004738.4(VAPB):c.*2819A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338964	20	57022110	20	58447054	338964	351263	rs74568509	
1388	NM_004738.4(VAPB):c.*3020A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338965	20	57022311	20	58447255	338965	345698	rs570716807	
1389	NM_004738.4(VAPB):c.*3027A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338966	20	57022318	20	58447262	338966	335940	rs140832542	
1390	NM_004738.4(VAPB):c.*3118C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338968	20	57022409	20	58447353	338968	351266	rs56310716	
1391	NM_004738.4(VAPB):c.*3118C>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338967	20	57022409	20	58447353	338967	350200	rs56310716	
1392	NM_004738.4(VAPB):c.*3134G>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338969	20	57022425	20	58447369	338969	345699	rs886056818	
1393	NM_004738.4(VAPB):c.*3192T>C	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338970	20	57022483	20	58447427	338970	345704	rs545089397	
1394	NM_004738.4(VAPB):c.*3260C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338971	20	57022551	20	58447495	338971	335941	rs886056819	
1395	NM_004738.4(VAPB):c.*3274C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338972	20	57022565	20	58447509	338972	335943	rs553170533	
1396	NM_004738.4(VAPB):c.*3315A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338973	20	57022606	20	58447550	338973	335948	rs772298515	
1397	NM_001195677.2(VAPB):c.*3498_*3505CATGTGTG[2]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338974	20	57022713 - 57022720	20	58447657 - 58447664	338974	350203	rs3069390	
1398	NM_004738.4(VAPB):c.*3493G>A	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338975	20	57022784	20	58447728	338975	351267	rs764048379	
1399	NM_004738.4(VAPB):c.*3516C>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338976	20	57022807	20	58447751	338976	350204	rs886056820	
1400	NM_004738.4(VAPB):c.*3566A>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338977	20	57022857	20	58447801	338977	345705	rs114038495	
1401	NM_004738.4(VAPB):c.*3628A>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338978	20	57022919	20	58447863	338978	350207	rs886056821	
1402	NM_004738.4(VAPB):c.*3725T>C	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338979	20	57023016	20	58447960	338979	345707	rs574293455	
1403	NM_004738.4(VAPB):c.*3764C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338980	20	57023055	20	58447999	338980	351270	rs376626781	
1404	NM_004738.4(VAPB):c.*3805G>C	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338981	20	57023096	20	58448040	338981	335951	rs561048421	
1405	NM_004738.4(VAPB):c.*3822C>G	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338982	20	57023113	20	58448057	338982	345712	rs150825395	
1406	NM_004738.4(VAPB):c.*3870G>C	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338983	20	57023161	20	58448105	338983	351272	rs886056822	
1407	NM_004738.4(VAPB):c.*3942C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338984	20	57023233	20	58448177	338984	345714	rs886056823	
1408	NM_004738.4(VAPB):c.*4052C>T	VAPB		Amyotrophic Lateral Sclerosis, Dominant|Spinal Muscular Atrophy, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338985	20	57023343	20	58448287	338985	345716	rs76295834	
1409	NM_004738.4(VAPB):c.*4072C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338986	20	57023363	20	58448307	338986	335960	rs190652187	
1410	NM_004738.4(VAPB):c.*4206G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338987	20	57023497	20	58448441	338987	350208	rs886056824	
1411	NM_004738.4(VAPB):c.*4240G>C	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338988	20	57023531	20	58448475	338988	350210	rs554043472	
1412	NM_004738.4(VAPB):c.*4265G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338989	20	57023556	20	58448500	338989	350211	rs780267648	
1413	NM_004738.4(VAPB):c.*4271A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338990	20	57023562	20	58448506	338990	350212	rs4549163	
1414	NM_004738.4(VAPB):c.*4306del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338991	20	57023593	20	58448537	338991	351273	rs536996969	
1415	NM_004738.4(VAPB):c.*4327A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338992	20	57023618	20	58448562	338992	351275	rs183197400	
1416	NM_004738.4(VAPB):c.*4418C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338993	20	57023709	20	58448653	338993	345718	rs774417253	
1417	NM_004738.4(VAPB):c.*4446G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338994	20	57023737	20	58448681	338994	350214	rs79623348	
1418	NM_004738.4(VAPB):c.*4520T>C	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338995	20	57023811	20	58448755	338995	345724	rs763514	
1419	NM_004738.4(VAPB):c.*4559A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338996	20	57023850	20	58448794	338996	345731	rs73296848	
1420	NM_004738.4(VAPB):c.*4862A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338997	20	57024153	20	58449097	338997	335961	rs143395644	
1421	NM_004738.4(VAPB):c.*4868C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338998	20	57024159	20	58449103	338998	335967	rs74748993	
1422	NM_004738.4(VAPB):c.*4923A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338999	20	57024214	20	58449158	338999	345732	rs776329339	
1423	NM_004738.4(VAPB):c.*4952C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339000	20	57024243	20	58449187	339000	351276	rs116665485	
1424	NM_004738.4(VAPB):c.*5095T>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339001	20	57024386	20	58449330	339001	335968	rs143424619	
1425	NM_004738.4(VAPB):c.*5114G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339002	20	57024405	20	58449349	339002	350215	rs886056826	
1426	NM_004738.4(VAPB):c.*5145T>C	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339003	20	57024436	20	58449380	339003	351278	rs79674150	
1427	NM_004738.4(VAPB):c.*5233_*5237del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339004	20	57024523 - 57024527	20	58449467 - 58449471	339004	350220	rs546553846	
1428	NM_004738.4(VAPB):c.*5250T>C	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339005	20	57024541	20	58449485	339005	350221	rs6015274	
1429	NM_004738.4(VAPB):c.*5298C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339006	20	57024589	20	58449533	339006	350223	rs6015275	
1430	NM_004738.4(VAPB):c.*5352C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339007	20	57024643	20	58449587	339007	345734	rs886056828	
1431	NM_004738.4(VAPB):c.*5511_*5513del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339008	20	57024801 - 57024803	20	58449745 - 58449747	339008	351279	rs556955970	
1432	NM_004738.4(VAPB):c.*5699_*5700insA	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339009	20	57024990 - 57024991	20	58449934 - 58449935	339009	335979	rs886056830	
1433	NM_004738.4(VAPB):c.*5769G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339010	20	57025060	20	58450004	339010	350224	rs150490845	
1434	NM_004738.4(VAPB):c.*5789C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339011	20	57025080	20	58450024	339011	350228	rs867023811	
1435	NM_004738.4(VAPB):c.*5790G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339012	20	57025081	20	58450025	339012	350229	rs192046748	
1436	NM_004738.4(VAPB):c.*5795T>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339013	20	57025086	20	58450030	339013	335980	rs886056831	
1437	NM_004738.4(VAPB):c.*5815G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339014	20	57025106	20	58450050	339014	335983	rs886056832	
1438	NM_004738.4(VAPB):c.*5826G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339015	20	57025117	20	58450061	339015	345735	rs780911883	
1439	NM_004738.4(VAPB):c.*5832G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339016	20	57025123	20	58450067	339016	335987	rs886056833	
1440	NM_004738.4(VAPB):c.*6088C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339017	20	57025379	20	58450323	339017	350231	rs147304840	
1441	NM_001195677.2(VAPB):c.*6187_*6190CTGT[1]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339018	20	57025407 - 57025410	20	58450351 - 58450354	339018	345740	rs143261907	
1442	NM_004738.4(VAPB):c.*6182C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339019	20	57025473	20	58450417	339019	345742	rs76708676	
1443	NM_004738.4(VAPB):c.*6238T>C	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339020	20	57025529	20	58450473	339020	335988	rs886056835	
1444	NM_004738.4(VAPB):c.*6257del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339021	20	57025548	20	58450492	339021	345745	rs750250276	
1445	NM_004738.4(VAPB):c.*6354G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339022	20	57025645	20	58450589	339022	335992	rs886056836	
1446	NM_001195677.2(VAPB):c.*6530_*6531GT[3]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339023	20	57025750 - 57025751	20	58450694 - 58450695	339023	345747	rs562701720	
1447	NM_004738.4(VAPB):c.*6578T>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339024	20	57025869	20	58450813	339024	351281	rs115932469	
1448	NM_004738.4(VAPB):c.*6619G>A	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339025	20	57025910	20	58450854	339025	345749	rs79091887	
1449	NM_001195677.2(VAPB):c.*6754_*6756ATG[1]	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339026	20	57025975 - 57025977	20	58450919 - 58450921	339026	336000	rs574681539	
1450	NM_004738.4(VAPB):c.*6746C>T	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339027	20	57026037	20	58450981	339027	351283	rs886056839	
1451	NM_004738.4(VAPB):c.*6842A>G	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339028	20	57026133	20	58451077	339028	336001	rs886056840	
1452	NM_198935.3(SS18L1):c.369T>G (p.Ile123Met)	SS18L1	I123M	not provided	Uncertain significance(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000144009	20	60736629	20	62161573	144009	153740	rs587777633	
1453	NM_198935.3(SS18L1):c.660_668del (p.219_221QGS[1])	SS18L1		not provided	Uncertain significance(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000144010	20	60738612 - 60738620	20	62163556 - 62163564	144010	153741	rs587777634	
1454	NM_198935.3(SS18L1):c.1162C>T (p.Gln388Ter)	SS18L1	Q388*, Q257*	not provided	Uncertain significance(Last reviewed: Jul 1, 2013)	no assertion criteria provided	VCV000144008	20	60749698	20	62174642	144008	153739	rs587777632	
1455	NM_000744.6(CHRNA4):c.1715A>G (p.Gln572Arg)	CHRNA4	Q572R, Q396R	Autosomal dominant nocturnal frontal lobe epilepsy|not provided	Uncertain significance(Last reviewed: Nov 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000205037	20	61981048	20	63349696	205037	203635	rs113794453	
1456	NM_000744.6(CHRNA4):c.1460G>A (p.Arg487Gln)	CHRNA4	R487Q, R311Q	Tobacco use disorder|not provided|Epilepsy, nocturnal frontal lobe, type 1|not specified|Seizures	Conflicting interpretations of pathogenicity(Last reviewed: Feb 21, 2019)	criteria provided, conflicting interpretations	VCV000098318	20	61981303	20	63349951	98318	104211	rs121912280	
1457	NM_000744.6(CHRNA4):c.1459C>T (p.Arg487Trp)	CHRNA4	R487W, R311W	Autosomal dominant nocturnal frontal lobe epilepsy|not provided	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000420221	20	61981304	20	63349952	420221	410794	rs200200279	
1458	NM_000744.6(CHRNA4):c.1060C>T (p.Arg354Cys)	CHRNA4	R354C, R178C	not provided|Autosomal dominant nocturnal frontal lobe epilepsy	Uncertain significance(Last reviewed: Oct 29, 2018)	criteria provided, multiple submitters, no conflicts	VCV000411846	20	61981703	20	63350351	411846	403683	rs758534439	
1459	NC_000020.10:g.(?_56993257)_(57967907_?)dup	VAPB		Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000663415	20	56993257 - 57967907			663415	653639		
1460	NM_000454.4(SOD1):c.-156G>C	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000369360	21	33031927	21	31659614	369360	353589	rs17878855	
1461	NM_000454.4(SOD1):c.-109A>G	SOD1		Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Jul 25, 2018)	criteria provided, multiple submitters, no conflicts	VCV000339660	21	33031974	21	31659661	339660	351578	rs7277748	
1462	NM_000454.4(SOD1):c.-84C>G	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339661	21	33031999	21	31659686	339661	351579	rs573544165	
1463	NM_000454.4(SOD1):c.-83T>C	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339662	21	33032000	21	31659687	339662	346279	rs377427683	
1464	NM_000454.4(SOD1):c.-56T>A	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339663	21	33032027	21	31659714	339663	350534	rs535066119	
1465	NM_000454.4(SOD1):c.-55C>T	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339665	21	33032028	21	31659715	339665	346282	rs16988395	
1466	NM_000454.4(SOD1):c.-55C>G	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339664	21	33032028	21	31659715	339664	351580	rs16988395	
1467	NM_000454.4(SOD1):c.-48T>A	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339666	21	33032035	21	31659722	339666	350535	rs142752986	
1468	NM_000454.4(SOD1):c.-26A>G	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339667	21	33032057	21	31659744	339667	336570	rs571199057	
1469	NM_000454.4(SOD1):c.13G>A (p.Ala5Thr)	SOD1	A4T, A5T	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 21, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014765	21	33032095	21	31659782	14765	29804	rs121912444	
1470	NM_000454.4(SOD1):c.14C>T (p.Ala5Val)	SOD1	A4V, A5V	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014763	21	33032096	21	31659783	14763	29802	rs121912442	
1471	NM_000454.4(SOD1):c.20G>T (p.Cys7Phe)	SOD1	C6F, C7F	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 3, 1999)	no assertion criteria provided	VCV000014771	21	33032102	21	31659789	14771	29810	rs121912448	
1472	NM_000454.4(SOD1):c.37G>C (p.Gly13Arg)	SOD1	G12R, G13R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014780	21	33032119	21	31659806	14780	29819	rs121912456	
1473	NM_000454.4(SOD1):c.49G>A (p.Gly17Ser)	SOD1	G16S, G17S	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014776	21	33032131	21	31659818	14776	29815	rs121912453	
1474	NM_000454.4(SOD1):c.56T>C (p.Ile19Thr)	SOD1	I19T	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Dec 17, 2018)	criteria provided, single submitter	VCV000652612	21	33032138	21	31659825	652612	648885		
1475	NM_000454.4(SOD1):c.59A>G (p.Asn20Ser)	SOD1	N20S	not specified|Amyotrophic lateral sclerosis type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jun 15, 2018)	criteria provided, conflicting interpretations	VCV000516816	21	33032141	21	31659828	516816	507475	rs768029813	
1476	NM_000454.4(SOD1):c.64G>A (p.Glu22Lys)	SOD1	E21K, E22K	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 1, 1994)	no assertion criteria provided	VCV000014773	21	33032146	21	31659833	14773	29812	rs121912450	
1477	NM_000454.4(SOD1):c.66G>A (p.Glu22=)	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339668	21	33032148	21	31659835	339668	350537	rs756458346	
1478	NM_000454.4(SOD1):c.73-108T>A	SOD1		not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Feb 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000440292	21	33035995	21	31663682	440292	433935	rs16988404	
1479	NM_000454.4(SOD1):c.112G>C (p.Gly38Arg)	SOD1	G38R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 25, 2018)	no assertion criteria provided	VCV000549678	21	33036142	21	31663829	549678	540470	rs121912431	
1480	NM_000454.4(SOD1):c.112G>A (p.Gly38Arg)	SOD1	G37R, G38R	Motor neuron disease|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000014752	21	33036142	21	31663829	14752	29791	rs121912431	
1481	NM_000454.4(SOD1):c.115C>G (p.Leu39Val)	SOD1	L38V, L39V	not provided|Amyotrophic lateral sclerosis type 1	Likely pathogenic(Last reviewed: Oct 1, 2018)	criteria provided, single submitter	VCV000014753	21	33036145	21	31663832	14753	29792	rs121912432	
1482	NM_000454.4(SOD1):c.122A>G (p.Glu41Gly)	SOD1	E41G	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000575420	21	33036152	21	31663839	575420	571472	rs1568809149	
1483	NM_000454.4(SOD1):c.124G>A (p.Gly42Ser)	SOD1	G41S, G42S	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Mar 4, 1993)	no assertion criteria provided	VCV000014754	21	33036154	21	31663841	14754	29793	rs121912433	
1484	NM_000454.4(SOD1):c.125G>A (p.Gly42Asp)	SOD1	G41D, G42D	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000014755	21	33036155	21	31663842	14755	29794	rs121912434	
1485	NM_000454.4(SOD1):c.131A>G (p.His44Arg)	SOD1	H43R, H44R	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jun 12, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014756	21	33036161	21	31663848	14756	29795	rs121912435	
1486	NM_000454.4(SOD1):c.137T>G (p.Phe46Cys)	SOD1	F45C, F46C	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 2001)	no assertion criteria provided	VCV000014781	21	33036167	21	31663854	14781	29820	rs121912457	
1487	NM_000454.4(SOD1):c.140A>G (p.His47Arg)	SOD1	H46R, H47R	Amyotrophic lateral sclerosis type 1|not provided	Pathogenic(Last reviewed: Jun 6, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014764	21	33036170	21	31663857	14764	29803	rs121912443	
1488	NM_000454.5(SOD1):c.146A>G (p.His49Arg)	SOD1	H49R	Amyotrophic lateral sclerosis type 1	Likely pathogenic(Last reviewed: Feb 26, 2018)	criteria provided, single submitter	VCV000807693	21	33036176	21	31663863	807693	798767		
1489	NM_000454.4(SOD1):c.148G>A (p.Glu50Lys)	SOD1	E50K	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Jul 12, 2018)	criteria provided, single submitter	VCV000658902	21	33036178	21	31663865	658902	648886		
1490	NM_000454.4(SOD1):c.217G>A (p.Gly73Ser)	SOD1	G72S, G73S	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Dec 9, 1997)	no assertion criteria provided	VCV000014779	21	33038809	21	31666496	14779	29818	rs121912455	
1491	NM_000454.4(SOD1):c.220G>A (p.Gly74Arg)	SOD1	G74R	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Dec 19, 2017)	criteria provided, single submitter	VCV000536143	21	33038812	21	31666499	536143	534335	rs1555836720	
1492	NM_000454.4(SOD1):c.242A>G (p.His81Arg)	SOD1	H80R, H81R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Nov 1, 2002)	no assertion criteria provided	VCV000014782	21	33039573	21	31667260	14782	29821	rs121912458	
1493	NM_000454.4(SOD1):c.253T>G (p.Leu85Val)	SOD1	L84V, L85V	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1995)	no assertion criteria provided	VCV000014775	21	33039584	21	31667271	14775	29814	rs121912452	
1494	NM_000454.4(SOD1):c.256G>C (p.Gly86Arg)	SOD1	G85R, G86R	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 18, 1998)	no assertion criteria provided	VCV000014758	21	33039587	21	31667274	14758	29797	rs121912436	
1495	NM_000454.4(SOD1):c.260A>G (p.Asn87Ser)	SOD1	N87S	Amyotrophic lateral sclerosis type 1	Likely pathogenic(Last reviewed: Jul 11, 2017)	criteria provided, single submitter	VCV000468253	21	33039591	21	31667278	468253	471562	rs11556620	
1496	NM_000454.4(SOD1):c.268G>A (p.Ala90Thr)	SOD1	A90T	not provided|Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: May 24, 2018)	criteria provided, multiple submitters, no conflicts	VCV000567744	21	33039599	21	31667286	567744	575146	rs1568810660	
1497	NM_000454.4(SOD1):c.272A>C (p.Asp91Ala)	SOD1	D90A, D91A	Amyotrophic Lateral Sclerosis, Dominant|Amyotrophic lateral sclerosis type 1|not provided|Amyotrophic lateral sclerosis 1, autosomal recessive	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000014766	21	33039603	21	31667290	14766	29805	rs80265967	
1498	NM_000454.4(SOD1):c.280G>C (p.Gly94Arg)	SOD1	G93R, G94R	Motor neuron disease|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000014784	21	33039611	21	31667298	14784	29823	rs121912437	
1499	NM_000454.4(SOD1):c.280G>T (p.Gly94Cys)	SOD1	G93C, G94C	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Feb 1, 2006)	no assertion criteria provided	VCV000014759	21	33039611	21	31667298	14759	29798	rs121912437	
1500	NM_000454.4(SOD1):c.281G>C (p.Gly94Ala)	SOD1	G93A, G94A	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jul 25, 1997)	no assertion criteria provided	VCV000014760	21	33039612	21	31667299	14760	29799	rs121912438	
1501	NM_000454.4(SOD1):c.289G>A (p.Asp97Asn)	SOD1	D96N, D97N	not provided|Amyotrophic lateral sclerosis 1, autosomal recessive	Uncertain significance(Last reviewed: Nov 20, 2018)	criteria provided, single submitter	VCV000014783	21	33039620	21	31667307	14783	29822	rs121912459	
1502	NM_000454.4(SOD1):c.290A>T (p.Asp97Val)	SOD1	D97V	Amyotrophic lateral sclerosis type 1	Likely pathogenic(Last reviewed: Mar 20, 2014)	criteria provided, single submitter	VCV000692200	21	33039621	21	31667308	692200	679942		
1503	NM_000454.4(SOD1):c.301G>A (p.Glu101Lys)	SOD1	E101K	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic/Likely pathogenic(Last reviewed: Jun 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000574319	21	33039632	21	31667319	574319	573721	rs76731700	
1504	NM_000454.4(SOD1):c.302A>G (p.Glu101Gly)	SOD1	E100G, E101G	Motor neuron disease|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Aug 31, 2016)	criteria provided, single submitter	VCV000014761	21	33039633	21	31667320	14761	29800	rs121912439	
1505	NM_000454.4(SOD1):c.313A>T (p.Ile105Phe)	SOD1	I104F, I105F	Amyotrophic lateral sclerosis 1, autosomal recessive	Pathogenic(Last reviewed: Nov 1, 1995)	no assertion criteria provided	VCV000014767	21	33039644	21	31667331	14767	29806	rs121912445	
1506	NC_000021.9:g.31667335C>T	SOD1	S106L	Amyotrophic lateral sclerosis	Pathogenic(Last reviewed: Sep 18, 2018)	criteria provided, single submitter	VCV000695024	21	33039648	21	31667335	695024	683149		
1507	NM_000454.4(SOD1):c.319C>G (p.Leu107Val)	SOD1	L106V, L107V	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000014757	21	33039650	21	31667337	14757	29796	rs121912440	
1508	NM_000454.4(SOD1):c.338T>C (p.Ile113Thr)	SOD1	I113T	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1997)	no assertion criteria provided	VCV000014762	21	33039669	21	31667356	14762	29801	rs74315452	
1509	NM_000454.4(SOD1):c.341T>C (p.Ile114Thr)	SOD1	I114T	Motor neuron disease|not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Feb 26, 2019)	criteria provided, multiple submitters, no conflicts	VCV000197145	21	33039672	21	31667359	197145	194306	rs121912441	
1510	NM_000454.4(SOD1):c.358-11A>G	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000014778	21	33040773	21	31668460	14778	29817		
1511	NM_000454.4(SOD1):c.358-10T>G	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000014770	21	33040774	21	31668461	14770	29809		
1512	NM_000454.4(SOD1):c.380T>A (p.Leu127Ter)	SOD1	L126*, L127*	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: May 1, 1997)	no assertion criteria provided	VCV000014777	21	33040806	21	31668493	14777	29816	rs121912454	
1513	NM_000454.4(SOD1):c.397_399GAA[1] (p.Glu134del)	SOD1	E134del	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Jun 27, 2018)	criteria provided, single submitter	VCV000576569	21	33040823 - 33040825	21	31668510 - 31668512	576569	573020	rs1568811423	
1514	NM_000454.4(SOD1):c.404G>A (p.Ser135Asn)	SOD1	S134N, S135N	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jan 1, 1997)	no assertion criteria provided	VCV000014774	21	33040830	21	31668517	14774	29813	rs121912451	
1515	NM_000454.4(SOD1):c.416G>A (p.Gly139Glu)	SOD1	G139E	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Aug 28, 2018)	criteria provided, single submitter	VCV000649792	21	33040842	21	31668529	649792	648887		
1516	NM_000454.4(SOD1):c.423T>A (p.Ala141=)	SOD1		not provided|Amyotrophic Lateral Sclerosis, Dominant	Benign/Likely benign(Last reviewed: Nov 28, 2018)	criteria provided, multiple submitters, no conflicts	VCV000339669	21	33040849	21	31668536	339669	351583	rs143100660	
1517	NM_000454.4(SOD1):c.434T>C (p.Leu145Ser)	SOD1	L144S, L145S	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Oct 31, 2018)	criteria provided, multiple submitters, no conflicts	VCV000014768	21	33040860	21	31668547	14768	29807	rs121912446	
1518	NM_000454.4(SOD1):c.435G>C (p.Leu145Phe)	SOD1	L145F	not provided|Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Nov 16, 2018)	criteria provided, multiple submitters, no conflicts	VCV000586637	21	33040861	21	31668548	586637	577887	rs1482760341	
1519	NM_000454.4(SOD1):c.436G>A (p.Ala146Thr)	SOD1	A145T, A146T	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Sep 1, 1995)	no assertion criteria provided	VCV000014769	21	33040862	21	31668549	14769	29808	rs121912447	
1520	NM_000454.4(SOD1):c.443G>A (p.Gly148Asp)	SOD1	G148D	Amyotrophic lateral sclerosis type 1	Likely pathogenic(Last reviewed: Jan 3, 2018)	criteria provided, single submitter	VCV000536142	21	33040869	21	31668556	536142	533771	rs1555836950	
1521	NM_000454.4(SOD1):c.455T>C (p.Ile152Thr)	SOD1	I151T, I152T	Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Jul 1, 1996)	no assertion criteria provided	VCV000014772	21	33040881	21	31668568	14772	29811	rs121912449	
1522	NM_000454.4(SOD1):c.*339C>T	SOD1		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339670	21	33041230	21	31668917	339670	336571	rs17880487	
1523	NC_000022.10:g.(?_24108011)_(24110169_?)dup	CHCD10		Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Oct 13, 2018)	criteria provided, single submitter	VCV000665651	22	24108011 - 24110169	22	23765824 - 23767982	665651	653686		
1524	NC_000022.10:g.(?_24108174)_(24110081_?)dup	CHCHD10		Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Nov 5, 2018)	criteria provided, single submitter	VCV000473419	22	24108174 - 24110081	22	23765987 - 23767894	473419	470842		
1525	NM_213720.3(CHCHD10):c.410G>T (p.Gly137Val)	CHCHD10	G137V, G144V	Myopathy, isolated mitochondrial, autosomal dominant|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Jul 6, 2018)	criteria provided, single submitter	VCV000648284	22	24108213	22	23766026	648284	649209		
1526	NM_213720.3(CHCHD10):c.386T>C (p.Leu129Pro)	CHCHD10	L129P, L136P	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: May 3, 2018)	criteria provided, single submitter	VCV000568579	22	24108338	22	23766151	568579	573279	rs1569149526	
1527	NM_213720.3(CHCHD10):c.377G>A (p.Ser126Asn)	CHCHD10	S126N, S133N	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000640224	22	24108347	22	23766160	640224	649210		
1528	NM_213720.3(CHCHD10):c.349A>T (p.Ser117Cys)	CHCHD10	S117C, S124C	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Aug 2, 2017)	criteria provided, single submitter	VCV000473426	22	24108375	22	23766188	473426	471379	rs931085449	
1529	NM_213720.3(CHCHD10):c.332A>G (p.Asp111Gly)	CHCHD10	D118G, D111G	Myopathy, isolated mitochondrial, autosomal dominant|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Sep 20, 2018)	criteria provided, single submitter	VCV000652408	22	24108392	22	23766205	652408	649211		
1530	NM_213720.3(CHCHD10):c.327C>G (p.Phe109Leu)	CHCHD10	F109L, F116L	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Nov 13, 2017)	criteria provided, single submitter	VCV000540612	22	24108397	22	23766210	540612	534606	rs1438034155	
1531	NM_213720.3(CHCHD10):c.312C>A (p.Tyr104Ter)	CHCHD10	Y104*, Y111*	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Feb 5, 2018)	criteria provided, single submitter	VCV000569761	22	24108412	22	23766225	569761	571718	rs9153	
1532	NM_213720.3(CHCHD10):c.312C>G (p.Tyr104Ter)	CHCHD10	Y104*, Y111*	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Aug 15, 2018)	criteria provided, single submitter	VCV000565755	22	24108412	22	23766225	565755	573956	rs9153	
1533	NM_213720.3(CHCHD10):c.312C>T (p.Tyr104=)	CHCHD10		Spinal muscular atrophy, jokela type|not specified	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000379953	22	24108412	22	23766225	379953	378642	rs9153	
1534	NM_213720.3(CHCHD10):c.286C>A (p.Pro96Thr)	CHCHD10	P96T, P103T	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Benign(Last reviewed: Jul 20, 2017)	criteria provided, single submitter	VCV000473424	22	24108438	22	23766251	473424	469920	rs111677724	
1535	NM_213720.3(CHCHD10):c.276T>A (p.Ala92=)	CHCHD10		Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: May 31, 2018)	criteria provided, single submitter	VCV000567906	22	24108448	22	23766261	567906	573283	rs1252496774	
1536	NM_213720.3(CHCHD10):c.274G>A (p.Ala92Thr)	CHCHD10	A92T, A99T	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Feb 15, 2018)	criteria provided, single submitter	VCV000540611	22	24108450	22	23766263	540611	534085	rs374353973	
1537	NC_000022.10:g.(?_24109551)_(24110169_?)del	CHCHD10		Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000654106	22	24109551 - 24110169	22	23767364 - 23767982	654106	653271		
1538	NM_213720.3(CHCHD10):c.239C>T (p.Pro80Leu)	CHCHD10	P80L	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|not provided	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204292	22	24109583	22	23767396	204292	200688	rs775332895	
1539	NM_213720.3(CHCHD10):c.224G>A (p.Gly75Glu)	CHCHD10	G75E	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Oct 24, 2018)	criteria provided, single submitter	VCV000640736	22	24109598	22	23767411	640736	649212		
1540	NM_213720.3(CHCHD10):c.214G>C (p.Ala72Pro)	CHCHD10	A72P	Myopathy, isolated mitochondrial, autosomal dominant|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Sep 24, 2018)	criteria provided, single submitter	VCV000652563	22	24109608	22	23767421	652563	649213		
1541	NM_213720.3(CHCHD10):c.214G>A (p.Ala72Thr)	CHCHD10	A72T	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Aug 31, 2017)	criteria provided, single submitter	VCV000473421	22	24109608	22	23767421	473421	470915	rs542541060	
1542	NM_213720.3(CHCHD10):c.197G>A (p.Gly66Asp)	CHCHD10	G66D	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Jul 26, 2018)	criteria provided, single submitter	VCV000572533	22	24109625	22	23767438	572533	573958	rs730880031	
1543	NM_213720.3(CHCHD10):c.197G>T (p.Gly66Val)	CHCHD10	G66V	Spinal muscular atrophy, jokela type	Pathogenic(Last reviewed: Apr 14, 2015)	no assertion criteria provided	VCV000180221	22	24109625	22	23767438	180221	178408	rs730880031	
1544	NM_213720.3(CHCHD10):c.196G>A (p.Gly66Ser)	CHCHD10	G66S	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Nov 14, 2018)	criteria provided, single submitter	VCV000655998	22	24109626	22	23767439	655998	649214		
1545	NM_213720.3(CHCHD10):c.190G>A (p.Val64Ile)	CHCHD10	V64I	Myopathy, isolated mitochondrial, autosomal dominant|Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Mar 6, 2018)	criteria provided, single submitter	VCV000573913	22	24109632	22	23767445	573913	573287	rs781304084	
1546	NM_213720.3(CHCHD10):c.176C>T (p.Ser59Leu)	CHCHD10	S59L	Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Pathogenic(Last reviewed: Apr 14, 2015)	no assertion criteria provided	VCV000140745	22	24109646	22	23767459	140745	150458	rs587777574	
1547	NM_213720.2(CHCHD10):c.[43C>A ;172G>C]	CHCHD10	G58R, R15S		Pathogenic(Last reviewed: Jan 1, 2015)	no assertion criteria provided	VCV000180222	22|22	24109650	22|22	23767463	180222	178410|178409	rs730880033|rs730880032	
1548	NM_213720.3(CHCHD10):c.151A>G (p.Thr51Ala)	CHCHD10	T51A	Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Aug 31, 2018)	criteria provided, single submitter	VCV000655109	22	24109671	22	23767484	655109	649215		
1549	NM_213720.3(CHCHD10):c.100C>T (p.Pro34Ser)	CHCHD10	P34S	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|not specified|not provided	Benign/Likely benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000204291	22	24109722	22	23767535	204291	200689	rs551521196	
1550	NM_213720.3(CHCHD10):c.44G>T (p.Arg15Leu)	CHCHD10	R15L	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|not provided	Pathogenic(Last reviewed: Oct 22, 2018)	criteria provided, single submitter	VCV000180220	22	24109778	22	23767591	180220	178407	rs730880030	
1551	NM_001301339.1(CHCHD10):c.[43C>G;172G>C]	CHCHD10	R15G, G58R		Pathogenic(Last reviewed: Apr 14, 2015)	no assertion criteria provided	VCV000204293	22|22	24109779	22|22	23767592	204293	200690|178410	rs730880032|rs730880033	
1552	NM_213720.3(CHCHD10):c.42C>T (p.Ser14=)	CHCHD10		Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000655645	22	24109780	22	23767593	655645	649216		
1553	NM_213720.3(CHCHD10):c.31C>G (p.Arg11Gly)	CHCHD10	R11G	Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Dec 26, 2018)	criteria provided, single submitter	VCV000570385	22	24110031	22	23767844	570385	573964	rs951686050	
1554	NM_213720.3(CHCHD10):c.21C>T (p.Ser7=)	CHCHD10		Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Likely benign(Last reviewed: Jul 21, 2017)	criteria provided, single submitter	VCV000473422	22	24110041	22	23767854	473422	469933	rs984321947	
1555	NM_021076.4(NEFH):c.1200C>T (p.Ala400=)	NEFH		Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000522275	22	29881828	22	29485839	522275	512965	rs165734	
1556	NM_021076.4(NEFH):c.1387G>A (p.Glu463Lys)	NEFH	E463K	not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000066729	22	29885016	22	29489027	66729	77626	rs59371099	
1557	NM_021076.4(NEFH):c.1740C>T (p.Ser580=)	NEFH		Amyotrophic lateral sclerosis type 1|not provided	Benign/Likely benign(Last reviewed: Feb 22, 2019)	criteria provided, multiple submitters, no conflicts	VCV000522276	22	29885369	22	29489380	522276	512966	rs114263951	
1558	NM_021076.4(NEFH):c.1844C>T (p.Pro615Leu)	NEFH	P615L	not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000066733	22	29885473	22	29489484	66733	77630	rs5763269	
1559	NM_021076.4(NEFH):c.1947_1964dup (p.646_651AKSPEK[3])	NEFH		not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Mar 6, 2019)	criteria provided, multiple submitters, no conflicts	VCV000522277	22	29885567 - 29885568	22	29489578 - 29489579	522277	512967	rs147489453	
1560	NM_021076.4(NEFH):c.2015_2056CAGAAGCAAAGTCCCCTGAGAAGGCCAAGTCCCCAGTGAAGG[1] (p.672_685AEAKSPEKAKSPVK[1])	NEFH		not provided|Amyotrophic lateral sclerosis, susceptibility to	risk factor(Last reviewed: Feb 1, 1999)	no assertion criteria provided	VCV000014035	22	29885610 - 29885651	22	29489621 - 29489662	14035	29074	rs606231212	
1561	NM_021076.4(NEFH):c.2232_2249del (p.746_751SPEKAK[1])	NEFH		not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: May 28, 2019)	criteria provided, multiple submitters, no conflicts	VCV000066738	22	29885859 - 29885876	22	29489870 - 29489887	66738	77635	rs59890097	
1562	NM_021076.4(NEFH):c.2232T>C (p.Ala744=)	NEFH		Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Sep 21, 2015)	criteria provided, multiple submitters, no conflicts	VCV000522183	22	29885861	22	29489872	522183	512884	rs165923	
1563	NM_021076.4(NEFH):c.2368_2370del (p.Lys790del)	NEFH	K790del	not provided|Amyotrophic lateral sclerosis type 1	Conflicting interpretations of pathogenicity(Last reviewed: May 28, 2019)	criteria provided, conflicting interpretations	VCV000066740	22	29885997 - 29885999	22	29490008 - 29490010	66740	77637	rs59551486	
1564	NM_021076.4(NEFH):c.2414A>C (p.Glu805Ala)	NEFH	E805A	not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000066741	22	29886043	22	29490054	66741	77638	rs165602	
1565	NM_021076.4(NEFH):c.2784A>G (p.Val928=)	NEFH		not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: Sep 21, 2015)	criteria provided, single submitter	VCV000066743	22	29886413	22	29490424	66743	77640	rs165625	
1566	NM_013444.3(UBQLN2):c.-277A>C	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368603	X	56590030	X	56563597	368603	349006	rs1057515973	
1567	NM_013444.3(UBQLN2):c.-271G>C	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368604	X	56590036	X	56563603	368604	352933	rs1057515974	
1568	NM_013444.3(UBQLN2):c.-163G>T	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368605	X	56590144	X	56563711	368605	339510	rs192883799	
1569	NM_013444.3(UBQLN2):c.-49_-48dupCT	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368606	X	56590251 - 56590252	X	56563818 - 56563819	368606	339513	rs1057515975	
1570	NM_013444.3(UBQLN2):c.243A>G (p.Leu81=)	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368607	X	56590549	X	56564116	368607	349009	rs778382794	
1571	NM_013444.3(UBQLN2):c.968C>T (p.Pro323Leu)	UBQLN2	P323L	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 26, 2017)	criteria provided, single submitter	VCV000539318	X	56591274	X	56564841	539318	534923	rs1555977386	
1572	NM_013444.3(UBQLN2):c.1170C>T (p.Pro390=)	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368608	X	56591476	X	56565043	368608	352934	rs1057515976	
1573	NM_013444.3(UBQLN2):c.1383G>A (p.Gly461=)	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant|not provided	Benign/Likely benign(Last reviewed: Dec 15, 2018)	criteria provided, multiple submitters, no conflicts	VCV000368609	X	56591689	X	56565256	368609	349010	rs142250604	
1574	NM_013444.3(UBQLN2):c.1461C>A (p.Thr487=)	UBQLN2		not specified|not provided|Amyotrophic Lateral Sclerosis, Dominant	Conflicting interpretations of pathogenicity(Last reviewed: Feb 14, 2019)	criteria provided, conflicting interpretations	VCV000260311	X	56591767	X	56565334	260311	257862	rs45559331	
1575	NM_013444.3(UBQLN2):c.1489C>T (p.Pro497Ser)	UBQLN2	P497S	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029951	X	56591795	X	56565362	29951	38906	rs387906710	
1576	NM_013444.3(UBQLN2):c.1490C>T (p.Pro497Leu)	UBQLN2	P497L	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000157594	X	56591796	X	56565363	157594	167455	rs387906709	
1577	NM_013444.3(UBQLN2):c.1490C>A (p.Pro497His)	UBQLN2	P497H	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029950	X	56591796	X	56565363	29950	38905	rs387906709	
1578	NM_013444.3(UBQLN2):c.1516C>A (p.Pro506Thr)	UBQLN2	P506T	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Pathogenic(Last reviewed: Aug 21, 2011)	no assertion criteria provided	VCV000029952	X	56591822	X	56565389	29952	38907	rs387906711	
1579	NM_013444.3(UBQLN2):c.1525C>T (p.Pro509Ser)	UBQLN2	P509S	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000029953	X	56591831	X	56565398	29953	38908	rs387906712	
1580	NM_013444.3(UBQLN2):c.1573C>T (p.Pro525Ser)	UBQLN2	P525S	not provided|Amyotrophic lateral sclerosis|Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Conflicting interpretations of pathogenicity(Last reviewed: Dec 28, 2017)	criteria provided, conflicting interpretations	VCV000029954	X	56591879	X	56565446	29954	38909	rs369947678	
1581	NM_013444.3(UBQLN2):c.1574C>T (p.Pro525Leu)	UBQLN2	P525L	Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Dec 4, 2018)	criteria provided, single submitter	VCV000640437	X	56591880	X	56565447	640437	650131		
1582	NM_013444.3(UBQLN2):c.*16T>C	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368610	X	56592197	X	56565764	368610	352384	rs1057515977	
1583	NM_013444.3(UBQLN2):c.*41G>T	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368611	X	56592222	X	56565789	368611	352935	rs990201540	
1584	NM_013444.3(UBQLN2):c.*881A>G	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368612	X	56593062	X	56566629	368612	352936	rs1057515979	
1585	NM_013444.3(UBQLN2):c.*1170dup	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368613	X	56593350 - 56593351	X	56566917 - 56566918	368613	339516	rs1057515980	
1586	NM_013444.3(UBQLN2):c.*1258C>T	UBQLN2		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000368614	X	56593439	X	56567006	368614	352385	rs41306757	
1587	NEK1, ARG261HIS	NEK1	R261H	AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24	risk factor(Last reviewed: Feb 28, 2018)	no assertion criteria provided	VCV000495119					495119	486673		
1588	NM_033409.3:c.1128-1129_insT	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Mar 17, 2015)	no assertion criteria provided	VCV000210034					210034	206634		
1589	NM_020919.2(ALS2):c.[3565delG];[3624+5G>C]				Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000042162					42162			
1590	NM_020919.2(ALS2):c.[1825_1826insCAGTG];[3529G>T]				Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000042138					42138			
1591	SOD1, IVS4AS, C-G, -304	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Nov 1, 2009)	no assertion criteria provided	VCV000014786					14786	29825		
1592	SOD1, 6-BP DEL, GGACCA	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	VCV000014785					14785	29824		
1593	PRPH, 1-BP DEL, 228C	PRPH		Amyotrophic lateral sclerosis, susceptibility to	risk factor(Last reviewed: Oct 29, 2004)	no assertion criteria provided	VCV000013706					13706	28745		
1594	ATXN2, (CAG)n REPEAT EXPANSION, INTERMEDIATE	ATXN2		Amyotrophic lateral sclerosis 13	risk factor(Last reviewed: Oct 1, 2011)	no assertion criteria provided	VCV000008114					8114	23153		
1595	OPTN, EX5DEL	OPTN		Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: May 13, 2010)	no assertion criteria provided	VCV000007100					7100	22139		
1596	FIG4, IVS11DS, G-T, +5	FIG4		Amyotrophic lateral sclerosis type 11	Pathogenic(Last reviewed: Jan 1, 2009)	no assertion criteria provided	VCV000001727					1727	16766		
